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A growing body of work has examined the contribution of stress to various health 
outcomes.  The hormone cortisol is likely to be a key mediator of the stress response that 
influences multiple physiologic systems that are involved in common chronic disease 
(including the cardiovascular system, immune system, and metabolism).  An individual’s 
daily cortisol response (e.g. waking, peak, end of day) has been shown to be patterned by 
race/ethnicity as well as socioeconomic factors.  Despite evidence of associations of 
various risk factors with cortisol levels, considerable intra- and inter-individual 
variability in cortisol remains unexplained.  Alone or through interaction with 
environmental features, genetic factors could contribute to unexplained variability in 
cortisol concentrations or cortisol responsivity.  Furthermore, genetic factors may 
influence how cortisol affects a wide range of anthropometric, metabolic, and 
inflammatory processes underlying chronic disease risk.  In this dissertation, both a 
candidate gene approach and a genome-wide association study (GWAS) were used to 
investigate genetic contributions to cortisol variability and its physiological effects in a 
sample of European Americans, African Americans, and Hispanic Americans from the 
Multi-Ethnic Study of Atherosclerosis (MESA).  The sequence kernel association test 
(SKAT) was used for gene-based analysis.  In the gene-based analysis of six stress 
response genes, we found that three genes had significant influence on cortisol features in 
[xiv] 
 
at least one ethnic group.  Only one gene, SLC6A4, had a significant effect across ethnic 
groups in meta-analysis (p < 0.05).  Extending this work to an analysis of gene-by-
cortisol interaction effects on BMI, glucose, and inflammatory factors, we used SKAT 
and its interaction based extension to identify four genes (ADRB2, NR3C1, NR3C2, 
SLC6A4) that have significant evidence of interaction with cortisol features to influence 
anthropometric, metabolic, and inflammatory markers (p < 0.05).  In GWAS, we found 
18 regions with p < 1x10
-6
 across the seven cortisol features evaluated in the three ethnic 
groups.  Meta-analyses across ethnic groups identified only five genomic regions with p 
< 5x10
-6
; none of the GWAS results replicated in meta-analysis.  Overall, this dissertation 
illustrates that genetic analyses across ethnic groups can provide new insights into the 




CHAPTER 1  
INTRODUCTION 
Introduction  
Cortisol concentrations follow a strong daily pattern, where they are high upon 
awakening, reach a maximum concentration approximately half an hour later, and slowly 
decrease throughout the rest of the day 
1-3
.  This natural diurnal cycle is affected by 
lifestyle choices and daily stressors, and it impacts many physiological systems that 
underlie the increased risk of chronic diseases.  Numerous studies have explored the 
environmental, psychological, social, and lifestyle factors that influence cortisol levels 
4-7
.  
Only recently have we begun to investigate the potential genetic causes and modifications 
of cortisol and its influence on the pathophysiology of chronic diseases. 
Several population-based studies have linked daily cortisol patterns to health 
outcomes, including elevated blood pressure, abdominal obesity, and coronary 
calcification 
8-10
.  For example, in a sample of 718 middle-aged black and white adults 
from the Coronary Artery Risk Development in Young Adults (CARDIA) study, 
individuals in the quartile with the flattest cortisol declines had higher odds of coronary 
artery calcification compared to individuals in other quartiles after adjustment for 




.  Cortisol concentrations and features of the cortisol curve have also been associated 
with diabetes 
11
 and inflammation 
12
.  Previous work in the Multi-ethnic Study of 
Atherosclerosis (MESA) has shown that persons with higher levels of interleukin-6 have 
a flatter cortisol awakening response and flatter decline 
12
. 
Despite evidence of associations of several demographic factors with cortisol, 




, considerable inter-individual variability in 
cortisol remains unexplained.  This unexplained variation has led to increased interest in 
identifying genetic predictors of cortisol phenotypes 
15
.  Twin studies have shown a range 
of heritability estimates for cortisol concentrations, ranging from 0% to 84% 
16-19
.  
However, in a combined analysis of cortisol heritability in multiple twin studies, basal 
cortisol concentrations had an estimated heritability of 62% 
20
.  These findings imply that 
cortisol concentrations have a genetic component. 
Most of the genetic investigations to date have focused on candidate gene 
associations of cortisol, notably the glucocorticoid receptor gene (NR3C1) and the 
mineralocorticoid receptor gene (NR3C2), which code for receptors involved in the action 
of cortisol on the brain 
21-23
.  Polymorphisms in these receptor genes have been 
inconsistently associated with a range of factors, including body composition and insulin 
response 
22, 24-26
.  While a growing body of work has investigated European American 




The MESA Study is a longitudinal cohort study focused on investigating the early 
stages of atherosclerosis.  This multi-site study began in 2000, and aimed to identify risk 
[3] 
 
factors of subclinical cardiovascular diseases.  The study includes more than 6,000 men 
and women recruited from six communities across the United States.  A wide range of 
demographic, anthropometric, psychosocial, biochemical, physiological, genetic, and 
clinical data has been collected on MESA participants.  In addition to the overarching 
MESA study, the MESA Stress Study collected multiple salivary cortisol samples across 
multiple days in a subsample of 1,000 MESA participants.  The goal of the MESA Stress 
Study was to examine biological stress markers, such as salivary cortisol and salivary 
amylase, in relationship to the other psychosocial and chronic disease risk factors 
collected by MESA. 
 
Psychosocial stress 
The field of public health has been concerned with the impacts of stress for more 
than 50 years.  Over the course of the last half-century the conceptualization of stress has 
grown.  In the 1950’s there was recognition that stress played a role in how the 
relationships between mental and physical health states could lead to clinically apparent 
disease 
27
.  A few years later, there was a shift in the understanding of stress from that of 
a negative force being exerted on the body to a potentially beneficial and necessary force.  
In a 1958 address, Dr. Howard Rusk stated that “[s]tress must be used as a therapeutic 
friend.  It’s a tool in our hands which I think we will find as valuable in the field of aging 
as antibiotics and some of the great new therapeutic treasures of the last decade seem to 





In the last few decades the understanding of stress has expanded.  It is now 
accepted that stress can manifest in multiple forms (acute, chronic) and can be the result 
of many different causes (physiological, psychological, and psychosocial).  An 
individual’s response to a stressor can also take multiple forms.  The first is considered 
the fight-or-flight response, due to the activation of the sympathetic nervous system, 
while the second is an emotional, depressive response as a result of hypothalamic-
pituitary-adrenal (HPA) axis activation 
29
.  The brain is the central hub of this 
multifaceted system.  It is responsible for evaluating whether a given stressor is an acute 
or chronic signal, whether it is positive (health-promoting) or negative (health-
damaging), and then finally for determining the appropriate response to that stressor.  
These responses could involve a wide range of behavioral or physiological reactions and 
recruit participation of the cardiovascular system, immune system, or metabolic system 




Much of the cascade of neurotransmitters in response to a stressor occurs through 
a multi-step pathway, the hypothalamic-pituitary-adrenal (HPA) axis.  Figure 1 briefly 
summarizes this pathway where the hypothalamus sends corticotrophin releasing factor 
(CRF) to the pituitary gland, which releases adrenocorticotrophic hormone (ACTH) that 
is in turn picked up by the adrenal glands, which then release glucocorticoids.  In addition 
to these factors having other peripheral effects, the glucocorticoids are involved in a 
negative feedback loop that turns off the HPA axis once a sufficient response to a stressor 
has occurred 
31
.  In the hypothalamus, the paraventricular nucleus releases CRF, which is 
[5] 
 
transported to the anterior pituitary, where it causes the release of ACTH into the blood 
stream. ACTH stimulates the adrenal cortex to synthesize and release the glucocorticoids 
cortisol (humans) or corticosterone (rodents). Glucocorticoids have a feedback 
mechanism at the level of the hippocampus, hypothalamus and pituitary to dampen 













Cortisol concentrations follow a strong daily pattern, where they are high upon 
awakening, reach a maximum concentration approximately half an hour later, and slowly 
decrease throughout the rest of the day 
1-3
.  Additionally, cortisol concentrations increase 
in response to stressors 
32
.  When exposed to a stressor the body activates the sympathetic 
nervous system and the HPA axis.  Once activated, the HPA axis increases production of 
stress hormones, including cortisol, which are released from the adrenal glands according 
to an ultradian rhythm of hourly pulses 
33
.  After release from the adrenal glands, cortisol 
as a ligand is taken up by receptors in the brain (negative feedback loop).   
In brain tissue, cortisol binds to two types of receptors, the mineralocorticoid 
receptors and the glucocorticoid receptors.  The mineralocorticoid receptors are occupied 
under basal conditions of the ultradian rhythm 
34, 35
.  The glucocorticoid receptors, 
conversely, are only occupied when cortisol concentrations are high (e.g. in response to a 
stressor), due to the lower affinity of these receptors 
36
.  Polymorphisms in both the 
mineralocorticoid and glucocorticoid receptor genes have been associated with stress 
responsivity 
37-39
.  A more detailed discussion of the variation in these and other genes 
follows in a later section (Stress response genes). 
The nature of within-person variability of cortisol concentrations over the day, as 
a result of these basal and stress related releases, requires the use of multiple cortisol 
measurements to completely assess an individual’s pattern. Cortisol concentrations can 
be measured from multiple biological samples: urine, blood serum, and saliva. Urine and 
blood collection methods are difficult in population studies because of the need for 
[7] 
 
repeated collection, making the ability to measure cortisol concentrations in saliva 
samples an ideal alternative 
40
.  Salivary cortisol concentrations have been shown to be 





Epidemiologic studies of cortisol 
In addition to within-person variability of cortisol concentrations throughout the 
day, there is considerable variability in cortisol concentrations across individuals and 
between groups.  In the control groups of a recent meta-analysis of studies comparing 
individuals with depression to non-depressed controls, average morning salivary cortisol 
concentrations ranged from a minimum of 7.8 nmol/L (SD=1.87) to 33.5 nmol/L 
(SD=9.5) while average evening salivary cortisol concentrations ranged from 2 nmol/L 
(SD=1.7) to 9.8 nmol/L (SD=5.9) 
4
.  Age has been shown to be a significant predictor of 
cortisol concentrations, where concentrations increase with age 
13
.  Additionally, there are 
gender differences with respect to salivary cortisol concentrations, with men having 
significantly higher mean levels than women 
14
.  Of particular note among women, 




Moving beyond age and gender, there is evidence that an individual’s daily 
cortisol profile is associated with race/ethnicity as well as socioeconomic factors.  Flatter 
declines later in the day (less steep slopes) have been observed in African Americans and 
Hispanic Americans compared to European Americans.  This pattern of flatter afternoon 
[8] 
 
decline has also been shown in lower socioeconomic status groups relative to higher 
socioeconomic status groups 
5-7
.   It has been suggested that chronic stress may explain 
the flatter declines in these individuals 
44, 45
.  Consistent with this hypothesis, cortisol 
patterns are also affected by psychosocial factors such as clinical hostility 
46
and 
neighborhood sources of stress such as neighborhood violence 
47
.  One of the goals of this 
dissertation is to extend the body of knowledge beyond demographic and psychosocial 
factors to investigate the potential influence of genetic factors on cortisol patterns (Aim 
3). 
 
Stress response genes 
The cortisol metabolic pathway suggests several key genes whose variation could 
affect cortisol levels or responsivity.  In this dissertation we will examine six selected 
stress response genes: a glucocorticoid receptor gene (NR3C1), a mineralocorticoid 
receptor gene (NR3C2), the tyrosine hydroxylase gene (TH), the alpha-2A-adrenergic 
receptor gene (ADRA2A), the beta-2-adrenergic receptor gene (ADRB2), and the 
serotonin transporter gene (SLC6A4).  Details on the chromosomal locations for each of 
these stress response genes can be found in Table 1. 
[9] 
 
Table1: Chromosomal locations of the stress response genes. 
Stress Response Gene Location 
Alpha-2A-adrenergic receptor gene (ADRA2A)  10q24-q26 
Beta-2-adrenergic receptor gene (ADRB2)  5q31-q32 
Glucocorticoid receptor gene (NR3C1) 5q31.3 
Mineralocorticoid receptor gene (NR3C2) 4q31.1 
Serotonin transporter gene (SLC6A4) 17q11.1-q12 
Tyrosine hydroxylase gene (TH)  11p5.5 
 
Mineralocorticoid and glucocorticoid receptors are located in brain tissue, in the 
hippocampus and dentate gyrus, where they influence stress reactivity, both through the 
downstream effects of cortisol and through down regulation of the HPA axis after 
responding to a stressor 
22,23
.  These two receptors operate together in responding to 
cortisol levels 
22
.  More specifically, NR3C2 (mineralocorticoid receptor gene) is 
involved under basal cortisol conditions and the early stages of response to a stressor, 
while NR3C1 is involved when cortisol concentrations are higher, later in the stress 
response after the mineralocorticoid receptors are filled 
21
.  Polymorphisms in both 
receptors have been associated with the stress response 
37-39
, which supports the interplay 
just described.  As a specific example, in the glucocorticoid receptor gene a well-studied 
SNP, N363S (an amino acid substitution from asparagine to serine; minor allele 
frequency 3%-7% 
48




The tyrosine hydroxylase (TH) gene, the alpha-2A-adrenergic receptor gene 
(ADRA2A) and the beta-2-adrenergic receptor gene (ADRB2) were selected as stress 
response candidate genes given prior work demonstrating associations between 
[10] 
 
polymorphisms in these genes and stress responsivity.  Tyrosine hydroxylase is involved 
in catecholamine biosynthesis 
49
.  In response to a stressor, catecholamine synthesis is up-
regulated as a result of tyrosine hydroxylase (TH) transcription 
50
.  Genetic 
polymorphisms of TH have been previously associated with catecholamine excretion 
51
 as 
well as hemodynamic responses to stress 
51, 52
, another demonstration of how stress has 
downstream implications on the cardiovascular system.   
The two adrenergic receptor genes also have hemodynamic implications. Located 
in the brain stem, alpha-2 adrenergic receptors impact blood vessels through the release 
of noradrenaline and adrenaline 
53
. Polymorphisms of this gene (a restriction fragment 
length polymorphism, resulting in a 6.3- or 6.7-kb allele, with the shorter allele being the 
minor allele) have been associated with the response to environmental stressors 
54
.  
Vasodilation occurs when adrenaline fills beta-2 adrenergic receptors, which can offset 
the hypertensive effects induced by the sympathetic nervous system in response to 
stressors 
55
.  Polymorphisms of ADRB2, the most functionally relevant being Arg16/Gly, 
have been previously shown to be related to blood pressure under conditions of physical 
and mental stress 
56
. 
The serotonin transporter gene (SLC6A4 or 5-HTT) gained widespread 
recognition after demonstration of gene-by- psychological stressor interaction.  However, 
difficulties with replication of promoter region (designated 5-HTTLPR)  polymorphisms 
demonstrating interaction effects with social and psychological stressors 
57-61
 has led to 
the hypothesis 5-HTTLPR may more generally have implications for stress responsivity 
through serotoninergic actions 
62
, rather than having specific implications for psychiatric 
[11] 
 
outcomes, which was the focus of the original research.  This hypothesis of the promoter 
region polymorphism conferring increased stress responsivity or susceptibility has been 
supported by brain imaging studies 
63
.  It has been suggested that serotoninergic activity 
may be related to stress responsivity through activation of the sympathetic nervous 
system 
64
.  Additionally, the 5-HTTLPR polymorphisms have also been shown to be 




Biological mechanisms linking stressors and chronic disease risk factors 
The pathway through which stress has downstream impacts on chronic disease 
risk factors involves the activation of the HPA axis.  Cushing’s syndrome, which is the 
results of chronic hypercortisolism, has a variety of anthropometric and metabolic 
characteristics, which include altered fat distribution as well as glucose intolerances and 
diabetes 
65
.  Even under less extreme circumstances, cortisol concentrations influence 
these anthropometric and metabolic systems.  Under conditions of chronic stress, which 
would result in prolonged exposure to increased circulating stress hormones and even 
HPA axis feedback dysregulation, the implications for glucose metabolism and 
anthropometric consequences may be more pronounced 
22, 29
.   
Beyond Cushing’s syndrome, cortisol levels have been previously associated with 
obesity 
29, 66, 67
 as well as diabetes-related outcomes 
8, 68-70
; however, findings have not 
always been consistent 
71, 72
.  There are a number of possible reasons for the inconsistent 
findings.  First, studies are generally limited in sample size.  Second, studies are often 
limited by the available cortisol measures, perhaps with samples collected only for one 
[12] 
 
day or for only one point in time (e.g. wakeup concentrations).  The lack of large, 
population-based samples limit the generalizability of findings and the restricted 
availability of cortisol measures throughout the day limit the interpretation of 
associations with anthropometric and metabolic factors. 
In addition to anthropometric and metabolic risk factors, inflammatory factors are 
also of interest.  There has been recent evidence that stress, particularly chronic stress, 
has implications for inflammatory systems, resulting in increased inflammatory marker 
concentrations 
73-75
.  Two recent studies have shown that chronic stress results in up-
regulation of inflammatory responses, even when cortisol concentrations are not 
heightened 
76, 77
.  The work on anthropometric, metabolic, and inflammatory factors 
combined suggests that cortisol concentrations do not have to be extreme to have 
downstream implications on chronic disease risk factors.   
In this dissertation features of daily cortisol profiles as well as a wealth of 
epidemiologic data from a sample of European American, African American, and 
Hispanic American participants in the MESA Stress Study were used to examine gene-
level associations between the known stress response genes and cortisol features (Chapter 
3), assess the influence of cortisol and known stress response genes on anthropometric, 
metabolic, and inflammatory factors (Chapter 4) and identify novel genome-wide loci 





STUDY POPULATION AND VARIABLE MEASUREMENTS 
 
Study Population 
The MESA Study 
The Multi-Ethnic study of Atherosclerosis (MESA) is a longitudinal cohort study 
focused on investigating the early stages of atherosclerosis.  This multisite study began 
participant recruitment in 2000 from six communities across the United States: 
Baltimore, MD; Chicago, IL; Forsyth, NC; Los Angeles, CA; New York, NY; and St. 
Paul, MN.  In order to be eligible to participate in the MESA Study, prospective 
participants had to be two criteria: be 45-84 years of age and free from history of 
cardiovascular disease.  At baseline, there were a total of 6,814 eligible men and women 
enrolled.  The MESA Study was designed to be a multi-ethnic study; as such an equal 
number of men and women from at least two ethnic groups, with a target of 
approximately 1,100 participants, were recruited from each of the six communities.  
Multiple ethnic groups were recruited at each site in order to minimize confounding of 
ethnicity by site.  Due to the variation in source population size and ethnic composition, a 
probability-based sample of participants was selected to achieve the desired age, gender, 
and ethnic group samples needed to reach an adequate number of new cardiovascular 
disease (CVD) events and to establish associations of risk factors with CVD events.  A 
[14] 
 
variety of population-based recruitment approaches developed by each field center were 
used to create this sample (e.g. lists of area residents, random digit dialing, etc.).  
 Baseline examinations occurred from 2000 to 2002 and four follow-up 
examinations have occurred.  Each examination consisted of questionnaire completion (in 
English, Spanish, or Chinese), a blood draw, anthropometric measurements, blood 
pressure measurement, and assessment of subclinical cardiovascular disease (Table 2).  In 
an effort to minimize loss to follow-up, participants were contacted every nine to 12 
months for information on cardiovascular endpoints, including diagnosis of new 
conditions, hospitalizations, treatments, interventions and behavioral changes in risk 














Exam component Exam 1 Exam 2 Exam 3 Exam 4 Exam 5 
Year 2001* 2003 2004 2006 2011 
Subclinical disease X X X X X 
Anthropometry X X X X X 
Blood Pressure X X X X X 
Phlebotomy X X X X X 
Questionnaires          
     SES X X X X X 
     Medical History X X X X X 
     Medications X X X X X 
     Diet X       X 
     Physical Activity X X X   X 
     Psychosocial X X X X X 




The MESA Stress Study 
In addition to the overarching MESA study an ancillary study, the MESA Stress 
Study, collected detailed stress hormone data, including multiple salivary cortisol 
samples over multiple days (see details below), on a subsample of 1002 MESA 
participants.  MESA Stress Study participants were recruited from the New York and Los 
Angeles sites.  The MESA Stress Study data collection occurred from 2004 to 2006, 
during the second and third follow-up examinations of the MESA cohort.  Participants for 
the MESA Stress Study were African Americans, European Americans, and Hispanic 
Americans and were enrolled as they presented for follow-up, until approximately 500 
participants were recruited at each of the two locations.  Information on age, gender and 
race/ethnicity was obtained from all MESA participants at baseline. Race and 
ethnicity was characterized using participants’ responses to questions modeled on the 
year 2000 census. Participants were classified as Hispanic, non-Hispanic white and 
non-Hispanic black. Basic demographic and health status information on the 1002 Stress 









      Columbia 52.2% 
      UCLA 47.8% 
Age  
      45-54 29.9% 
      55-64 27.7% 
      65-74 30.3% 
      75-84 12.1% 
Race  
      European American 18.6% 
      African American 28.6% 
      Hispanic American 52.8% 
Gender  
      Male 47.6% 
      Female 52.4% 
Education Level  
      Less than High School 27.0% 
      Completed High School 20.2% 
      Some College 29.7% 
      Bachelor’s or higher 23.2% 
Income  
      < $20,000 29.3% 
      $20,000-34,999 27.5% 
      $35,000-$49,999 16.5% 
      $50,000 or higher 26.8% 
Percent Current Smokers 11.3% 
Percent Diabetic 13.5% 
Body Mass Index (BMI) >=30 36.7% 
 
Compared to other African American, European American, and Hispanic 
American participants at the New York and Los Angeles Field Centers, there was a 
smaller proportion of Stress Study participants in the oldest age category of 75 years or 
older (18.2% overall versus 12.1% in the Stress Study).  There were also slightly more 
males in the Stress Study (47.6% versus 44.7%), and more Stress Study participants had 
[17] 
 
completed at least some college (29.7% versus 23.9%).  Stress Study participants had a 
higher prevalence of obesity (BMI >=30) (36.7% versus 33.3%) and a lower prevalence 
of Diabetes (13.5% versus 17.6%). 
 
Cortisol Samples and Cortisol Features 
Daily Salivary Cortisol Samples 
Each MESA Stress Study participant was given detailed instructions on the 
collection of daily salivary cortisol samples.  Each participant was to collect six saliva 
samples per day over three consecutive weekdays, for a maximum of 18 samples per 
participant, using Salivette collection tubes.  The samples were to be taken using the 
following schedule: the first sample taken upon waking and before getting out of bed 
(Sample 1); the second sample taken 30 minutes later (Sample 2); the third sample at 
10:00am (Sample 3); the fourth sample at 12:00 noon or before lunch, whichever came 
first (Sample 4); the fifth sample at 6:00pm or before dinner, whichever came first 
(Sample 5); the sixth sample at bedtime (Sample 6).  Each Salivette collection tube was 
equipped with a time tracking device on the cap (track-caps), which recorded the time 
when the swabs were removed for sample collection.  Participants were aware of the time 
tracking device, and earlier work has shown that knowledge of the time tracking device 
improves sample collection compliance 
79
.   Saliva samples were stored at -20 degrees 
Celsius until being prepared for assay.  Frozen samples were thawed and centrifuged at 
3000 rmp for 3 minutes before cortisol levels were determined using a chemi-
[18] 
 
luminescence assay with a high sensitivity of 0.16 ng/mL (IBL – Hamburg, Germany).  
Intra- and inter-assay coefficients of variation were <8%. 
Figure 2 shows the distribution of the recorded time of each sample collected, 
relative to time since wakeup.  The initial peak along the y-axis represents the number of 
samples taken at wakeup.  The second peak should have been at 30 minutes after wakeup, 
however note that there is more of a cluster from 30 minutes to an hour and a half after 
wakeup.  The first mode from approximately an hour and a half to 8 hours after wakeup, 
captures the 10:00am and lunchtime samples, while the second and third modes capture 
dinner and bedtime samples, respectively. 
 
 




The cortisol profile has a diurnal shape, rising and falling during the course of the 
day.  In general, cortisol concentrations are high upon awakening (1
st
 sample) and reach a 
peak approximately 30 minutes later (2
nd





 samples, after which the declining rate gradually flattens out 
through the 6
th
 samples.  Raw cortisol sample concentrations were measured in nmol per 
liter 
80
.  As a data preprocessing step, cortisol concentrations were log-transformed to 
more closely approximate a normal distribution 
5, 12, 80
.  Figure 3 shows the median log-
transformed cortisol concentration, in time since wakeup.  Median log-transformed 
cortisol concentrations among MESA Stress participants follow the expected pattern, 
fairly high at wakeup, peaking shortly thereafter, and then declining throughout the day.  
From hours 16 to 19 after wakeup concentrations plateau, then begin to climb again.  
When referencing cortisol concentrations from here forward, we mean the log-
transformation concentrations, unless otherwise noted. 
 
Cortisol Features 
Specifically for these analyses, several cortisol features were computed: Wakeup, 
Bedtime, Cortisol awakening response (CAR), Area under the curve (AUC), Early 
Decline Slope, Late Decline Slope, and Overall Decline Slope.  Figure 4 is graphical 
representation of these features.  The Peak measurements were used for feature 
calculation, but were not used in analysis.  Table 4 provides a description of the features 




Figure 3: Median log-transformed salivary cortisol concentration across three days (n=16,342 

































AUC 16hr = CAR AUC + Early Decline AUC + Late Decline AUC
 
Figure 4: Representation of the diurnal cortisol curve describing the cortisol features of interest.  
For these analyses we specifically used Wakeup, Bedtime, Cortisol awakening response (CAR), 
Area under the curve (AUC) from 0-16 hours, Early Decline Slope, Late Decline Slope, and 
Overall Decline Slope. 
[21] 
 
Table 4: Features of the diurnal cortisol curve.  Cortisol concentrations were log-transformed. 
 
Time point specific cortisol features, Wakeup and Bedtime, were created by 
taking the average of the log-transformed time point specific cortisol measurement for an 
individual across all three days of cortisol sample collection.  Averages were created 
across all available days of data, such that Wakeup or Bedtime values were considered 
missing if there were no available Wakeup or Bedtime measurements for an individual 
across all three days.   
The cortisol awakening response is the slope between Sample 2 and Sample 1.  
The Cortisol awakening response variable (CAR) is the average of the three days’ slopes.  
If either Sample 1 or Sample 2 for a given day is missing, then that days’ CAR is then 
missing.  Based on the cortisol sampling protocol, Sample 2 was supposed to be taken 
~30 minutes after wakeup.  However, if Sample 2 was taken more than one hour after 
wakeup, it was considered missing.  The average CAR was taken over the days with 
CAR available, such that average CAR is only considered missing if CAR was not 




Average cortisol concentration from wakeup for an 
individual (Sample 1). 
Bedtime 
Average cortisol concentration at bedtime for an individual 
(Sample 6). 
Area  
Area under the curve 
(AUC) 
Standardized AUC  for the interval  0hr-16hr since wakeup 




The average difference in cortisol concentrations between 
the peak and wakeup measurements (Sample 2 – Sample 1). 
Early Decline Slope 
(EDSlope) 
The slope from 0.5 hours and 2 hours since wakeup pooled 
across all days for an individual. 
Late Decline Slope 
(LDSlope) 
The slope from 2 hours to 16 hours since wakeup pooled 
across all days for an individual 
Overall Decline Slope 
(ODSlope) 
The overall decline slope ignoring the peak value from 
wakeup to bedtime pooled across all days for an individual. 
[22] 
 
available for all the three days.  Missingness for CAR is mainly due to compliance issues 
with the timing of Sample 2 collection. 
An area under the curve measure was calculated for each day of cortisol 
availability, and the three days were averaged together to create AUC.  For the daily area 
under the curve calculations, the trapezoid rule was used to estimate the area beneath the 
cortisol curve for an individual.  Dividing the area estimate by the length of the time 
period for which the estimate was calculated, which was 16 hours, was used to 
standardize this area estimate.  The standardized area measure can be interpreted as the 
average log(cortisol) concentration during the interval from wakeup to 16 hours later. 
Determination of the 16 hour window that was used for the AUC calculations 
varied depending on the timing of sample collection for an individual participant.  If 
Sample 5 was taken within the 16-hour window, then Sample 5 and Sample 6 were 
connected by a straight line that was used to predict the log(cortisol) concentration at 16 
hours after wakeup. If Sample 5 was taken later than 16 hours since wakeup, then 
Samples 4 and 5 were connected by a straight line and used to predict the log(cortisol) 
concentration at 16 hours after wakeup.  In the situation where less than 3 samples were 
collected on a given day, or both of the two samples needed to predict log(cortisol) at 16 
hours since wakeup were missing, then the daily area estimate was considered missing.  
The averaged AUC measure used for analysis was considered missing only if all three 
daily area estimates were missing.   
Individuals who stayed awake for longer hours had a wider range of the cortisol 
curve captured than those individuals who stayed awake for fewer hours.  Specifically for 
[23] 
 
the computation of the slope features, combining these different bedtime patterns 
prohibits a true representation of the declining trend by underestimating the extent of 
decline as a result of including the rise in concentrations seen on the right hand side of 
the x-axis is Figure 3. Therefore, in order to more accurately compute the declining 
slopes, samples taken after 16 hours since wake up were excluded.  In choosing the cutoff 
of 16 hours we are not losing a substantial amount of information as only approximately 
8% of samples were taken after the 16-hour window.  
The Early Decline Slope (EDSlope) is the difference between Sample 2 and 
Sample 3 pooled across all days for an individual.  Piecewise linear model, shown below, 
was used to estimate the slope between Sample 2 and Sample 3 by pooling across all 
available days of cortisol collection: 
 
where,  is the log(cortisol) concentration and   is the time of sample collection.  The 
estimate of slope was ,which is in the units of log(cortisol) concentration 
per hour.  EDSlope was only considered missing if the piecewise linear model could not 
be fit due to design matrix singularity or the value was identified as an outlier.  The 
Rosner Extreme Studentized Deviate method was used to identify and remove outlying 
observations 
81
.  There were 10 outliers removed from EDSlope. 
The Late Decline Slope (LDSlope) is the difference between 2 hours and 16 hours 
after wakeup pooled across all available days of cortisol collection.  The estimate of the 
slope was obtained by fitting a simple linear model:  
[24] 
 
where,  is the log(cortisol) concentration,  is the time of sample collection, and the 
slope is  (log(cortisol) concentration per hour).  LDSlope could not be defined when 
there were fewer than two data points available after 2 hours since wakeup across all days 
for an individual, and therefore was considered missing. The Rosner Extreme Studentized 
Deviate method was also used for LDSlope to identify and remove outlying observations 
81
.  There were 10 outliers removed LDSlope 
The Overall Decline Slope (ODSlope) is the difference between wakeup and 16 
hours after wakeup, pooled across all available days of cortisol collection.  For this 
feature we were interested in the overall difference between where and individual’s 
concentration starts at wakeup and their end of the day measurement, and therefore 
ignored the influence of other time points, specifically the Peak, which have been 
captured in the other features.  The estimate of the slope was obtained by fitting a simple 
linear model:  
where,  is the log cortisol concentration,  is the time of sample collection, and the 
slope is (log(cortisol) concentration per hour).  If after excluding the Peak value 
there were fewer than two data points for an individual, then ODSlope was defined as 
missing.   
 Details on the number of total missing or removed observations are available in 
Table 5.    The CAR has the greatest number of missing observations.  Most of this 
missingness is due to sampling compliance issues with cortisol Sample 2.  Based on the 
sampling protocol Sample 2 was to be taken at ~30 minutes after wakeup.  Often, this 
sample was taken an hour or more after wakeup.  At that time interval, the concentration 
[25] 
 
captured by the sample would no longer be representative of the maximum concentration 
for that day, as the cortisol curve quickly declines from the peak.  Therefore, when 
Sample 2 was taken too late it was no longer representative of the peak and was defined 
as missing.  With the exception of the CAR, overall missingness for each cortisol feature 
is at roughly 3% or less. 
The distributions of the cortisol features, by ethnic group, are represented in Table 
6.  The cortisol feature means varied across ethnic groups. Wakeup means ranged from 
2.38 to 2.58, Bedtime means ranged from 0.49 to 0.98, CAR means ranged from 0.35 to 
0.45, AUC means ranged from 1.46 to 1.64, EDSlope means ranged from -0.53 to -0.40, 
LDSlope means ranged from -0.13 to -0.10, and ODSlope means ranged from -0.12 to -
0.10.  The ANOVA procedure was used to assess whether or not the mean for each 
cortisol feature differed across the ethnic groups.  There was a statistically significant 
difference in means across the ethnic groups for all cortisol features except CAR.  
Figures 5-7 demonstrate the distributions of the cortisol features, by ethnic group, and 
their approximation of the normal distribution.  Overall, the log-transformed features 
have a centered, bell-shaped distribution.  The Hispanic American features, in general, 
have longer tail distributions than the other ethnic groups. 
[26] 
 
Table 5: Number (percentage) of missing cortisol feature observations. 
 Cortisol Feature  
 Wakeup Bedtime CAR AUC EDSlope LDSlope ODSlope Total 
Total Missing 9 (0.98%) 13 (1.42%) 68 (7.42%) 23 (2.51%) 28 (3.05%) 7 (0.76%) 4 (0.44%) 917 
Race         
African Americans 1 (0.42%) 3 (1.27%) 13 (5.49%) 7 (2.95%) 6 (2.53%) 1 (0.42%) 1 (0.42%) 237 
European Americans 4 (2.22%) 4 (2.22%) 10 (5.56%) 4 (2.22%) 7 (3.89%) 3 (1.67%) 1 (0.56%) 180 
Hispanic Americans 4 (0.80%) 6 (1.20%) 45 (9.00%) 12 (2.40%) 15 (3.00%) 3 (0.60%) 2 (0.40%) 500 
Gender         
Male 4 (0.90%) 6 (1.35%) 32 (7.21%) 12 (2.70%) 13 (2.93%) 3 (0.68%) 2 (0.45%) 444 




Table 6: Distributions of cortisol features by ethnic group. 
 African Americans European Americans Hispanic Americans ANOVA 
Cortisol Feature N Mean (SD) N Mean (SD) N Mean (SD) p-value 
Wakeup 214 2.38 (0.55) 166 2.58 (0.54) 450 2.38 (0.58) 0.0002 
Bedtime 212 0.98 (0.74) 166 0.78 (0.77) 448 0.49 (0.84) <0.0001 
CAR 203 0.35 (0.46) 160 0.45 (0.46) 412 0.37 (0.52) 0.17 
AUC 209 1.60 (0.42) 166 1.64 (0.43) 442 1.46 (0.51) <0.0001 
EDSlope 209 -0.42 (0.44) 163 -0.53 (0.35) 433 -0.40 (0.44) 0.003 
LDSlope 211 -0.10 (0.06) 164 -0.12 (0.06) 447 -0.13 (0.06) <0.0001 
ODSlope 214 -0.10 (0.06) 169 -0.12 (0.07) 452 -0.12 (0.06) <0.0001 













Figure 7: Distributions of log-transformed cortisol features among Hispanic Americans.  
[30] 
 
Given that the cortisol features are derived from the same data points, it was 
expected that some of the features would be highly correlated.  Pearson’s product 
moment correlation coefficients were used to assess the correlation between features 
(Table 7).  The most highly correlated features were Bedtime with AUC, and LDSlope 
with ODSlope, which ranged from a correlation of approximately 0.6 to 0.8 depending on 
ethnic group.  The bolded correlations coefficients represent significant (p<0.05) 
correlations between any two cortisol features.  In those instances where the correlation 
coefficient is not significant, generally those cortisol features were derived from different 
data points.  Take the correlation between Bedtime and EDSlope.  Unlike the other 
decline slope features which are anchored by end of day cortisol concentrations,  
EDSlope is not computed using Bedtime concentrations, which explains why the two 




Table 7: Pearson’s product moment correlation coefficients between cortisol summary features. 
Panel A: Combined ethnic groups 
  Wakeup Bedtime CAR AUC EDSlope LDSlope ODSlope 
Wakeup 1.00       
Bedtime 0.39 1.00      
CAR -0.44 -0.14 1.00     
AUC 0.49 0.74 -0.01 1.00    
EDSlope -0.24 -0.05 -0.29 0.08 1.00   
LDSlope 0.08 0.50 -0.08 0.35 -0.39 1.00  
ODSlope -0.34 0.43 0.18 0.39 0.04 0.72 1.00 
        
Panel B: African Americans 
  Wakeup Bedtime CAR AUC EDSlope LDSlope ODSlope 
Wakeup 1.00       
Bedtime 0.38 1.00      
CAR -0.30 -0.13 1.00     
AUC 0.51 0.66 -0.07 1.00    
EDSlope -0.36 -0.13 -0.30 0.05 1.00   
LDSlope 0.10 0.46 -0.08 0.30 -0.38 1.00  
ODSlope -0.41 0.36 0.04 0.35 0.19 0.60 1.00 
        
Panel C: European Americans 
  Wakeup Bedtime CAR AUC EDSlope LDSlope ODSlope 
Wakeup 1.00       
Bedtime 0.23 1.00      
CAR -0.58 -0.08 1.00     
AUC 0.39 0.66 0.04 1.00    
EDSlope -0.18 0.01 -0.20 0.19 1.00   
LDSlope -0.05 0.38 -0.05 0.28 -0.35 1.00  
ODSlope -0.40 0.30 0.31 0.19 0.02 0.78 1.00 
        
Panel D: Hispanic Americans 
  Wakeup Bedtime CAR AUC EDSlope LDSlope ODSlope 
Wakeup 1.00       
Bedtime 0.46 1.00      
CAR -0.47 -0.16 1.00     
AUC 0.51 0.78 -0.01 1.00    
EDSlope -0.18 -0.02 -0.30 0.09 1.00   
LDSlope 0.11 0.52 -0.08 0.37 -0.42 1.00  
ODSlope -0.29 0.47 0.21 0.48 -0.02 0.74 1.00 
        
Bold = p<0.05 
[32] 
 
Given that the previous literature has shown associations between cortisol features 
and age, sex, socioeconomic status, and race/ethnicity, each of these characteristics was 
examined across the seven cortisol features used in this analysis.  First the univariate 
associations between age, sex, and education were examined (Table 8).  We used an 
individual’s highest completed education level, which was assessed at the baseline 
MESA exam, as a proxy for socioeconomic status.  With the ethnic groups combined, age 
at baseline is a significant (p<0.05) predictor for five of the seven cortisol features.  Sex 
was a significant predictor for only AUC and EDSlope, with males having lower mean 
concentrations compared to females.  Education was a significant (p<0.05) predictor of 
three cortisol features, Wakeup, Bedtime, and EDSlope. 
In examining the associations between the different ethnic groups and the cortisol 
features (Table 9), the effects for African Americans and Hispanic Americans are 
presented relative to the European Americans (reference group).  Overall, there is a 
significant difference between European Americans and the minority racial/ethnic groups 
with the cortisol features.  Given the strength of many of the associations between 
racial/ethnic group and the cortisol features, the analyses for this dissertation will be 
racial/ethnic group specific.   
In examining the multivariable associations of age and sex with the cortisol 
features stratified by race (Table 10), age is a significant (p<0.05) predictor for nearly 
every feature across the ethnic groups.  Sex was less commonly a significant predictor in 
these multivariable models. Education was not a significant predictor for any of the 
cortisol features.  While previous work has shown that cortisol concentrations vary based 
[33] 
 
on oral contraceptive use, among the MESA Stress participants there were only seven 
reports of oral contraceptive or hormone replacement therapy use.  Therefore, use of 
hormones does not substantially contribute as a source of variation.  
 
Table 8: Univariate associations with cortisol features. 
Cortisol Feature 
N Age Sex Education 
 β p-value β p-value β p-value 
Wakeup 830 0.009 <0.0001 -0.020 0.62 0.022 0.009 
Bedtime 826 0.023 <0.0001 0.027 0.64 0.025 0.04 
CAR 775 -0.003 0.08 0.062 0.08 0.003 0.70 
AUC 817 0.012 <0.0001 -0.106 0.002 0.014 0.05 
EDSlope 805 0.001 0.70 -0.120 <0.0001 -0.013 0.03 
LDSlope 822 0.001 0.002 0.002 0.66 0.0008 0.41 




Table 9: Associations of race with cortisol features. 
Race
a
 Wakeup Bedtime CAR AUC 
β  p-value β  p-value β  p-value β  p-value 
AFA -0.201  0.0006 0.207  0.01 -0.094  0.07 -0.040  0.41 
HIS -0.207  <0.0001 -0.283  0.0001 -0.073  0.11 -0.182  <0.0001 
 EDSlope LDSlope ODSlope   
 β  p-value β  p-value β  p-value   
AFA 0.112  0.01 0.015  0.02 0.016  0.01   
HIS 0.134  0.0006 -0.012  0.04 -0.007  0.20   
a. European American reference group. 
[34] 
 
Table 10: Racial/ethnic group stratified multivariable associations of age, sex, and education with 
cortisol features. 
 African Americans 
Cortisol 
Feature 
N Age Sex Education R
2
 
 β p-value β p-value β p-value  
Wakeup 214 0.009 0.02 0.017 0.83 0.007 0.74 0.025 
Bedtime 212 0.011 0.04 0.005 0.96 0.001 0.70 0.021 
CAR 203 -0.0009 0.79 0.102 0.12 -0.010 0.56 0.014 
AUC 209 0.009 0.003 -0.060 0.30 -0.011 0.46 0.058 
EDSlope 209 -0.004 0.26 -0.196 0.001 0.000002 0.99 0.057 
LDSlope 211 0.0006 0.21 0.010 0.26 -0.0001 0.96 0.015 
ODSlope 214 0.00006 0.88 -0.005 0.52 -0.002 0.38 0.006 
 European Americans 
Cortisol 
Feature 
N Age Sex Education R
2
 
 β p-value β p-value β p-value  
Wakeup 166 0.002 0.58 0.0002 0.99 -0.005 0.81 0.003 
Bedtime 166 0.023 <0.0001 0.089 0.45 0.011 0.69 0.095 
CAR 160 -0.004 0.31 0.069 0.35 0.021 0.25 0.022 
AUC 166 0.006 0.07 -0.102 0.13 0.017 0.29 0.041 
EDSlope 163 0.006 0.02 -0.113 0.04 0.001 0.94 0.059 
LDSlope 164 0.0003 0.55 -0.013 0.20 -0.0007 0.79 0.013 
ODSlope 169 0.0007 0.24 -0.019 0.09 0.0001 0.96 0.027 
 Hispanic Americans 
Cortisol 
Feature 
N Age Sex Education R
2
 
 β p-value β p-value β p-value  
Wakeup 450 0.013 <0.0001 -0.035 0.52 0.024 0.08 0.050 
Bedtime 448 0.028 <0.0001 -0.016 0.83 -0.007 0.72 0.107 
CAR 412 -0.005 0.08 0.040 0.45 -0.011 0.38 0.011 
AUC 442 0.015 <0.0001 -0.139 0.003 -0.003 0.78 0.102 
EDSlope 433 0.001 0.58 -0.091 0.03 -0.011 0.31 0.013 
LDSlope 447 0.0009 0.006 0.001 0.82 -0.001 0.46 0.019 
ODSlope 452 0.0008 0.004 -0.009 0.11 -0.003 0.05 0.033 




Genotype data included both measured and imputed SNPs available through 
participation in MESA SHARe (SNP Health Association Resource) project.   Under the 
SHARe project, genome-wide genotyping was obtained using the Affymetrix Genome-
Wide Human SNP Array 6.0 platform.  Imputation to HapMap was completed at the 
MESA Genetics Centers using the IMPUTE2 
82
 program with the following reference 
panels:  the HapMap Phase I and II, the human genome reference sequence (NCBI Build 
36).  The HapMap project is based on ethnic specific reference panels, composed of the 
following groups: Yoruba in Ibadan, Nigeria (abbreviation: YRI), Japanese in Tokyo, 
Japan (abbreviation: JPT), Han Chinese in Beijing, China (abbreviation: CHB), CEPH 
(Utah residents with ancestry from northern and western Europe) (abbreviation: CEU).  
Imputation for African Americans and Hispanic Americans was performed using the 
CEU+YRI+CHB+JPT reference panels (release #22). Imputation for European 
Americans was performed using only the CEU reference panel (release #24).  All 
imputed and genotyped SNPs were aligned to the “+” strand of the human genome 
reference sequence (NCBI Build 36). 
In order to account for population structure and admixture within MESA samples, 
principal components were extracted from genome-wide data from MESA Classic 
participants, in each ethnic group separately.  The multivariable associations of the top 10 
principal components for each cortisol feature, stratified by ethnic group, are presented in 
Tables 11-17.  There was limited evidence of association with the principal components 
in predicting the cortisol features among European Americans.  As there was only 
[36] 
 
evidence for a few principal components on Bedtime, we did not adjust for principal 
components in European Americans for the genome-wide association analyses.  There 
were a number of significant (p<0.05) principal components for African Americans and 
Hispanic Americans.  These associations indicate that there is underlying population 
structure beyond what is being captured by stratifying by race/ethnicity.   Given this 
evidence, we adjusted for the top 10 principal components for the African Americans and 
Hispanic Americans. 
 





AFA (n=214) EA (n=166) HIS (n=450) 
β (SE) p-value β (SE) p-value β (SE) p-value 
PC1 2.87 (1.50) 0.057 -1.97 (1.91) 0.30 -1.19 (1.01) 0.24 
PC2 -4.95 (1.59) 0.002 1.70 (1.61) 0.29 -1.30 (1.06) 0.22 
PC3 -0.05 (1.63) 0.98 -1.99 (3.01) 0.51 0.41 (0.65) 0.53 
PC4 1.54 (1.97) 0.44 -0.86 (2.87) 0.77 -1.29 (1.87) 0.49 
PC5 -3.54 (2.29) 0.12 3.44 (2.83) 0.23 0.76 (0.92) 0.41 
PC6 2.53 (1.91) 0.19 1.49 (2.69) 0.58 0.94 (1.42) 0.51 
PC7 -2.56 (1.80) 0.16 4.59 (2.68) 0.09 0.72 (1.94) 0.71 
PC8 1.34 (2.37) 0.57 5.20 (5.25) 0.32 0.83 (0.98) 0.39 
PC9 -0.95 (2.08) 0.68 3.68 (4.39) 0.40 -0.20 (1.19) 0.86 
PC10 -0.23 (2.26) 0.91 4.94 (4.25) 0.25 -0.48 (0.75) 0.52 
 Model R
2
 0.10 Model R
2
 0.05 Model R
2
 0.03 
AFA = African Americans.  EA = European Americans. HIS = Hispanic Americans. PC = 











AFA (n=212) EA (n=166) HIS (n=448) 
β (SE) p-value β (SE) p-value β (SE) p-value 
PC1 2.68 (2.05) 0.19 1.07 (2.69) 0.69 2.74 (1.45) 0.06 
PC2 -5.92 (2.17) 0.007 -0.69 (2.27) 0.76 -1.57 (1.52) 0.30 
PC3 1.43 (2.23) 0.52 3.39 (4.10) 0.41 -0.45 (0.93) 0.63 
PC4 3.29 (2.69) 0.22 6.72 (4.02) 0.10 -1.21 (2.70) 0.65 
PC5 -4.45 (3.11) 0.15 -1.51 (3.97) 0.70 1.26 (1.33) 0.34 
PC6 -0.79 (2.60) 0.76 -1.60 (3.78) 0.67 2.34 (2.04) 0.25 
PC7 -0.47 (2.47) 0.85 9.95 (3.67) 0.008 2.67 (2.78) 0.34 
PC8 -2.57 (3.23) 0.42 21.80 (7.40) 0.004 0.12 (1.41) 0.93 
PC9 1.09 (2.84) 0.70 3.74 (6.17) 0.55 0.16 (1.71) 0.92 
PC10 -0.03 (3.10) 0.99 5.02 (5.93) 0.40 -0.82 (1.08) 0.45 
 Model R
2
 0.07 Model R
2
 0.09 Model R
2
 0.03 
AFA = African Americans.  EA = European Americans. HIS = Hispanic Americans. PC = 









AFA (n=203) EA (n=160) HIS (n=412) 
β (SE) p-value β (SE) p-value β (SE) p-value 
PC1 0.82 (1.30) 0.53 0.20 (1.69) 0.90 -0.08 (0.95) 0.93 
PC2 1.56 (1.51) 0.30 -1.00 (1.43) 0.48 0.72 (1.01) 0.47 
PC3 1.22 (1.41) 0.39 1.28 (2.66) 0.63 0.20 (0.60) 0.74 
PC4 -0.04 (1.69) 0.98 2.46 (2.60) 0.35 1.98 (1.76) 0.26 
PC5 2.03 (2.03) 0.32 -3.12 (2.47) 0.21 -0.59 (0.84) 0.48 
PC6 -0.75 (1.69) 0.66 -0.07 (2.38) 0.98 -1.82 (1.31) 0.17 
PC7 1.67 (1.58) 0.29 -0.46 (2.37) 0.85 1.52 (1.77) 0.39 
PC8 -1.33 (2.03) 0.51 -3.86 (4.65) 0.41 -0.29 (0.90) 0.75 
PC9 -0.05 (1.85) 0.98 0.96 (3.92) 0.81 0.36 (1.09) 0.74 
PC10 -3.49 (1.95) 0.07 -2.04 (3.80) 0.59 0.63 (0.69) 0.36 
 Model R
2
 0.05 Model R
2
 0.04 Model R
2
 0.02 
AFA = African Americans.  EA = European Americans. HIS = Hispanic Americans. PC = 









AFA (n=209) EA (n=166) HIS (n=442) 
β (SE) p-value β (SE) p-value β (SE) p-value 
PC1 2.19 (1.18) 0.06 -0.62 (1.54) 0.69 1.80 (.89) 0.04 
PC2 -1.98 (1.24) 0.11 -0.49 (1.30) 0.71 -0.53 (0.93) 0.57 
PC3 0.34 (1.28) 0.79 0.67 (2.35) 0.78 -0.43 (0.57) 0.45 
PC4 1.22 (1.54) 0.43 2.77 (2.30) 0.23 0.61 (1.66) 0.71 
PC5 -2.87 (1.82) 0.12 -1.41 (2.27) 0.54 -0.55 (0.81) 0.49 
PC6 -1.35 (1.50) 0.37 -0.68 (2.17) 0.76 1.09 (1.25) 0.39 
PC7 -1.27 (1.43) 0.37 1.83 (2.11) 0.39 2.79 (1.69) 0.10 
PC8 -1.41 (1.86) 0.45 3.05 (4.24) 0.47 0.39 (0.86) 0.65 
PC9 0.80 (1.64) 0.62 1.25 (3.54) 0.72 -0.20 (1.05) 0.85 
PC10 0.82 (1.79) 0.65 1.15 (3.40) 0.73 0.25 (0.66) 0.70 
 Model R
2
 0.06 Model R
2
 0.02 Model R
2
 0.03 
AFA = African Americans.  EA = European Americans. HIS = Hispanic Americans. PC = 









AFA (n=209) EA (n=163) HIS (n=433) 
β (SE) p-value β (SE) p-value β (SE) p-value 
PC1 -0.91 (1.23) 0.45 0.19 (1.25) 0.88 0.90 (0.77) 0.24 
PC2 4.01 (1.30) 0.002 -1.75 (1.06) 0.10 0.93 (0.82) 0.26 
PC3 -0.20 (1.33) 0.88 -0.18 (1.97) 0.93 -0.99 (0.49) 0.05 
PC4 -0.36 (1.61) 0.83 1.75 (1.94) 0.37 0.58 (1.44) 0.69 
PC5 0.78 (1.87) 0.68 0.75 (1.84) 0.68 -0.73 (0.70) 0.30 
PC6 -2.77 (1.57) 0.08 -3.40 (1.76) 0.05 2.19 (1.09) 0.04 
PC7 -0.09 (1.47) 0.95 -2.47 (1.71) 0.15 -2.02 (1.46) 0.19 
PC8 0.37 (1.93) 0.85 3.28 (3.46) 0.34 -0.44 (0.74) 0.56 
PC9 0.63 (1.72) 0.71 -5.66 (2.87) 0.05 -1.00 (0.91) 0.27 
PC10 2.08 (1.84) 0.26 -4.11 (2.82) 0.15 0.07 (0.57) 0.91 
 Model R
2
 0.07 Model R
2
 0.07 Model R
2
 0.03 
AFA = African Americans.  EA = European Americans. HIS = Hispanic Americans. PC = 









AFA (n=211) EA (n=164) HIS (n=447) 
β (SE) p-value β (SE) p-value β (SE) p-value 
PC1 -0.05 (0.18) 0.77 -0.17 (0.23) 0.46 0.17 (0.11) 0.12 
PC2 -0.35 (0.19) 0.07 0.23 (0.19) 0.23 -0.02 (0.12) 0.87 
PC3 0.01 (0.20) 0.95 0.03 (0.36) 0.94 0.01 (0.07) 0.91 
PC4 0.06 (0.24) 0.79 -0.28 (0.34) 0.41 -0.20 (0.21) 0.35 
PC5 0.23 (0.28) 0.41 -0.50 (0.34) 0.13 -0.04 (0.10) 0.72 
PC6 0.15 (0.23) 0.51 0.70 (0.32) 0.03 0.01 (0.16) 0.94 
PC7 -0.12 (0.22) 0.59 -0.12 (0.31) 0.71 0.31 (0.21) 0.15 
PC8 -0.21 (0.29) 0.47 -0.43 (0.63) 0.49 0.00 (0.11) 0.99 
PC9 0.05 (0.25) 0.83 0.15 (0.52) 0.78 0.11 (0.13) 0.43 
PC10 0.02 (0.28) 0.94 0.41 (0.51) 0.43 0.01 (0.08) 0.92 
 Model R
2
 0.03 Model R
2
 0.07 Model R
2
 0.02 
AFA = African Americans.  EA = European Americans. HIS = Hispanic Americans. PC = 









AFA (n=214) EA (n=169) HIS (n=452) 
β (SE) p-value β (SE) p-value β (SE) p-value 
PC1 -0.04 (0.15) 0.81 0.00 (0.25) 0.99 0.34 (0.10) 0.0005 
PC2 0.04 (0.16) 0.81 0.11 (0.21) 0.59 -0.05 (0.10) 0.61 
PC3 -0.06 (0.17) 0.74 -0.54 (0.39) 0.17 -0.06 (0.06) 0.33 
PC4 0.02 (0.20) 0.92 -0.39 (0.38) 0.31 0.08 (0.18) 0.67 
PC5 0.12 (0.24) 0.62 -0.42 (0.38) 0.27 -0.15 (0.10) 0.10 
PC6 -0.20 (0.20) 0.30 0.02 (0.36) 0.95 0.03 (0.14) 0.83 
PC7 0.00 (0.19) 0.99 -0.45 (0.35) 0.20 0.28 (0.19) 0.13 
PC8 -0.45 (0.24) 0.07 -0.07 (0.70) 0.92 -0.05 (0.10) 0.60 
PC9 0.34 (0.22) 0.11 -0.04 (0.58) 0.94 0.03 (0.12) 0.83 
PC10 0.29 (0.23) 0.21 -0.86 (0.56) 0.13 0.09 (0.07) 0.23 
 Model R
2
 0.05 Model R
2
 0.06 Model R
2
 0.05 
AFA = African Americans.  EA = European Americans. HIS = Hispanic Americans. PC = 





Chronic Disease Risk Factors 
Body Mass Index 
A variety of anthropometric measurements, including height, weight, hip 
circumference, and waist circumference, are measured at each MESA examination using 
standardized instruments and procedures.  For this dissertation research, the 
anthropometric variable of interest is body mass index (BMI), calculated as weight in 
kilograms/height in meters squared.  We chose BMI as the anthropometric variable of 
interest since HPA axis dysfunction has been previously linked to abdominal obesity 
9
.  
We did not examine waist circumference in addition to BMI as previous MESA work did 
not find associations between waist circumference and multiple cortisol features (CAR, 
overall decline, and AUC) 
83
.  Given the repeat assessment of BMI at multiple MESA 
exams, an averaged measure of BMI was created.  Averaged BMI ranged from 15 to 55 
kg/m
2
, with a mean of 29 kg/m
2
 (standard deviation of 5.6 kg/m
2
) (Figure 8).  In 
examining the distribution of BMI stratified by the different racial/ethnic groups (Figure 









Figure 9: Distribution of averaged BMI in kg/m
2
, by racial/ethnic group. 
[42] 
 





 European Americans African Americans Hispanic Americans ANOVA 
 N Min Max Mean (SD) N Min Max Mean (SD) N Min Max Mean (SD) p-value 
BMI 170 18.2 47.0 26.6 (4.5) 215 15.3 54.0 30.1 (6.3) 454 18.7 54.9 29.5 (5.3) <0.0001 
ln(Glucose) 170 4.2 5.1 4.5 (0.1) 213 4.3 5.4 4.6 (0.2) 452 4.3 5.6 4.6 (0.2) <0.0001 
ln(IL-6 + 1) 166 0.5 2.5 1.1 (0.4) 205 0.4 2.5 1.2 (0.5) 434 0.4 2.6 1.3 (0.4) 0.009 




The MESA Study collects a range of variables capturing metabolic parameters.  
For this dissertation, fasting glucose is the feature of interest.  Fasting glucose 
concentrations were chosen rather than diabetes status due to the additional information 
and power in analysis of a continuous trait compared to the dichotomous trait derived 
from a continuous distribution.  Fasting glucose concentrations were measured in mg/dl.  
Given the repeat assessment of fasting glucose at multiple MESA exams, an averaged 
measure of fasting glucose concentrations was created.  Averaged fasting glucose ranged 








Given the extreme right tail for averaged fasting glucose concentrations, we 
natural log-transformed this variable.  After transformation ln(Glucose) ranged from 4.25 
to 5.71 mg/dl, with a mean of 4.60 mg/dl (standard deviation of 0.22 mg/dl) (Figure 11).  
In examining the distribution of ln(Glucose) stratified by the different racial/ethnic 









Figure 12: Distribution of ln(Glucose) concentrations, by racial/ethnic group. 
 
 Among the African American and Hispanic American histograms in Figure 12, 
there are long right side tails.  In examining the data for outliers, we plotted ln(Glucose) 
concentrations against age (Figure 13).  It was noted that there were a large number of 
points where ln(Glucose) concentrations were greater than 5.0.  In examining for outliers 
there were 21 observations which had a studentized residual (r) with an absolute value 
greater than 3.  These large residuals corresponded to ln(Glucose) concentrations that 
ranged from 5.28 to 5.71.  In evaluating for high leverage points, there were 37 





Figure 13: Scatter plot of natural log-transformed average fasting glucose concentrations versus age, by racial/ethnic group. 
[47] 
 
None of the data points with large residuals were high leverage points.  We decided to 
exclude individuals with ln(Glucose) concentrations that were greater than ±4 standard 




The MESA Study has data available on a range of markers of inflammation.  This 
dissertation specifically focuses on two inflammatory measures, interleukin-6 (IL-6) and 
tumor necrosis factor-α (TNF-α), in an effort to expand on previous work in the MESA 
Study that showed associations between these measures and cortisol features 
12
.  Both IL-
6 and TNF-α were measured from fasting blood draws at the MESA Exam that 
corresponds to an individual’s cortisol collection. 
Serum from the blood draws was frozen then shipped and stored at the Central 
Blood Analysis Laboratory at the University of Vermont.  IL-6 was measured by an IL-6 
assay (Quantikine HS Human IL-6 Immunoassay; R&D Systems, Minneapolis, MN), 
with an average coefficient of variation of 6.3%.  TNF-α was measured using the 
LINCOplex Human Cardiovascular Disease Panel 3 Kit (Millipore Corporation, St. 
Charles, MO), with an average coefficient of variation of 10.3%.  The unit of 
measurement for both markers of inflammation was pg/ml.  Both assays were completed 
at the Laboratory for Clinical Biochemistry Research at the University of Vermont.   
IL-6 concentrations ranged from 0.45 to 12.19 pg/ml, with a mean of 2.81 pg/ml 
(standard deviation 2.00 pg/ml) (Figure 14). Given the extreme right tail for IL-6 
[48] 
 
concentrations, we transformed this variable as ln(IL-6 + 1) (Figure 15).  ln(IL-6 + 1) 
concentrations ranged from 0.37 to 2.58 pg/ml, and averaged 1.23 pg/ml (standard 
deviation 0.43 pg/ml).  In examining the distribution of ln(IL-6 + 1) stratified by the 
different racial/ethnic groups (Figure 16, Table 18), the means are statistically different 
from each other (p=0.009). 
 
 




Figure 15: Distribution of ln(IL-6 + 1) in pg/ml. 
 
 
Figure 16: Distribution of ln(IL-6 + 1) concentrations, by racial/ethnic group. 
[50] 
 
TNF-α concentrations ranged from 0.060 to 140.89 pg/ml, with a mean of 4.38 
pg/ml (standard deviation 6.61 pg/ml) (Figure 17). Given the extreme right tail for TNF-α 
concentrations, the two outlying observations (at concentrations of 90 and 140 pg/ml) 
were removed and we transformed this variable as ln(TNF-α + 1) (Figure 18).  ln(TNF-α 
+ 1) concentrations ranged from 0.058 to 3.68 pg/ml, and averaged 1.46 pg/ml (standard 
deviation 0.59 pg/ml).  In examining the distribution of ln(TNF-α + 1) stratified by the 
different racial/ethnic groups (Figure 19, Table 18), the means are statistically different 
from each other (p=0.009). 
 




Figure 18: Distribution of ln(TNF-α + 1)in pg/ml. 
 
 




The univariate association of covariates and cortisol summary features on all four 
chronic disease risk factor outcomes is provided in Table 19.  The associations between 
age, sex, and African American race and the chronic disease risk factor outcomes are not 
consistent with respect to direction of effect.  Nor are the associations consistent between 
many of the cortisol features and the chronic disease risk factor outcomes with respect to 
direction of effect.  For BMI, every covariate is a significant predictor (p<0.05) with the 
exception of four cortisol features.  Fewer of the covariates are significantly predictive of 
ln(Glucose) and ln(IL-6 +1).  Only age was a significant predictor in the univariate 





Table 19: The univariate associations of covariates and cortisol features on average BMI, ln(Glucose), ln(IL6 + 1), and ln(TNF-α +1). 
  BMI Glucose IL6 TNF-α 
  β p-value β  p-value β  p-value β  p-value 
Age -0.07 0.0003 0.0008 0.29 0.01 <0.0001 0.01 <0.0001 
Sex -1.44 0.0002 0.04 0.01 -0.03 0.30 -0.03 0.46 
AFA 1.41 0.001 -0.007 0.70 0.01 0.68 -0.02 0.66 
HIS 0.97 0.01 0.07 <0.0001 0..06 0.05 0.07 0.10 
Education -0.37 <0.0001 -0.02 <0.0001 -0.03 <0.0001 -0.01 0.38 
Wakeup -1.76 <0.0001 -0.03 0.01 -0.06 0.03 -0.03 0.45 
Bedtime -0.29 0.22 -0.004 0.64 0.06 0.002 0.02 0.41 
CAR -0.29 0.48 -0.02 0.16 -0.02 0.50 -0.0004 0.93 
AUC -1.11 0.006 -0.01 0.46 0.10 0.002 0.04 0.34 
EDSlope 1.37 0.003 0.06 0.0005 0.15 <0.0001 0.09 0.07 
LDSlope -0.53 0.86 -0.11 0.34 0.63 0.008 0.31 0.34 




In the next chapter, I begin the discussion of the individual studies that comprise 
this dissertation.  I detail the investigation of the gene-level associations between stress 
responses candidate genes and each of the seven cortisol features. I also present the 
results from the gene-level meta-analysis, which allows for comparison of the ethnic 





 VARIATION IN STRESS RESPONSE GENES IS RELATED TO 
FEATURES OF DIURNAL CORTISOL CURVES IN THE MULTI-




Cortisol concentrations follow a strong daily pattern.  They are high upon 
awakening, reach a maximum concentration approximately half an hour later, and slowly 
decrease throughout the rest of the day 
1-3
.  Additionally, cortisol concentrations increase 
in response to stressful situations, such as public speaking 
32
.  Under conditions of 
chronic stress, prolonged increased concentrations could have detrimental downstream 
physiological effects. 
Several population-based studies have linked daily cortisol patterns to health 
outcomes, including elevated blood pressure, abdominal obesity, and coronary 
calcification 
8-10
.  Cortisol concentrations and various features of the cortisol daily profile 
have also been linked to diabetes mellitus 
11
 and markers of inflammation 
12
.  
Despite evidence of associations of various risk factors with cortisol, considerable 
inter-individual variability in cortisol remains unexplained.  This has led to increased 
interest in examining genetic predictors of cortisol phenotypes 
15
, as genetic factors could 




cortisol to date has focused on candidate gene associations, notably the glucocorticoid 
receptor gene (NR3C1) and the mineralocorticoid receptor gene (NR3C2) 
21-23
. 
The increase in cortisol concentrations in response to a stressor 
32
 occurs through 
the activation of the hypothalamic-pituitary-adrenal (HPA) axis, which has downstream 
implications for the cardiovascular system, immune system, and metabolism 
30, 31
. The 
cortisol metabolic pathway suggests several key genes whose variation could affect 
cortisol levels.  We selected genes with downstream implications for either cortisol 
concentrations or cortisol responsivity.  The six stress response genes of interest for this 
work include a glucocorticoid receptor gene (NR3C1), a mineralocorticoid receptor gene 
(NR3C2), the tyrosine hydroxylase gene (TH), the alpha-2A-adrenergic receptor gene 
(ADRA2A), the beta-2-adrenergic receptor gene (ADRB2), and the serotonin transporter 
gene (SLC6A4), all of which have been suggested to be involved in the physiologic 
response to psychological stressors 
22, 52, 54, 56, 62
.  However, few if any population based 
studies have investigated the associations between polymorphisms in these genes and 
cortisol levels in multiple ethnic groups. 
In this study we investigate how variation in six stress response genes is related to 
diurnal cortisol features within and across ethnic groups utilizing a gene-level analysis 
approach, the sequence kernel association test (SKAT) 
84
.  When comparing single 
nucleotide polymorphism (SNP)-level results across multiple ethnic groups, difference in 
ethnic specific linkage disequilibrium structures may result in inconsistent findings.  The 
gene-level analysis bypasses the problem that different tagging SNPs within gene regions 




gene structure (exon and intron organization) is not likely to differ across ethnic groups, 
making the assessment of entire genes a better analytic approach than individual SNPs.  
We performed a gene-level analysis for each of the six stress response gene regions 
(defined as all SNPs within the gene and 5 kilobases (kb) window up- and downstream of 
each gene) for multiple cortisol features in each ethnic group separately.  We also utilize 





The MESA Stress Study is an ancillary study to the Multi-Ethnic Study of 
Atherosclerosis (MESA).  The MESA study is a longitudinal cohort study focused on 
investigating the early stages of atherosclerosis.  Eligible participants were 45-84 years of 
age and free from history of cardiovascular disease at the baseline examination (2000-
2002) 
78
. The MESA Stress Study took place in the context of MESA examinations 3 and 
4 conducted between 2004 and 2006, and obtained detailed stress hormone data on a 
subsample of 1002 MESA participants recruited from the New York and Los Angeles 
Field sites.  Participants for the MESA Stress Study were African Americans, European 
Americans, and Hispanic Americans and were enrolled as they presented for follow-up, 
until approximately 500 participants were recruited from each location. 
Of the 1002 MESA Stress Study participants, after exclusions for 1) raw cortisol 




consent for use of genetic information, and 4) concurrent corticosteroid usage, our 
resultant sample size was 839 individuals.  The ethnic specific distribution of this sample 
is as follows: 170 European Americans, 215 African Americans, 454 Hispanic 
Americans. 
Cortisol Sample Collection 
Each MESA Stress Study participant was asked to collect six saliva samples per 
day at pre-specified times over three consecutive weekdays, for a maximum of 18 
samples per participant, using Salivette collection tubes.  The samples were collected 
using the following schedule: sample (1) upon waking and before getting out of bed; (2) 
30 minutes later; (3) around 10:00am; (4) around 12:00 noon or before lunch, whichever 
came first; (5) around 6:00pm or before dinner, whichever came first; (6) just before bed.  
Because earlier work has shown that the use of a time tracking device improves sample 
collection compliance 
79
, each collection tube was equipped with a time tracking device, 
which recorded the time when the swabs were removed for sample collection. 
Cortisol Features 
Rather than explore only cortisol concentrations at specific time points, we 
explored multiple features of the diurnal cortisol cycle (Table 20, Figure 20).  Features 
were selected for investigation because prior work has hypothesized or demonstrated 
their associations with health risk factors or health outcomes 
11,12,83,85
.  Features were 
modeled using all available salivary cortisol data (up to six samples per day collected 
over three days).  Raw cortisol concentrations, measured in nmol/L, were log-






































AUC 16hr = CAR AUC + Early Decline AUC + Late Decline AUC
 
Figure 20: Representation of the diurnal cortisol curve describing the cortisol features of interest.  
For these analyses we specifically used Wakeup, Bedtime, Cortisol awakening response (CAR), 
Area under the curve (AUC) from 0-16 hours, Early Decline Slope, Late Decline Slope, and 
Overall Decline Slope. 




Average cortisol concentration from wakeup for an 
individual (Sample 1). 
Bedtime 
Average cortisol concentration at bedtime for an individual 
(Sample 6). 
Area  
Area under the curve 
(AUC) 
Standardized AUC  for the interval  0hr-16hr since wakeup 




The average difference in cortisol concentrations between 
the peak and wakeup measurements (Sample 2 – Sample 1). 
Early Decline Slope 
(EDSlope) 
The slope from 0.5 hours and 2 hours since wakeup pooled 
across all days for an individual. 
Late Decline Slope 
(LDSlope) 
The slope from 2 hours to 16 hours since wakeup pooled 
across all days for an individual 
Overall Decline Slope 
(ODSlope) 
The overall decline slope ignoring the peak value from 






Genotyping data included both measured and imputed SNPs available through 
participation in MESA SHARe (SNP Health Association Resource) project.   Under the 
SHARe project, genome-wide genotyping was obtained using the Affymetrix Genome-
Wide Human SNP Array 6.0 platform.  Imputation to HapMap was completed at the 
MESA Genetics Centers using the IMPUTE2 
82
 program with the following reference 
panels:  the HapMap Phase I and II, the human genome reference sequence (NCBI Build 
36).  The HapMap project is based on ethnic specific reference panels, composed of the 
following groups: Yoruba in Ibadan, Nigeria (abbreviation: YRI), Japanese in Tokyo, 
Japan (abbreviation: JPT), Han Chinese in Beijing, China (abbreviation: CHB), CEPH 
(Utah residents with ancestry from northern and western Europe) (abbreviation: CEU).  
Imputation for African Americans and Hispanic Americans was performed using the 
CEU+YRI+CHB+JPT reference panels (release #22). Imputation for European 
Americans was performed using only the CEU reference panel (release #24).  All 
imputed and genotyped SNPs were aligned to the “+” strand of the human genome 
reference sequence (NCBI Build 36).  Based on the imputed allele probabilities (AA, AB, 
BB), most like genotypes were assigned as 0, 1, 2 counts of the minor allele.  If the 
probability of AA was greater than the probability of BB, then allele A was considered 
the effect allele.  If the allele frequency of A was < 0.5, it was considered the minor 




Stress Response Genes 
 We defined the six stress response gene regions as the entire gene, plus a window 
±5kb around each gene.  Base pair start and end positions for each gene were assigned 
based off annotation from the UCSC Genome Browser 
86
.  Starting base pair positions 
were rounded down to the nearest kb and ending positions were rounded up to the nearest 
kb.  An additional 5kb were then added upstream of the starting positions and 
downstream of the ending positions.  These gene regions were then restricted to SNPs 
within the entire gene ±5kb window that were common variants (minor allele frequency 
(MAF) >5%).  Due to the small ethnic group sample sizes, a threshold for the MAF of 
5% was chosen to limit the influence of unstable frequency estimates being driven by 
small sample sizes.  Specific details on the chromosomal locations of each of the six 
genes, the overall size of their regions, and the number of ethnic group specific SNPs in 




We performed SKAT separately for each gene region, in each ethnic group, for 
each cortisol feature separately.  All analyses were adjusted for baseline age, sex, and 
education.  The result was a score statistic, Q, for each analysis. 





Where Yi  is the outcome corresponding to subject i, α0 is an intercept term, Xi is a vector 
of non-genetic covariates, Gi is a vector of genotypes, and measurement error εi follows 
any distribution with mean zero and variance σ2.   α is a vector of regression coefficients 
for the covariates, and β is a vector of regression coefficients for the genotypes. In SKAT 
one assumes that each of the βj, j=1,..,p, follows an arbitrary distribution with mean zero 
and variance wjτ.  Testing H0: τ = 0 is equivalent to testing H0: β = 0.   
The SKAT framework allows for the specification of multiple kernel types, which 
determine how the genotype information is included in the model, as well as multiple 
weighting functions.  The weights wj can be specified or set to 1 for instances where 
weighting in unnecessary.  SKAT was designed with rare variant analyses in mind and as 
such allows for the up-weighting of rare variants, under the assumption that common 
variants are less likely to have large effects.  As we are interested in the effect of common 
variants, there was no need to utilize the up-weighting algorithms available in SKAT.  
Instead, we executed the gene level analyses implementing the linear kernel. 
Meta-analysis  
 A new methodology available through the SKAT framework allows for the meta-
analysis of the gene-level results across groups, MetaSKAT.  MetaSKAT allows for the 
analysis of either cohort level summary statistics or individual level results.  We utilized 
individual-level genotype data since it was available.  Given that we have multi-ethnic 
sample and that minor allele frequencies may vary across groups, we allowed for a 
heterogeneous genetic effects model that used ethnic group specific minor allele 




As we were using common variants we set weights.beta=c(1,1) to unweight the kernel.  
In SKAT, the Q statistic, a variance-component score statistic, is defined as Q = (y – 
û)’K(y – û).  In MetaSKAT, the heterogeneous genetic effects model results in a sum of 
the ethnic group specific Q statistics.  Both SKAT and MetaSKAT were packages 




 To estimate power for gene-based association testing, we used the following 
SKAT power calculation parameters: 100 simulations over a 40kb gene region, and 
setting the maximum effect to 2, percentage of causal SNPs to 5%, and the frequency of 
negative interaction effects to 20%.  We tested three ethnic groups, six gene regions, and 
seven cortisol outcomes, for a total of 126 tests.  Using an alpha level of 0.05 and a 
Bonferroni correction, the result is a significance threshold at p<4x10
-4
.  Table 21 
presents the SKAT output table showing power calculations, based on the criteria above. 
Given the limited sample size of each ethnic group, we expect roughly 50% power 
among the Caucasian Americans (n=170), 58% among the African Americans (n=215), 





Table 21: Gene-level power calculations. 
Sample Size Alpha Level 
0.01 1e-04 4e-04 1e-06 
50 0.33 0.20 0.22 0.15 
100 0.51 0.32 0.37 0.23 
150 0.61 0.45 0.49 0.33 
200 0.68 0.53 0.56 0.42 
250 0.73 0.58 0.61 0.49 
300 0.77 0.62 0.66 0.54 
350 0.80 0.66 0.69 0.57 
400 0.82 0.68 0.72 0.60 
450 0.85 0.71 0.74 0.63 
500 0.86 0.73 0.77 0.65 
 
 
However, given the significant (p<0.05) correlation between cortisol features (Table 22), 
the Bonferoni corrected estimates represent a conservative lower bound as the tests are 
not independent.  Therefore, the significance threshold for both SKAT and MetaSKAT 
were set to p<0.05.  P-values that ranged from 0.05-0.10 were considered suggestive. 
 
 
Table 22: Pearson’s product moment correlation coefficients between cortisol summary features, 
all ethnic groups combined.  
  Wakeup Bedtime CAR AUC EDSlope LDSlope ODSlope 
Wakeup 1.00       
Bedtime 0.39 1.00      
CAR -0.44 -0.14 1.00     
AUC 0.49 0.74 -0.01 1.00    
EDSlope -0.24 -0.05 -0.29 0.08 1.00   
LDSlope 0.08 0.50 -0.08 0.35 -0.39 1.00  
ODSlope -0.34 0.43 0.18 0.39 0.04 0.72 1.00 
        





 Basic demographic information on the Stress Study participants is provided in 
Table 23.  Hispanic Americans represented the largest proportion of participants (52.8%), 
relative to the African Americans (28.6%) and European Americans (18.6%).  The 
gender distribution was fairly equal (52.4% female).  Overall, cortisol feature means 
varied across ethnic groups (Table 24).  There was a statistically significant difference in 
means across the ethnic groups for all cortisol features except CAR. 
  





      Columbia 52.2% 
      UCLA 47.8% 
Age  
      45-54 29.9% 
      55-64 27.7% 
      65-74 30.3% 
      75-84 12.1% 
Race  
      European American 18.6% 
      African American 28.6% 
      Hispanic American 52.8% 
Gender  
      Male 47.6% 
      Female 52.4% 
Education Level  
      Less than High School 27.0% 
      Completed High School 20.2% 
      Some College 29.7% 
      Bachelor’s or higher 23.2% 
Income  
      < $20,000 29.3% 
      $20,000-34,999 27.5% 
      $35,000-$49,999 16.5% 
      $50,000 or higher 26.8% 
Percent Current Smokers 11.3% 
Percent Diabetic 13.5% 





Table 24: Distributions of cortisol summary features. 
Cortisol concentrations (nmol/L) were log-transformed and combined across the three days of collection to 
create each feature.  The mean and standard deviation (SD) of the transformed and summarized features are 
presented by ethnic group. 
 
In the gene-level analyses of each gene region on each cortisol feature, there were 
a number of statistically significant associations.  ADRA2A was a significant (p-
value<0.05) predictor of AUC and EDSlope in European Americans and Bedtime in 
Hispanic Americans (Table 25).  It was also a suggestive (p-value<0.1) predictor of AUC 
in Hispanic Americans and CAR in African Americans.  In the meta-analysis across the 
three ethnic groups, ADRA2A was a marginal predictor of four out of the seven cortisol 
features.  ADRB2 was a significant predictor for Bedtime, CAR, and ODSlope features in 
the European Americans (Table 26).  In the meta-analysis across the three ethnic groups, 
ADRB2 was a significant predictor of CAR, an association that was driven by the strength 
of the association within the European Americans.  There was suggestive evidence that 
SLC6A4 is predictive of CAR among European Americans (Table 27).  This gene region 
also showed a suggestive association for European Americans and a significant 
association for Hispanic Americans in predicting EDSlope.  There was also a significant 
meta-analysis across ethnics of SLC6A4 on EDSlope.  TH had suggestive associations for 










 N Mean (SD) N Mean (SD) N Mean (SD) p-value 
Wakeup 166 2.58 (0.54) 214 2.38 (0.55) 450 2.38 (0.58) 0.0002 
Bedtime 166 0.78 (0.77) 212 0.98 (0.74) 448 0.49 (0.84) <0.0001 
CAR 160 0.45 (0.46) 203 0.35 (0.46) 412 0.37 (0.52) 0.17 
AUC 166 1.64 (0.43) 209 1.60 (0.42) 442 1.46 (0.51) <0.0001 
EDSlope 163 -0.53 (0.35) 209 -0.42 (0.44) 433 -0.40 (0.44) 0.003 
LDSlope 164 -0.12 (0.06) 211 -0.10 (0.06) 447 -0.13 (0.06) <0.0001 




predictive of any of the cortisol features.  Tables of the gene-level and meta-analysis 
results for NR3C1, NR3C2, and TH can be found in the Appendix (Tables A4-A6). 
 
 
Table 25: Gene-level main effect and meta-analysis results for ADRA2A. 
    SKAT MetaSKAT 
Outcome Race Q p-value p-value 
AUC AFA 75.08 0.94  
 EA 620.63 0.03**  
 HIS 1457.32 0.05* 0.05* 
     
Bedtime AFA 134.79 0.88  
  EA 267.43 0.22  
  HIS 1584.18 0.04** 0.08* 
     
CAR AFA 691.99 0.08*  
  EA 266.52 0.21  
  HIS 739.46 0.22 0.09* 
     
EDSlope AFA 142.07 0.78  
  EA 542.72 0.04**  
  HIS 524.09 0.38 0.22 
     
LDSlope AFA 69.02 0.95  
  EA 161.94 0.41  
  HIS 579.57 0.35 0.61 
     
ODSlope AFA 755.55 0.07*  
  EA 146.87 0.45  
  HIS 1041.60 0.13 0.07* 
     
Wakeup AFA 610.42 0.13  
  EA 26.34 0.92  
  HIS 781.66 0.23 0.22 




Table 26: Gene-level main effect and meta-analysis results for ADRB2. 
    SKAT MetaSKAT 
Outcome Race Q p-value p-value 
AUC AFA 2981.16 0.33  
 EA 1490.07 0.41  
 HIS 1803.27 0.92 0.76 
     
Bedtime AFA 3321.44 0.26  
  EA 4224.59 0.02**  
  HIS 830.64 0.99 0.46 
     
CAR AFA 2885.84 0.34  
  EA 5368.71 0.01**  
  HIS 4557.04 0.37 0.06* 
     
EDSlope AFA 1996.78 0.69  
  EA 1958.35 0.25  
  HIS 4648.10 0.40 0.43 
     
LDSlope AFA 959.33 0.99  
  EA 2544.81 0.13  
  HIS 3532.02 0.61 0.70 
     
ODSlope AFA 3997.07 0.14  
  EA 4885.04 0.01**  
  HIS 3525.88 0.62 0.22 
     
Wakeup AFA 2560.95 0.49  
  EA 2793.26 0.11  
  HIS 2707.73 0.77 0.55 




Table 27: Gene-level main effect and meta-analysis results for SLC6A4. 
    SKAT MetaSKAT 
Outcome Race Q p-value p-value 
AUC AFA 1353.92 0.21  
 EA 981.95 0.22  
 HIS 189.82 0.99 0.56 
     
Bedtime AFA 782.57 0.61  
  EA 626.78 0.38  
  HIS 261.03 0.97 0.89 
     
CAR AFA 731.20 0.62  
  EA 1675.96 0.07*  
  HIS 262.30 0.97 0.49 
     
EDSlope AFA 793.66 0.59  
  EA 1924.14 0.05*  
  HIS 5685.99 0.03** 0.01** 
     
LDSlope AFA 1515.22 0.16  
  EA 424.99 0.53  
  HIS 2300.88 0.24 0.25 
     
ODSlope AFA 1655.41 0.13  
  EA 504.80 0.47  
  HIS 635.64 0.78 0.56 
     
Wakeup AFA 738.96 0.65  
  EA 165.94 0.83  
  HIS 677.54 0.75 0.92 
* p<0.1, ** p<0.05 
 
 
The association between SLC6A4 and EDSlope had the strongest meta-analysis 
evidence of significant (p<0.05) gene-level associations across ethnic groups. To further 
investigate the associations of SLC6A4 on EDSlope in European Americans and Hispanic 
Americans, we used LocusZoom plots 
88
 to examine the association between individual 
SNPs within the gene region and EDSlope (Figures 21-23).  In the European Americans 




with one other SNP.  In the Hispanic Americans a different SNP has the strongest 
association (rs4583306), and is in high linkage disequilibrium with several other SNPs. In 
the LocusZoom plots there does appear to be similar structure in the overall pattern of 
association for the suggestive p-values (-log10(p-value)<1) in the European Americans 
and Hispanic Americans.  In contrast, the plot of the SNP associations for the African 
Americans has a different overall pattern.  LocusZoom plots for the other significant and 





Figure 21: LocusZoom plot of the correlation between loci of the SLC6A4 gene region among 







Figure 22: LocusZoom plot of the correlation between loci of the SLC6A4 gene region among 




Figure 23: LocusZoom plot of the correlation between loci of the SLC6A4 gene region among 




Since SKAT does not provide estimates of specific SNP parameters (i.e. 
magnitude or direction of effect) we examined the effects of the index SNPs across the 
ethnic groups (Table 28), which were available from a genome-wide association study of 
EDSlope.  GWAS were performed in each ethnic group separately, using SNPTest 
genetic analysis software (version 2) 
89
.  Linear regression was used to estimate the 
additive genetic effect of each SNP.  We used the Frequentist=1 and Method=Expected 
specifications, which allowed for an additive model of association and use of expected 
genotype dosages, respectively.   The primary model included age and sex as covariates.  
The top 10 principal components were also included in the model for African Americans 
and Hispanics after linear modeling indicated evidence of association between 
background genetic structure represented by the principal components and features of the 
cortisol curve.  There was limited evidence of association in the Europeans, and as such 
we did not adjust for PCs.  Filtering was performed to remove results for SNPs with 
minor allele frequency (MAF) less than 5% or with imputation quality (Info) < 0.5.  The 
index SNPs were not significant (p<0.05) in the other ethnic groups, and rs2020936 in 











Table 28: Comparison of SLC6A4 index SNPs across ethnic groups. 
Index SNP Race Effect Allele Frequency B p-value 
rs2066713 AFA G 0.76 -0.06 0.23 
 CAU* G 0.63 0.10 0.01 
 HIS G 0.66 0.04 0.24 
      
rs4583306 AFA G 0.21 0.02 0.71 
  CAU G 0.47 0.06 0.12 
  HIS* G 0.45 0.07 0.02 
      
rs2020936 AFA* G 0.40 -0.08 0.06 
 CAU G 0.15 0.07 0.18 
 HIS G 0.19 -0.05 0.21 
      




 This study investigated the associations between selected stress response genes 
and cortisol features in a multi-ethnic population by utilizing a gene-level analysis 
approach, SKAT.  We found statistical evidence that variation in established stress 
response gene regions is related to features of the diurnal cortisol curve, both across and 
within ethnic groups.  Three of the six stress response gene regions revealed indication of 
across group effects, as evidenced by the suggestive and significant meta-analyses.  There 
was evidence of ADRA2A having either marginal or suggestive statistical associations 
across ethnic groups in meta-analysis of multiple cortisol features: AUC, Bedtime, CAR, 
and ODSlope.  The ethnic group that is driving the main effect associations of these 
meta-analyses differ by cortisol feature, indicating that the repeated association of 
ADRA2A is not due to low allele frequencies in one ethnic group alone.  Minor allele 




Americans, 0.05-0.27 in European Americans, and 0.07-0.43 in Hispanic Americans.  
Alpha-2A adrenergic receptors are found primarily in the brain stem and regulate the 
release of noradrenaline and adrenaline 
53
.  There is evidence that polymorphisms of this 
gene are associated with autonomic responses to environmental stressors 
54
. 
Other stress response genes implicated in the gene-region meta-analyses include 
ADRB2 for its suggestive association with CAR and SLC6A4 for its significant 
association with EDSlope.  Stimulation of beta-2 adrenergic receptors by adrenaline leads 
to vasodilation which counteracts the hypertensive effects of sympathetic activation by 
stressors 
55
.  SLC6A4 may modulate the serotoninergic response to stress 
62
.  This 
hypothesis is supported by brain imaging studies showing that carriers of the “s” allele of 
SLC6A4 are more responsive to emotional stimuli 
63
.  A recent study found that SLC6A4 
polymorphisms were associated with CAR 
62
.  While there was no statistical meta-
analysis association between SLC6A4 and CAR across the three ethnic groups in this 
study, there was a suggestive main effect association in the European Americans. 
The differences in the index SNPs in the associations between EDSlope and 
SLC6A4 as well as the correlation patterns with the index SNPs may be a result of 
underlying differences in the linkage disequilibrium patterns for the SLC6A4 gene region 
for the three ethnic groups.  Linkage disequilibrium plots were made using the SNP & 
Variation Suite v7 
90
 (Appendix Figures A12-A14).  The red colored blocks represent 
strong linkage disequilibrium, with an R
2
>0.8.  The European Americans and Hispanic 




African Americans.  The weaker correlation between SNPs among African Americans 
may contribute to the lack of association found in that group. 
The SKAT methodology used for these analyses has several advantages over 
other gene-based association methods (e.g. Cohort Allelic Sum Test (CAST) 
91
, Weighted 
Sum Statistic (WSS) 
92
, C-alpha test 
93
).  First, SKAT is a more powerful method, even 
when sample sizes are small (n=500) 
84
, which is of particular importance given the small 
ethnic group specific sample sizes for these analyses.  Second, SKAT allows for the 
individual variant effects to vary from mean zero in either direction, and does not assume 
that all variants have similar direction or magnitude of effect.  Thirdly, it allows for the 
adjustment of covariates.  SKAT additionally allows for the assessment of common 
variants by implementing an unweighted linear kernel, which fit our needs since we are 
using HapMap imputed genome-wide data.   
There are two main limitations to this work.  The first is a design limitation due 
the use of HapMap imputed variants, which are not functional SNPs.  However, as the 
HapMap tagging SNPs may be in linkage disequilibrium with causal SNPs they are still 
useful for identifying genomic regions of potential interest.  Secondly, compliance with 
cortisol sampling protocols is necessary for estimating reliable cortisol features 
79, 94
.  
Compliance with taking samples within 10 minutes the requested times was greatest for 
wakeup (68%) and bedtime (75%) collections, and poorest during the middle of the day, 
ranging from 43%-57%.  Stability of the cortisol features is of particular importance for 




individual variants are expected to be modest and large variation in features estimates 
could mask true associations. 
Despite the limitations, this work is novel in the ability to examine the variation in 
multiple gene regions across ethnic groups in predicting cortisol features, which was 
possible through the use of the innovative SKAT methodologies as well has the unique, 
highly detailed cortisol phenotype information.  The gene-level analytic approach allows 
us to address the concern that individual SNPs may not replicate across ethnic groups due 
to differences in underlying patterns of linkage disequilibrium or to differences in allele 
frequencies 
95-97
, by examining a larger analysis unit which is unlikely to differ across 
populations.  Our demonstration of the associations with different loci and correlation 
patterns for the results on SLC6A4 in European Americans and Hispanic Americans 
emphasizes the need for gene-level approaches.  The gene-based analyses presented here 







INTERACTIONS BETWEEN CORTISOL LEVELS AND STRESS 
RESPONSE GENES IN PREDICTING CHRONIC DISEASE RISK 





Multiple population-based studies have linked daily cortisol patterns to health 
outcomes, including elevated blood pressure, abdominal obesity, and coronary 
calcification 
8-10
.  Cortisol concentrations and various features of the cortisol daily profile 
have also been associated with diabetes mellitus 
11
 and markers of inflammation 
12
. 
Environmental stressors that activate the cortisol-regulating HPA axis have a wide 
range of physiological and cellular implications.  The cascade effect of the HPA axis on 
many tissues raises the question of whether gene-cortisol interactions play a role in the 
predisposition to many common chronic diseases. 
The cortisol metabolic pathway suggests several key candidate genes whose 
variation could affect cortisol levels and/or influence the metabolic consequences of 
cortisol levels.  In this paper we focus on six stress response genes: a glucocorticoid 
receptor gene (NR3C1), a mineralocorticoid receptor gene (NR3C2), the tyrosine 
hydroxylase gene (TH), the alpha-2A-adrenergic receptor gene (ADRA2A), the beta-2-




which have been suggested to be involved in the physiologic response to psychological 
stressors 
22, 52, 54, 56, 62
.  In particular, studies have suggested that genetic polymorphisms 
of the glucocorticoid receptor gene (NR3C1) may modify the cardiovascular and 
metabolic effects of cortisol 
22, 24-26
.   
Few, if any, population-based studies have investigated these interactions in large 
samples, which may explain some inconsistencies in studies examining the relationship 
between stress and disease.  In addition, genetic differences in linkage disequilibrium 
structures across ethnic groups may lead to different results across studies.  To address 
this issue, we applied a novel gene-level analysis approach to investigate the influence of 
gene-by-cortisol interactions on anthropometric, metabolic, and inflammatory traits using 
the sequence kernel association test (SKAT) 
84
.  This gene-level analysis bypasses the 
problem that different SNPs may be associated with different relationships between 
cortisol and chronic disease the risk factors in different ethnicities because it makes a 
single gene-based assessment based on the distribution of all SNP-by-Cortisol 
interactions in the gene region. 
Using several measures of the daily cortisol profile, in the Multi-ethnic Study of 
Atherosclerosis (MESA), we investigated whether genetic polymorphisms of 6 stress-
region gene regions influenced the relationship between cortisol features and 







The MESA Stress Study is an ancillary study to the Multi-Ethnic Study of 
Atherosclerosis (MESA).  The MESA study is a longitudinal cohort study focused on 
investigating the early stages of atherosclerosis.  Eligible participants were 45-84 years of 
age and free from history of cardiovascular disease at the baseline examination (2000-
2002) 
78
. The MESA Stress Study took place in the context of MESA examinations 3 and 
4 conducted between 2004 and 2006, and obtained detailed stress hormone data on a 
subsample of 1002 MESA participants recruited from the New York and Los Angeles 
sites.  Participants for the MESA Stress Study were African Americans, European 
Americans, and Hispanic Americans and were enrolled as they presented for follow-up, 
until approximately 500 participants were recruited from each location. 
Of the 1002 MESA Stress Study participants, after exclusions for 1) raw cortisol 
data missingness, 2) unavailable genotype or principal component information, 3) no 
consent for use of genetic information, and 4) concurrent corticosteroid usage, our 
resultant sample size was 839 individuals.  The ethnic specific distribution of this sample 
is as follows: 170 European Americans, 215 African Americans, and 454 Hispanic 
Americans. 
Cortisol Sample Collection 
Each MESA Stress Study participant was asked to collect six saliva samples per 
day at pre-specified times over three consecutive weekdays, for a maximum of 18 




following schedule: sample (1) upon waking and before getting out of bed; (2) 30 
minutes later; (3) around 10:00am; (4) around 12:00 noon or before lunch, whichever 
came first; (5) around 6:00pm or before dinner, whichever came first; (6) just before bed.  
Because earlier work has shown that the use of a time tracking device improves sample 
collection compliance 
79
, each collection tube was equipped with a time tracking device, 
which recorded the time when the swabs were removed for sample collection. 
Cortisol Features 
Rather than explore only cortisol concentrations at specific time points, we explored 
multiple features of the diurnal cortisol cycle (Table 29, Figure 24).  Features were 
selected for investigation because prior work has hypothesized or demonstrated their 
associations with health risk factors or health outcomes 
11, 12, 83, 85
.  Features were 
modeled using all available salivary cortisol data (up to six samples per day collected 
over three days).  Raw cortisol concentrations, measured in nmol/L, were log-







































AUC 16hr = CAR AUC + Early Decline AUC + Late Decline AUC
 
Figure 24: Representation of the diurnal cortisol curve describing our summary features of 
interest.  For these analyses we specifically used Wakeup, Bedtime, Cortisol awakening response 
(CAR), Area under the curve (AUC) from 0-16 hours, Early Decline Slope, Late Decline Slope, 
and Overall Decline Slope. 




Average cortisol concentration from wakeup for an 
individual (Sample 1). 
Bedtime 
Average cortisol concentration at bedtime for an individual 
(Sample 6). 
Area  
Area under the curve 
(AUC) 
Standardized AUC  for the interval  0hr-16hr since wakeup 




The average difference in cortisol concentrations between 
the peak and wakeup measurements (Sample 2 – Sample 1). 
Early Decline Slope 
(EDSlope) 
The slope from 0.5 hours and 2 hours since wakeup pooled 
across all days for an individual. 
Late Decline Slope 
(LDSlope) 
The slope from 2 hours to 16 hours since wakeup pooled 
across all days for an individual 
Overall Decline Slope 
(ODSlope) 
The overall decline slope ignoring the peak value from 





Genotyping data included both measured and imputed SNPs available through 
participation in MESA SHARe (SNP Health Association Resource) project.   Under the 
SHARe project, genome-wide genotyping was obtained using the Affymetrix Genome-
Wide Human SNP Array 6.0 platform.  Imputation to HapMap was completed at the 
MESA Genetics Centers using the IMPUTE2 
82
 program with the following reference 
panels:  the HapMap Phase I and II, the human genome reference sequence (NCBI Build 
36).  Imputation for African Americans and Hispanic Americans was performed using the 
CEU+YRI+CHB+JPT reference panels (release #22). Imputation for European 
Americans was performed using only the CEU reference panel (release #24).  All 
imputed and genotyped SNPs were aligned to the “+” strand of the human genome 
reference sequence (NCBI Build 36).  Based on the imputed allele probabilities (AA, AB, 
BB), most like genotypes were assigned as 0, 1, 2 counts of the minor allele.  If the 
probability of AA was greater than the probability of BB, then allele A was considered 
the effect allele.  If the allele frequency of A was < 0.5, it was considered the minor 
allele; otherwise allele B was considered minor. 
Stress Response Genes 
 We defined the six stress response gene regions as the entire gene, plus a window 
±5kb around each gene.  Base pair start and end positions for each gene were assigned 
based off annotation from the UCSC Genome Browser 
86
.  Starting base pair positions 
were rounded down to the nearest kb and ending positions were rounded up to the nearest 




downstream of the ending positions.  These gene regions were then restricted to SNPs 
within the entire gene ±5kb window that were common variants (minor allele frequency 
(MAF) >5%).  Due to the small ethnic group specific sample sizes, a threshold for the 
MAF of 5% was chosen to limit the influence of unstable frequency estimates being 
driven by small sample sizes.  Details on the chromosomal locations of each of the six 
genes, overall size, and the number of SNPs in each gene region by ethnic group can be 
found in the Appendix (Tables 1-3). 
Outcome variables 
Body mass index (BMI) was calculated as weight in kilograms/height in meters 
squared.  Given the repeat assessment of BMI at each MESA exam, average BMI was 
estimated for each participant.  Given that the MESA participants were adults, we 
assumed that an individual’s weight was fairly stable across MESA exams, such that the 
average BMI was a stable representation of an individual’s anthropometric 
characteristics.  Fasting glucose concentrations were assessed by fasting blood draws and 
measured in mg/dl.  Average fasting glucose concentrations across MESA exams was 
estimated for each participant.  This average concentration was then natural log 
transformed.  Within each ethnic group, individuals who were greater than ±4 standard 
deviations from the mean were excluded.  Two markers of inflammation IL-6 and TNF-α 
were measured from fasting blood samples at the MESA Exam corresponding to an 
individual’s cortisol collection.  IL-6 concentrations were natural log transformed.  There 
were two extreme observations for TNF-α which were removed; after which TNF-α 





We performed SKAT separately for each gene, in each ethnic group, for each 
cortisol summary feature separately.  The general SKAT model for testing genetic main 
effects is as follows: 
 
Where Yi  is the outcome corresponding to subject i, α0 is an intercept term, Xi is a vector 
of non-genetic covariates, Gi is a vector of genotypes, and measurement error εi follows 
any distribution with mean zero and variance σ2.   α is a vector of regression coefficients 
for the covariates, and β is a vector of regression coefficients for the genotypes. In SKAT 
one assumes that each of the βj’s, j=1,..,p, follows an arbitrary distribution with mean 
zero and variance wjτ. The weights wj can be specified or set to 1 for instances where 
weighting in unnecessary. Testing H0: τ = 0 is equivalent to testing H0: β = 0.    
A version of SKAT, GESAT 
98
, allows for the evaluation of gene-by-environment 
interactions, after adjustment for covariates by the inclusion of an interaction term that 
represents the matrix of interactions: 
 
Where Xi is a vector of non-genetic covariates, Ei is the environmental factor, Gi is a 
vector of genetic markers, and Si is a vector of gene-by-environment interaction terms.  
One assumes that each of the βj’s, j=1,..,p, follows an arbitrary distribution with mean 
zero and common variance τ2, and that the βj’s are independent.  Testing H0: τ
2
 = 0 is 




interaction.  The cortisol features is the environment.  Covariates include age, sex, and 
education at baseline.  GESAT was implemented for each gene, for each cortisol feature, 
in each ethnic group, separately. 
 Since SKAT does not provide estimates of specific SNP-by-cortisol interaction 
parameters (i.e. magnitude or direction of effect) we also used traditional least squares 
regression approaches to estimate SNP-by-cortisol interaction terms when there was 
evidence of a significant gene-level interaction. 
 In GESAT, the number of markers in each SNP set cannot exceed the number of 
individuals, which was problematic for NR3C2, where the number of SNPs with a MAF 
> 5% in the SNPs sets ranges from 322 to 358 (African Americans, n=215; European 
Americans, n=170; Hispanic Americans, n=454).  To work around this matrix structure 
limitation, NR3C2 was split into five smaller SNP sets within each ethnic group. 
Power Calculations 
 To estimate power for gene-based association testing, we used the following 
SKAT power calculation parameters: 100 simulations over a 40kb gene region, and 
setting the maximum effect to 2, percentage of causal SNPs to 5%, and the frequency of 
negative interaction effects to 20%.  We tested three ethnic groups, four outcomes, six 
gene regions, and seven cortisol outcomes, for a total of 504 tests.  Using an alpha level 
of 0.05 and a Bonferroni correction, the result is a significance threshold at p<9x10
-5
.  
Table 30 presents the SKAT output table showing power calculations, based on the 
criteria above.  Given the limited sample size of each ethnic group, we expect roughly 




Americans (n=215), and 76% among the Hispanic Americans (n=454).  However, given 
the significant (p<0.05) correlation between cortisol features (Table 31), the Bonferoni 
corrected estimates represent a conservative lower bound as the tests are not independent.  
Therefore, the significance threshold for GESAT was set to p<0.05.   
 
Table 30: Gene-level power calculations. 
Sample Size Alpha Level 
0.01 9e-05 1e-06 
50 0.40 0.25 0.15 
100 0.57 0.39 0.23 
150 0.67 0.50 0.33 
200 0.73 0.58 0.42 
250 0.78 0.63 0.49 
300 0.81 0.68 0.54 
350 0.83 0.72 0.57 
400 0.85 0.74 0.60 
450 0.86 0.76 0.63 




Table 31: Pearson’s product moment correlation coefficients between cortisol summary features, 
all ethnic groups combined. 
  Wakeup Bedtime CAR AUC EDSlope LDSlope ODSlope 
Wakeup 1.00       
Bedtime 0.39 1.00      
CAR -0.44 -0.14 1.00     
AUC 0.49 0.74 -0.01 1.00    
EDSlope -0.24 -0.05 -0.29 0.08 1.00   
LDSlope 0.08 0.50 -0.08 0.35 -0.39 1.00  
ODSlope -0.34 0.43 0.18 0.39 0.04 0.72 1.00 
        





Basic demographic information on the Stress Study participants is provided in 
Table 32.  Hispanic Americans represented the largest proportion of participants (52.8%), 
relative to the African Americans (28.6%) and European Americans (18.6%).  The 
gender distribution was fairly equal (52.4% female).  Overall, cortisol feature means 
varied across ethnic groups (Table 33).  There was a statistically significant difference in 
means across the ethnic groups for all cortisol features except CAR.   
 





      Columbia 52.2% 
      UCLA 47.8% 
Age  
      45-54 29.9% 
      55-64 27.7% 
      65-74 30.3% 
      75-84 12.1% 
Race  
      European American 18.6% 
      African American 28.6% 
      Hispanic American 52.8% 
Gender  
      Male 47.6% 
      Female 52.4% 
Education Level  
      Less than High School 27.0% 
      Completed High School 20.2% 
      Some College 29.7% 
      Bachelor’s or higher 23.2% 
Income  
      < $20,000 29.3% 
      $20,000-34,999 27.5% 
      $35,000-$49,999 16.5% 
      $50,000 or higher 26.8% 
Percent Current Smokers 11.3% 
Percent Diabetic 13.5% 
















 N Mean (SD) N Mean (SD) N Mean (SD) p-value 
Wakeup 166 2.58 (0.54) 214 2.38 (0.55) 450 2.38 (0.58) 0.0002 
Bedtime 166 0.78 (0.77) 212 0.98 (0.74) 448 0.49 (0.84) <0.0001 
CAR 160 0.45 (0.46) 203 0.35 (0.46) 412 0.37 (0.52) 0.17 
AUC 166 1.64 (0.43) 209 1.60 (0.42) 442 1.46 (0.51) <0.0001 
EDSlope 163 -0.53 (0.35) 209 -0.42 (0.44) 433 -0.40 (0.44) 0.003 
LDSlope 164 -0.12 (0.06) 211 -0.10 (0.06) 447 -0.13 (0.06) <0.0001 
ODSlope 169 -0.12 (0.07) 214 -0.10 (0.06) 452 -0.12 (0.06) <0.0001 
Cortisol concentrations (nmol/L) were log-transformed and combined across the three days of collection to 
create each feature.  The mean and standard deviation (SD) of the transformed and summarized features are 
presented by ethnic group. 
 
 BMI was available for all individuals with phenotype and genotype information.  
ln(Glucose) and ln(TNF-α + 1) were available for nearly all individuals, while ln(IL-6 
+1) and the greatest missingness (Table 34).  In examining the difference in means 
between ethnic groups (Table 35), the means were significantly different from each other 
for all of the chronic disease risk factor outcomes except ln(TNF-α + 1).  We ran 
multivariable models to assess the impact of the cortisol features on BMI, ln(Glucose), 
ln(IL-6 + 1), and ln(TNF-α + 1), adjusting for age, gender, race, and education at baseline 
(Tables 36-42).  After accounting for covariates, every cortisol feature was a significant 
predictor of at least one outcome, with the exception of CAR. 
 
Table 34: Distribution of outcome variables. 
Outcome N Mean (SD) Range 
BMI kg/m
2
 839 29.0 (5.6) 15.3-54.9 
ln(Glucose) mg/dl 835 4.6 (0.2) 4.2-5.6 
ln(IL-6 + 1) pg/ml 805 1.2 (0.4) 0.4-2.6 




Table 35: Ethnic group specific distributions of chronic disease risk factors. 
 European Americans African Americans Hispanic Americans ANOVA 
 N Min Max Mean (SD) N Min Max Mean (SD) N Min Max Mean (SD) p-value 
BMI  170 18.2 47.0 26.6 (4.5) 215 15.3 54.0 30.1 (6.3) 454 18.7 54.9 29.5 (5.3) <0.0001 
ln(Glucose) 170 4.2 5.1 4.5 (0.1) 213 4.3 5.4 4.6 (0.2) 452 4.3 5.6 4.6 (0.2) <0.0001 
ln(IL-6 + 1) 166 0.5 2.5 1.1 (0.4) 205 0.4 2.5 1.2 (0.5) 434 0.4 2.6 1.3 (0.4) 0.009 
ln(TNF-α + 1) 167 0.1 3.5 1.4 (0.6) 214 0.1 3.7 1.4 (0.6) 440 0.1 3.1 1.5 (0.6) 0.19 
 
Table 36: Multivariable associations on chronic disease risk factors for AUC. 
Outcome N 
Age Gender AFA HIS Education AUC 
B p-value B p-value B p-value B p-value B p-value B p-value 
BMI 817 -0.06 0.002 -1.29 0.0007 2.94 <0.0001 1.91 0.001 -0.26 0.007 -0.48 0.24 
ln(Glucose) 813 0.001 0.18 0.04 0.008 0.06 0.01 0.08 0.0004 -0.01 0.007 -0.01 0.58 
ln(IL-6 + 1) 785 0.01 <0.0001 -0.03 0.36 0.10 0.03 0.11 0.02 -0.02 0.02 0.08 0.02 
ln(TNF-α + 1) 801 0.01 <0.0001 -0.03 0.42 0.08 0.18 0.15 0.02 0.01 0.43 0.01 0.82 
 
Table 37: Multivariable associations on chronic disease risk factors for Bedtime. 
Outcome N 
Age Gender AFA HIS Education Bedtime 
B p-value B p-value B p-value B p-value B p-value B p-value 
BMI 826 -0.06 0.002 -1.39 0.0002 3.05 <0.0001 1.99 0.0006 -0.24 0.01 -0.12 0.61 
ln(Glucose) 822 0.001 0.26 0.04 0.01 0.06 0.008 0.08 0.0002 -0.01 0.01 0.0003 0.97 
ln(IL-6 + 1) 793 0.01 <0.0001 -0.02 0.48 0.09 0.05 0.10 0.03 -0.02 0.02 0.04 0.07 





Table 38: Multivariable associations on chronic disease risk factors for CAR. 
Outcome N 
Age Gender AFA HIS Education CAR 
B p-value B p-value B p-value B p-value B p-value B p-value 
BMI 775 -0.08 0.0001 -1.34 0.0005 3.18 <0.0001 2.01 0.0006 -0.24 0.01 -0.41 0.29 
ln(Glucose) 771 0.001 0.27 0.04 0.005 0.07 0.003 0.09 0.0002 -0.01 0.03 -0.01 0.33 
ln(IL-6 + 1) 745 0.01 <0.0001 -0.01 0.72 0.10 0.04 0.09 0.05 -0.02 0.03 -0.01 0.78 
ln(TNF-α + 1) 759 0.01 <0.0001 -0.02 0.71 0.10 0.13 0.15 0.02 0.01 0.60 0.01 0.77 
 
Table 39: Multivariable associations on chronic disease risk factors for EDSlope. 
Outcome N 
Age Gender AFA HIS Education EDSlope 
B p-value B p-value B p-value B p-value B p-value B p-value 
BMI 805 -0.07 0.0003 -1.51 <0.0001 2.85 <0.0001 1.80 0.002 -0.23 0.02 1.30 0.004 
ln(Glucose) 801 0.001 0.24 0.04 0.02 0.06 0.01 0.08 0.0008 -0.01 0.02 0.04 0.01 
ln(IL-6 + 1) 773 0.01 <0.0001 -0.04 0.24 0.09 0.06 0.07 0.11 -0.02 0.04 0.14 0.0001 
ln(TNF-α + 1) 789 0.01 <0.0001 -0.03 0.54 0.09 0.13 0.14 0.02 0.01 0.48 0.08 0.12 
 
Table 40: Multivariable associations on chronic disease risk factors for LDSlope. 
Outcome N 
Age Gender AFA HIS Education LDSlope 
B p-value B p-value B p-value B p-value B p-value B p-value 
BMI 822 -0.07 0.0006 -1.26 0.0008 2.99 <0.0001 2.09 0.0003 -0.25 0.008 0.18 0.95 
ln(Glucose) 818 0.001 0.26 0.04 0.007 0.07 0.003 0.08 0.0003 -0.01 0.008 -0.08 0.47 
ln(IL-6 + 1) 789 0.01 <0.0001 -0.02 0.48 0.09 0.05 0.11 0.02 -0.02 0.03 0.48 0.04 






Table 41: Multivariable associations on chronic disease risk factors for ODSlope. 
Outcome N 
Age Gender AFA HIS Education ODSlope 
B p-value B p-value B p-value B p-value B p-value B p-value 
BMI 835 -0.07 0.0002 -1.39 0.0002 2.93 <0.0001 2.18 0.0001 -0.23 0.01 6.89 0.03 
ln(Glucose) 831 0.001 0.29 0.04 0.007 0.06 0.006 0.08 0.0002 -0.01 0.009 0.08 0.49 
ln(IL-6 + 1) 801 0.01 <0.0001 -0.04 0.20 0.07 0.10 0.10 0.02 -0.02 0.04 1.18 <0.0001 
ln(TNF-α + 1) 817 0.01 <0.0001 -0.04 0.34 0.07 0.24 0.15 0.02 0.01 0.29 0.40 0.24 
 
Table 42: Multivariable associations on chronic disease risk factors for Wakeup. 
Outcome N 
Age Gender AFA HIS Education Wakeup 
B p-value B p-value B p-value B p-value B p-value B p-value 
BMI 830 -0.05 0.003 -1.27 0.0006 2.95 <0.0001 2.06 0.0003 -0.22 0.02 -1.19 0.0003 
ln(Glucose) 826 0.001 0.19 0.04 0.004 0.06 0.004 0.08 0.0002 -0.01 0.02 -0.02 0.07 
ln(IL-6 + 1) 796 0.01 <0.0001 -0.02 0.52 0.09 0.05 0.09 0.05 -0.02 0.03 -0.07 0.008 





 The results for the GESAT gene-level assessment of gene-by-cortisol interactions 
are presented in Tables 43-46.  Given concerns with multiple testing, we considered 
instances where there was evidence of gene-level interaction (p<0.05) in at least two of 
the three ethnic groups for any gene-by-cortisol feature combination to provide the 
strongest evidence of gene-level interaction effects.  There were six instances where the 
interaction p-value was < 0.05 in more than one ethnic group: for ln(Glucose), the  
interaction between SLC6A4 and ODSlope; for ln(IL-6 + 1), the interaction between, 
ADRB2 and Bedtime, NR3C2 and Bedtime, and NR3C2 and EDSlope; for TNF-α, the 
interaction between NR3C1 and Bedtime, and the interaction between NR3C2 and 





Table 43: Gene-by-cortisol interactions for BMI. 
Cortisol   ADRA2A ADRB2 NR3C1 NR3C2 SLC6A4 TH 
Feature Race p-value p-value p-value p-value p-value p-value 
AUC AFA 0.002 0.28 0.27 0.31 0.32 0.97 
  EA 0.18 0.57 0.62 0.22 0.001 0.39 
  HIS 0.68 0.62 0.63 0.32 0.09 0.09 
Bedtime AFA 0.14 0.14 0.03 0.20 0.36 0.51 
  EA 0.67 0.10 0.06 0.52 0.001 0.28 
  HIS 0.34 0.89 0.86 0.06 0.94 0.41 
CAR AFA 0.88 0.50 0.42 0.23 0.22 0.89 
  EA 0.03 0.14 0.76 0.06 0.16 0.22 
  HIS 0.78 0.05 0.81 0.22 0.97 0.09 
EDSlope AFA 0.41 0.43 0.03 0.71 0.16 0.98 
  EA 0.77 0.27 0.86 0.005 0.47 0.84 
  HIS 0.50 0.66 0.22 0.36 0.55 0.01 
LDSlope AFA 0.09 0.79 0.06 0.29 0.02 0.03 
  EA 0.53 0.09 0.20 0.45 0.13 0.94 
  HIS 0.78 0.98 0.10 0.43 0.63 0.91 
ODSlope AFA 0.28 0.09 0.06 0.20 0.08 0.12 
  EA 0.71 0.25 0.69 0.10 0.12 0.86 
  HIS 0.93 0.41 0.16 0.42 0.72 0.12 
Wakeup AFA 0.06 0.13 0.21 0.65 0.41 0.34 
  EA 0.14 0.45 0.76 0.01 0.52 0.46 





Table 44: Gene-by-cortisol interactions for ln(Glucose). 
Cortisol    ADRA2A ADBR2 NR3C1 NR3C2 SLC6A4 TH 
Feature Race p-value p-value p-value p-value p-value p-value 
AUC AFA 0.76 0.58 0.93 0.12 0.65 1.00 
  EA 0.75 0.87 0.26 0.09 0.004 0.13 
  HIS 0.02 0.35 0.61 0.80 0.86 0.92 
Bedtime AFA 0.98 0.98 0.98 0.12 0.98 0.60 
  EA 0.99 0.78 0.23 0.33 0.04 0.01 
  HIS 0.13 0.81 0.93 0.17 0.61 0.96 
CAR AFA 0.83 0.73 0.37 0.27 0.43 0.22 
  EA 0.38 0.86 0.57 0.24 0.54 0.07 
  HIS 0.06 0.79 0.44 0.53 0.15 0.50 
EDSlope AFA 0.33 0.23 0.21 0.48 0.96 0.16 
  EA 0.66 0.47 0.01 0.30 0.39 0.45 
  HIS 0.63 0.26 0.06 0.66 0.81 0.10 
LDSlope AFA 0.37 0.21 0.18 0.10 0.003 0.01 
  EA 0.20 0.36 0.20 0.27 0.20 0.63 
  HIS 0.43 0.52 0.11 0.03 0.73 0.44 
ODSlope AFA 0.11 0.40 0.18 0.27 0.002 0.03 
  EA 0.48 0.29 0.62 0.06 0.01 0.47 
  HIS 0.11 0.58 0.67 0.48 0.93 0.66 
Wakeup AFA 0.08 0.10 0.34 0.51 0.37 0.43 
  EA 0.63 0.62 0.92 0.008 0.20 0.26 





Table 45: Gene-by-cortisol interactions for ln(IL-6 + 1). 
Cortisol    ADRA2A ADBR2 NR3C1 NR3C2 SLC6A4 TH 
Feature Race p-value p-value p-value p-value p-value p-value 
AUC AFA 0.38 0.006 0.24 0.07 0.28 0.19 
  EA 0.30 0.80 0.22 0.02 0.008 0.37 
  HIS 0.24 0.55 0.31 0.09 0.19 0.83 
Bedtime AFA 0.07 0.03 0.81 0.02 0.14 0.16 
  EA 0.09 0.37 0.07 0.02 0.02 0.41 
  HIS 0.31 0.03 0.59 0.18 0.46 0.97 
CAR AFA 0.85 0.15 0.86 0.02 0.34 0.69 
  EA 0.52 0.01 0.20 0.05 0.02 0.06 
  HIS 0.68 0.16 0.59 0.08 0.14 0.17 
EDSlope AFA 0.14 0.46 0.16 0.02 0.37 0.53 
  EA 0.19 0.77 0.73 0.02 0.38 0.15 
  HIS 0.65 0.22 0.11 0.05 0.77 0.03 
LDSlope AFA 0.07 0.07 0.95 0.08 0.03 0.54 
  EA 0.29 0.09 0.23 0.08 0.24 0.48 
  HIS 0.24 0.44 0.40 0.40 0.98 0.34 
ODSlope AFA 0.69 0.09 0.23 0.08 0.52 0.65 
  EA 0.06 0.23 0.30 0.04 0.29 0.05 
  HIS 0.23 0.96 0.11 0.31 0.95 0.85 
Wakeup AFA 0.98 0.34 0.25 0.20 0.23 0.26 
  EA 0.95 0.12 0.52 0.04 0.21 0.62 





Table 46: Gene-by-cortisol interactions for ln(TNF-a + 1). 
Cortisol    ADRA2A ADBR2 NR3C1 NR3C2 SLC6A4 TH 
Feature Race p-value p-value p-value p-value p-value p-value 
AUC AFA 0.71 0.41 0.82 0.05 0.28 0.74 
  EA 0.45 0.59 0.39 0.42 0.98 0.09 
  HIS 0.28 0.45 0.01 0.13 0.27 0.95 
Bedtime AFA 0.45 0.95 0.42 0.08 0.39 0.49 
  EA 0.39 0.83 0.01 0.04 0.82 0.25 
  HIS 0.86 0.62 0.01 0.22 0.60 0.51 
CAR AFA 0.80 0.15 0.16 0.18 0.62 0.64 
  EA 0.72 0.81 0.86 0.54 0.21 0.76 
  HIS 0.90 0.88 0.65 0.43 0.62 0.20 
EDSlope AFA 0.86 0.79 0.02 0.10 0.89 0.64 
  EA 0.28 0.43 0.33 0.11 0.08 0.70 
  HIS 0.22 0.18 0.86 0.10 0.50 0.37 
LDSlope AFA 0.65 0.31 0.07 0.77 0.93 0.48 
  EA 0.81 0.67 0.56 0.23 0.64 0.46 
  HIS 0.65 0.02 0.02 0.11 0.92 0.60 
ODSlope AFA 0.69 0.54 0.63 0.13 0.70 0.22 
  EA 0.68 0.97 0.55 0.05 0.27 0.65 
  HIS 0.08 0.39 0.02 0.44 0.71 0.33 
Wakeup AFA 0.82 0.23 0.59 0.52 0.50 0.73 
  EA 0.44 0.37 0.43 0.03 0.69 0.45 
  HIS 0.007 0.50 0.66 0.04 0.54 0.46 
 Bold = p<0.05 
 
To further investigate the gene-by-cortisol interactions where there was 
significant evidence (p < 0.05) in two ethnic groups, we examined the individual SNP-
by-cortisol interactions in these regions.  The interaction between SLC6A4 and ODSlope 
had the most significant evidence across the ethnic groups, with interaction p-values 
≤0.01 for African Americans and European Americans.  The individual SNP-by-cortisol 
interaction results for this association are shown in Table 47.  SNP level results for the 




Table 47: Individual SNP-by-ODSlope interactions in predicting ln(Glucose). 
  Cortisol       Coded   SNP Effects Cortisol Effects Interaction Effects 
Outcome Feature Gene Race SNP Allele Freq B p-value B p-value B p-value 
ln(Glucose) ODSlope SLC6A4 AFA rs9303628 T 0.37 0.09 0.02 -0.91 0.02 1.02 0.004 
  
   
rs3794808 T 0.40 -0.08 0.04 0.70 0.05 -0.99 0.004 
  
   
rs2066713 G 0.76 0.10 0.01 -0.65 0.04 1.05 0.004 
  
   
rs2020942 T 0.24 0.10 0.01 -0.68 0.04 0.98 0.008 
  
   
rs25528 T 0.49 0.11 0.009 -1.02 0.02 0.96 0.01 
  
   
rs8076005 G 0.63 0.11 0.006 -0.69 0.05 0.81 0.02 
  
   
rs140701 T 0.30 -0.06 0.20 0.38 0.26 -0.89 0.03 
  
   
rs2054848 T 0.90 -0.05 0.42 0.25 0.40 -1.08 0.04 
  




EA rs140701 T 0.47 -0.07 0.004 0.56 0.02 -0.42 0.02 
  
   
rs2020942 T 0.37 0.05 0.06 -0.26 0.18 0.45 0.02 
  
   
rs2020939 G 0.52 -0.06 0.01 0.53 0.03 -0.41 0.03 
  
   
rs4583306 G 0.47 -0.06 0.007 0.52 0.03 -0.40 0.03 
  
   
rs3794808 T 0.47 -0.07 0.003 0.52 0.03 -0.38 0.03 




Interestingly, four SNPs, rs2020942, rs140701, rs2066713, and rs3794808, had 
significant interaction p-values in both African Americans and European Americans.  The 
direction of effect for each SNP is also consistent across the ethnic groups. 
Some of the individual SNP findings may be driven by linkage disequilibrium 
patterns within the gene regions.  LocusZoom  
88
plots were used to evaluate the linkage 
disequilibrium with top SNPs in the six instances where there was evidence of gene-by-
cortisol in two ethnic groups.  The plot for the association between SLC6A4 and ODSlope 
is shown in Figures 25 and 26.  In the African Americans there is not strong evidence of 
linkage disequilibrium between the index SNP, rs9303628, and other SNPs in SLC6A4.  
In the European Americans, however, there is strong linkage disequilibrium (r
2
>0.8) 
between the index SNP, rs140701, and a number of other SNPs.  The plots for the other 







Figure 25: LocusZoom plot of the interaction between loci of the SLC6A4 gene region and 





Figure 26: LocusZoom plot of the interaction between loci of the SLC6A4 gene region and 




The initial individual SNP-by-cortisol interaction models assumed an additive 
effect of the minor allele.  We also ran agnostic models that did not assume an additive 
effect.  Table 48 presents the results for the SNP and interaction effects for the individual 
SNP-by-ODSlope interactions in predicting ln(Glucose).  These models compare the 
effects of having one copy of the minor allele to zero, as well as the presence of two 
copies of the minor allele to zero.  The SNPs in Table 48 are ordered the same as in Table 
47, where they were initially ranked in order of p-value by ethnic group where the 
interaction p-value was <0.05.  The direction of SNP effects for one or two copies of the 
minor allele are consistent for this set of SNPs.  With one exception, the p-values for the 
interaction between two copies of the minor allele and ODSlope were more significant 
that the p-values of the interaction with one copy.  The tables for the agnostic approach 




Table 48: Two degree of freedom test of individual SNP-by-ODSlope interactions in predicting ln(Glucose) 
  Cortisol       Coded   Minor  SNP Effects Interaction Effects 
Outcome Feature Gene Race SNP Allele Freq Alleles B p-value B p-value 
ln(Glucose) ODSlope SLC6A4 AFA rs9303628 T 0.37 1 0.05 0.45 0.87 0.12 
  
      
2 0.20 0.01 2.02 0.005 
  
   
rs3794808 T 0.40 1 -0.13 0.05 -0.70 0.20 
  
      
2 -0.15 0.06 -2.12 0.002 
  
   
rs2066713 G 0.76 1 0.03 0.61 0.37 0.51 
  
      
2 0.25 0.005 2.73 0.001 
  
   
rs2020942 T 0.24 1 0.03 0.62 0.23 0.67 
  
      
2 0.26 0.005 2.74 0.001 
  
   
rs25528 T 0.49 1 0.09 0.23 0.47 0.45 
  
      
2 0.23 0.007 2.08 0.008 
  
   
rs8076005 G 0.63 1 0.07 0.25 0.20 0.72 
  
      
2 0.23 0.004 1.98 0.006 
  
   
rs140701 T 0.30 1 -0.05 0.39 -0.70 0.18 
  
      
2 -0.15 0.20 -2.26 0.04 
  
   
rs2054848 T 0.90 1 -0.01 0.88 -0.97 0.09 
  
      
2 -0.29 0.25 -3.35 0.17 
  




EA rs140701 T 0.47 1 -0.10 0.04 -0.57 0.09 
  
      
2 -0.14 0.05 -0.89 0.02 
  
   
rs2020942 T 0.37 1 0.03 0.04 0.35 0.21 
  
      
2 0.10 0.05 0.97 0.02 
  
   
rs2020939 G 0.52 1 -0.09 0.05 -0.63 0.07 
  
      





   
rs4583306 G 0.47 1 -0.08 0.04 -0.48 0.15 
  
      
2 -0.13 0.05 -0.82 0.03 
  
   
rs3794808 T 0.47 1 -0.10 0.05 -0.48 0.16 
  
      
2 -0.14 0.05 -0.83 0.02 
  
   
rs2066713 G 0.63 1 0.02 0.04 0.28 0.32 





 This paper examined the key question of whether gene-by-cortisol interactions 
influence chronic disease risk factors.  There was evidence of stress response gene-by-
cortisol interaction in predicting BMI, Glucose, IL6, and TNF-α across all seven cortisol 
features and three ethnic groups.  While there were numerous significant (p<0.05) 
individual gene-by-cortisol interactions in one ethnic group, there were six instances 
when there was a significant interaction among two ethnic groups. 
 The evidence of interaction between NR3C1 and cortisol features is particularly 
interesting.  NR3C1 is a glucocorticoid receptor that is occupied when cortisol 
concentrations are high 
36
.  The interactions indicate that variation in NR3C1 influences 
the effect of cortisol on the downstream outcomes of glucose and TNF- α concentrations. 
 Additionally, there were several instances where within an ethnic group there 
were consistent associations across chronic disease risk factor outcomes.   In European 
Americans, the interaction between NR3C2 and Wakeup was significant (p<0.05) for all 
four chronic disease risk factor outcomes.  Also in European Americans, the interactions 
between AUC and Bedtime with SLC6A4 were significant predictors of BMI, 
ln(Glucose), and ln(IL-6 + 1).  In African Americans, the interaction between LDSlope 
and SLC6A4 was also significant for BMI, ln(Glucose), and ln(IL-6 + 1).  While 
previous work has shown that polymorphisms in the promoter region of SLC6A4 are 
associated with CAR 
62
, to my knowledge there is no published information on 
associations with the other cortisol features examined in this study.  As SLC6A4 is 




region and stress hormone levels having downstream effects on chronic disease risk 
factors is a novel and important finding.   
 Previous work has examined the relationship between cortisol and chronic disease 
risk factors.  The consequences of HPA axis dysfunction and the extreme 
hypercortisolism associated with Cushing’s syndrome are well known and include 
glucose intolerance, type II diabetes, and alterations of fat distribution 
65
.  However, 
cortisol also has important metabolic consequences at normal physiologic levels, which if 
extended over long periods as a consequence of chronic stress could result in HPA axis 
dysregulation that has important downstream effects on glucose metabolism, insulin 
resistance, and fat deposition 
22, 29
.  There is some evidence that cortisol and cortisol 
dysregulation are related to body fat distribution, obesity 
29, 66, 67
, and diabetes-related 
outcomes 
8, 68-70
.  Additionally, there has been increasing evidence that chronic stress can 
result in elevations of systemic inflammatory markers 
73-75
.  Recent work has noted 
associations between CRP (C-reactive protein, a marker of inflammation) and the cortisol 
awakening response 
99




The SKAT methodology used for these analyses has several advantages over 
other gene-based association methods (e.g. Cohort Allelic Sum Test (CAST) 
91
, Weighted 
Sum Statistic (WSS) 
92
, C-alpha test 
93
).  First, SKAT is a more powerful method, even 
when sample sizes are small (n=500) 
84
, which is of particular importance given the small 
ethnic group specific sample sizes for these analyses.  Second, SKAT allows for the 




that all variants have similar direction or magnitude of effect.  Thirdly, it allows for the 
adjustment of covariates.  SKAT additionally allows for the assessment of common 
variants by implementing an unweighted linear kernel, which fit our needs since we are 
using HapMap imputed genome-wide data.   
We followed up the SKAT analyses with individual SNP-by-cortisol associations, 
using traditional least squares regression approaches.  These analyses began with 
assuming and additive model for the genetic effects.  However, assuming additive SNP 
effects confines the SNP effects such that the difference between zero and one copy of 
the minor allele is expected to be equivalent to the difference between one and two 
copies.  Therefore, we also ran agnostic models that did not assume perfectly additive 
effects, but allowed for a comparison of the effect of one copy of the minor allele 
compared to zero and the effect of two copies of the minor allele compared to zero.  If the 
effects had been perfectly additive, the effect of two copies of the minor allele should 
have been double that of one copy.  We did not see evidence of this perfect minor allele 
dose response.  These analyses should be followed up, looking at each genotype class 
separately in order to model the effects of each genotype-by-cortisol interaction in 
predicting the chronic disease risk factor outcomes. 
 This study has some limitations.  First, compliance with cortisol sampling 
protocols is necessary for estimating reliable cortisol features 
79, 94
.  Compliance with 
taking samples within 10 minutes the requested times was greatest for wakeup (68%) and 
bedtime (75%) collections, and poorest during the middle of the day, ranging from 43%-




not functional SNPs.  Third, these analyses assumed an additive genetic effect, which 
ignores the possible influence of dominant or epistatic variations. 
 Fourth, the gene-level analysis method was unable to handle the original matrix 
dimensions of NR3C2 given the limited ethnic group specific sample sizes.  The SKAT 
methodology assesses sets of SNPs which do not necessarily have to make up a gene, and 
as such evaluating smaller sections of a large gene solves a structural problem.  As SKAT 
assesses whether the individual SNP effects vary from a mean of zero in either direction, 
the cumulative effect of individual SNPs in the sub-set regions may not reflect the overall 
cumulative effect across NR3C2. 
Despite the limitations, this work is novel in the ability to examine gene-by-
cortisol interactions, considering multiple gene regions, cortisol features, and ethnic 
groups, in predicting chronic disease risk factors, which was possible through the use of 
the innovative SKAT methodologies as well has the unique, highly detailed cortisol 
phenotype information.  The gene-level analytic approach allows us to address the 
concern that individual SNPs may not replicate across ethnic groups due to differences in 
underlying patterns of linkage disequilibrium or to differences in allele frequencies 
95-97
.  
Future work should expand to other HPA axis genes and also take advantage of new 






A GENOME-WIDE ASSOCIATION STUDY (GWAS) OF SALIVARY 




A growing body of work has examined the contribution of stress and related 
constructs such as allostatic load to various health outcomes 
100, 101
.  The hormone cortisol 
is likely to be a key mediator of the stress response that has implications for various 
physiologic systems (such as the cardiovascular system, immune system, and 
metabolism) involved in chronic disease 
30, 31
.  Consequently several studies have focused 
on understanding both predictors and consequences of cortisol levels 
102, 103
. 
Cortisol concentrations follow a strong daily pattern.  They are high upon 
awakening, reach a maximum concentration approximately half an hour later, and slowly 
decrease throughout the rest of the day 
1-3
.  Additionally, cortisol concentrations increase 
in response to a stressor 
32
.  Under conditions of chronic stress, prolonged increased 
concentrations could have detrimental downstream physiological effects. 
The nature of within person variability of cortisol necessitates the use of multiple 
measures over the day to characterize a given person’s daily profile. Cortisol 
concentrations can be measured from multiple biological samples: urine, blood serum, 




of the need for repeated collection, making the ability to measure cortisol concentrations 
in salivary samples an ideal alternative 
40, 41
.  Salivary cortisol concentrations have been 
shown to be highly correlated with blood serum cortisol concentrations, with correlations 
ranging from 0.71-0.96 
2, 40-43
.  
An individual’s daily cortisol response has been shown to be associated with 
several demographic factors.  Age has been shown to be a significant predictor of cortisol 
concentrations, where concentrations increase with age 
13
.  Additionally, there are gender 
differences with respect to salivary cortisol concentrations, with men having significantly 
higher mean levels than women 
14
.  Associations with race/ethnicity and socioeconomic 
factors have also been reported.  Flatter declines later in the day (less steep slopes) have 
been observed in African Americans compared to European Americans.  This pattern of 
flatter afternoon decline has also been shown in lower socioeconomic status groups 
relative to higher socioeconomic status groups 
5-7
.   It has been suggested that chronic 
stress may explain the flatter declines in these individuals 
44, 45
.   
Several population-based studies have linked daily cortisol patterns to health 
outcomes, including elevated blood pressure, abdominal obesity, and coronary 
calcification 
8-10
.  Cortisol concentrations and various features of the cortisol daily profile 
have also been associated with diabetes mellitus 
11
 and markers of inflammation 
12
.  
Despite evidence of associations of various risk factors with cortisol, considerable 
inter-individual variability in cortisol remains unexplained, which has led to increased 
interest in examining genetic predictors of cortisol phenotypes 
15
.  In a combined analysis 





.  While the high heritability estimate for basal cortisol concentrations indicates that 
there is a genetic component to concentration levels, it is unknown what genetic factors 
are driving this association. 
Alone or in interaction with environmental features, genetic factors could 
contribute to unexplained variability in cortisol concentrations or cortisol responsivity. 
Most of the work to date has focused on candidate gene associations of cortisol, notably 




To our knowledge only one genome-wide association study (GWAS) has been 
conducted on salivary cortisol.  This study examined the area under the cortisol curve in a 
group of roughly 1,700 European participants from the Rotterdam Study, which found 
evidence of associations with FKBP5 
104
.  Additionally, there has been one published 
GWAS study of morning serum cortisol concentrations in a group of approximately 500 
Hutterites in the western United States, which found evidence of association for two 
microsatellite markers, one on chromosome 11 and the other on chromosome 14 
105
. 
We conducted a genome-wide association study of salivary cortisol 
concentrations among participants of the Multi-Ethnic Study of Atherosclerosis (MESA) 
Stress Study to identify novel loci associated with multiple features of the diurnal cortisol 
curve in European Americans (n=170), African Americans (n=215), and Hispanic 
Americans (n=454) separately.  An important strength of the MESA Stress Study is the 
availability of multiple measures of cortisol over several days. The richness of this data 




awakening response, the slope of declines, and area under the cortisol curve. In addition, 
the availability of measures over multiple days allows improved characterization of the 
cortisol features. In this paper we use traditional methods for genome-wide association 
analysis in each ethnic group and use sample size weighted meta-analysis methods for 
comparing those results across groups 
106




The MESA Stress Study is an ancillary study to the Multi-Ethnic Study of 
Atherosclerosis (MESA).  The MESA study is a longitudinal cohort study focused on 
investigating the early stages of atherosclerosis.  Eligible participants were 45-84 years of 
age and free from history of cardiovascular disease at the baseline examination (2000-
2002) 
78
. The MESA Stress Study took place in the context of MESA examinations 3 and 
4 conducted between 2004 and 2006, and obtained detailed stress hormone data on a 
subsample of 1002 MESA participants recruited from the New York and Los Angeles 
sites.  Participants for the MESA Stress Study were African Americans, European 
Americans, and Hispanic Americans and were enrolled as they presented for follow-up, 
until approximately 500 participants were recruited from each location. We used 
individual covariate data from the MESA examination in which an individual’s cortisol 
data collection occurred.  
Of the 1002 MESA Stress Study participants, exclusions for 1) raw cortisol data 




for use of genetic information, and 4) concurrent corticosteroid usage, resulted in a 
sample size of 839 individuals.  The ethnic specific distribution of this sample is as 
follows: European Americans (n= 170), African Americans (n= 215), Hispanic 
Americans (n = 454).  
Cortisol Sample Collection 
Each MESA Stress Study participant was asked to collect six saliva samples per 
day at pre-specified times over three consecutive weekdays, for a maximum of 18 
samples per participant, using Salivette collection tubes.  The samples were collected 
using the following schedule: sample (1) upon waking and before getting out of bed; (2) 
30 minutes later; (3) around 10:00am; (4) around 12:00 noon or before lunch, whichever 
came first; (5) around 6:00pm or before dinner, whichever came first; (6) just before bed.  
Because earlier work has shown that the use of a time tracking device improves sample 
collection compliance 
79
, each collection tube was equipped with a time tracking device, 
which recorded the time when the swabs were removed for sample collection.   
Cortisol Features 
Rather than explore only cortisol concentrations at specific time points, we 
explored multiple features of the diurnal cortisol cycle (Table 49, Figure 27).  Features 
were selected for investigation because prior work has hypothesized or demonstrated 
their associations with health risk factors or health outcomes 
11, 12, 83, 85
.  Features were 
modeled using all available salivary cortisol data (up to six samples per day collected 
over three days).  Raw cortisol concentrations, measured in nmol/L, were log-





































AUC 16hr = CAR AUC + Early Decline AUC + Late Decline AUC
 
Figure 27: Representation of the diurnal cortisol curve describing our summary features of 
interest.  For these analyses we specifically used Wakeup, Bedtime, Cortisol awakening response 
(CAR), Area under the curve (AUC) from 0-16 hours, Early Decline Slope, Late Decline Slope, 
and Overall Decline Slope. 




Average cortisol concentration from wakeup for an 
individual (Sample 1). 
Bedtime 
Average cortisol concentration at bedtime for an individual 
(Sample 6). 
Area  
Area under the curve 
(AUC) 
Standardized AUC  for the interval  0hr-16hr since wakeup 




The average difference in cortisol concentrations between 
the peak and wakeup measurements (Sample 2 – Sample 1). 
Early Decline Slope 
(EDSlope) 
The slope from 0.5 hours and 2 hours since wakeup pooled 
across all days for an individual. 
Late Decline Slope 
(LDSlope) 
The slope from 2 hours to 16 hours since wakeup pooled 
across all days for an individual 
Overall Decline Slope 
(ODSlope) 
The overall decline slope ignoring the peak value from 





Genotyping data included both measured and imputed SNPs available through 
participation in MESA SHARe (SNP Health Association Resource) project.   Under the 
SHARe project, genome-wide genotyping was obtained using the Affymetrix Genome-
Wide Human SNP Array 6.0 platform.  Imputation to HapMap was completed at the 
MESA Genetics Centers using the IMPUTE2 
82
 program with the following reference 
panels:  the HapMap Phase I and II, the human genome reference sequence (NCBI Build 
36).  The HapMap project is based on ethnic specific reference panels, composed of the 
following groups: Yoruba in Ibadan, Nigeria (abbreviation: YRI), Japanese in Tokyo, 
Japan (abbreviation: JPT), Han Chinese in Beijing, China (abbreviation: CHB), CEPH 
(Utah residents with ancestry from northern and western Europe) (abbreviation: CEU).  
Imputation for African Americans and Hispanic Americans was performed using the 
CEU+YRI+CHB+JPT reference panels (release #22). Imputation for European 
Americans was performed using only the CEU reference panel (release #24).  All 
imputed and genotyped SNPs were aligned to the “+” strand of the human genome 
reference sequence (NCBI Build 36).  In order to account for population structure and 
admixture within MESA samples, principal components were extracted from genome-
wide data in each ethnic group separately.   
Statistical Strategy 
Genome-wide association studies (GWAS) were conducted in each ethnic group 
separately, using SNPTest genetic analysis software (version 2) 
89
.  Linear regression was 




(SNP).  We used the Frequentist=1 and Method=Expected specifications, which allowed 
for an additive model of association and use of expected genotype dosages, respectively.   
The primary model included age and sex as covariates.  Ethnic specific principal 
components were estimated using MESA Classic participants, and outliers were removed.  
The top 10 principal components were included in the model for African Americans and 
Hispanics after linear modeling indicated evidence of association between background 
genetic structure represented by the principal components and features of the cortisol 
curve.  There was limited evidence of association in the European Americans, and as 
such we did not adjust for PCs.  Filtering was performed to remove results for SNPs with 
minor allele frequency (MAF) less than 5% or with imputation quality (Info) < 0.5.    
After filtering the ethnic specific number of SNPs considered was 2,516,994 for African 
Americans, 2,256,299 for European Americans, and 2,258,434 for Hispanic Americans.  
A p-value<5x10
-8
 was considered the genome-wide significance threshold, and a p-
value<1x10
-6
 was considered suggestive of genome-wide significance.  
The R (version 2.14.0) 
87
 package METAL 
106
 (March 2011 release) was used to 
conduct a random-effects meta-analysis of the GWAS results from each ethnic group for 
each cortisol feature.  We carried out a sample size weighted analysis based on p-values, 
where, an overall z-statistic for each SNP is calculated based on the sum of the individual 
z-statistics from each ethnic group, weighted by the square-root of the number of 





Basic demographic information on the Stress Study participants is provided in 
Table 50.  Hispanic Americans represented the largest proportion of participants (52.8%), 
relative to the African Americans (28.6%) and European Americans (18.6%).  The 
gender distribution was fairly equal (52.4% female).  Overall, cortisol feature means 
varied across ethnic groups (Table 51).  There was a statistically significant difference in 
means across the ethnic groups for all cortisol features except CAR. 
 
 





      Columbia 52.2% 
      UCLA 47.8% 
Age  
      45-54 29.9% 
      55-64 27.7% 
      65-74 30.3% 
      75-84 12.1% 
Race  
      European American 18.6% 
      African American 28.6% 
      Hispanic American 52.8% 
Gender  
      Male 47.6% 
      Female 52.4% 
Education Level  
      Less than High School 27.0% 
      Completed High School 20.2% 
      Some College 29.7% 
      Bachelor’s or higher 23.2% 
Income  
      < $20,000 29.3% 
      $20,000-34,999 27.5% 
      $35,000-$49,999 16.5% 
      $50,000 or higher 26.8% 
Percent Current Smokers 11.3% 
Percent Diabetic 13.5% 















 N Mean (SD) N Mean (SD) N Mean (SD) p-value 
Wakeup 166 2.58 (0.54) 214 2.38 (0.55) 450 2.38 (0.58) 0.0002 
Bedtime 166 0.78 (0.77) 212 0.98 (0.74) 448 0.49 (0.84) <0.0001 
CAR 160 0.45 (0.46) 203 0.35 (0.46) 412 0.37 (0.52) 0.17 
AUC 166 1.64 (0.43) 209 1.60 (0.42) 442 1.46 (0.51) <0.0001 
EDSlope 163 -0.53 (0.35) 209 -0.42 (0.44) 433 -0.40 (0.44) 0.003 
LDSlope 164 -0.12 (0.06) 211 -0.10 (0.06) 447 -0.13 (0.06) <0.0001 
ODSlope 169 -0.12 (0.07) 214 -0.10 (0.06) 452 -0.12 (0.06) <0.0001 
Cortisol concentrations (nmol/L) were log-transformed and combined across the three days of collection to 
create each feature.  SD = Standard Deviation.   
 
GWAS Results 
Graphical representations of the GWAS results in each ethnic group for the seven 
cortisol features are represented in the Appendix Materials by Q-Q Plots (Appendix 
Figures A24-A44) and Manhattan Plots (Appendix Figures A45-A51).  One locus 
reached genome-wide significance (p<5x10
-8
) and an additional 17 loci reached a 
suggestive level of association (p<1x10
-6
).  In the African American analysis of the 
cortisol awakening response (CAR) (Figure 28), two SNPs on chromosome 1 passed the 
genome-wide significance threshold (p = 9.42x10
-10
 and p = 1.76x10
-09
).  As these two 
SNPs were in high linkage disequilibrium (r
2
 >0.8), they represent one signal.  Table 52 
lists the most strongly associated SNPs (p<1x10
-6
) for each feature, ranked in order of 
significance. When a locus identified multiple SNPs that were in high linkage 
disequilibrium (r
2





Figure 28: GWAS results for cortisol awakening response (CAR) in African Americans.  
Individual SNP p-values located above the blue line are suggestive of genome-wide significance 
–log10(p<1x10
-6
).  Individual SNP p-values located above the red line have reached genome-wide 
significance –log10 (p<5x10
-8





Table 52: Most strongly associated SNPs (at 1x10
-6
 or less) for each cortisol summary feature.  Only single SNPs in regions where there was 
strong LD are displayed. 
Cortisol 
Feature 
Race SNP CHR POS 
Effect 
Allele 
Freq Beta  p-value 
Nearest 
Gene(s) ±50kb 
Wakeup CAU rs7701889 5 126043888 G 0.9331 0.566  5.28E-07 ---- 
Wakeup AFA rs7217942 17 6087394 T 0.1020 -0.377  5.96E-07 ---- 
Wakeup HIS rs1320124 2 240941561 G 0.7973 0.260  8.23E-07 ---- 
            
Bedtime AFA rs10448237 9 36838997 G 0.4490 -0.348  3.56E-07 PAX5* 
Bedtime CAU rs715262 16 59384147 G 0.3090 0.430  6.73E-07 ---- 
            
CAR AFA rs290827 1 97246872 G 0.3634 -0.278  9.42E-10 ---- 
CAR CAU rs17582686 12 40248012 T 0.8836 -0.419  1.13E-07 PDZRN4* 
CAR AFA rs7687462 4 11544862 T 0.6108 -0.236  1.81E-07 ---- 
            
AUC HIS rs10490591 2 146720035 G 0.0956 -0.287  5.65E-07 ---- 
            
EDSlope CAU rs3791682 2 211957951 T 0.6881 0.196  9.47E-07 ERBB4* 
            
LDSlope AFA rs1052199 9 76951677 G 0.5600 0.034  2.73E-07 OSTF1* 
LDSlope CAU rs3734068 11 129320230 G 0.0828 -0.067 3.51E-07 PRDM10* 
LDSlope HIS rs6557164 6 152044625 T 0.1566 -0.034 7.59E-07 ERS1 
            
ODSlope AFA rs8086616 18 22049890 G 0.0689 0.049 8.89E-08 
TAF4B; 
PSMA8 
ODSlope AFA rs11024350 11 17613262 T 0.0813 0.046  2.99E-07 ---- 
ODSlope HIS rs2827248 21 22420514 G 0.8496 0.025  3.48E-07 ---- 
ODSlope CAU rs12526290 6 160529342 G 0.0709 -0.056  3.74E-07 
SLC22A1; 
SLC22A2 
ODSlope AFA rs2503663 6 92811107 T 0.5157 0.026  6.82E-07 ---- 





After meta-analysis none of the GWAS SNPs reached genome-wide significance, 
although there were promising results in four of the seven cortisol summary features at p 
< 5x10
-6
.  Table 53 shows the meta-analysis results for the four features (AUC, Bedtime, 
CAR, and Wakeup) in which the SNP was available in at least two of the three ethnic 
groups.  These SNPs are located across the genome, on chromosomes 8, 11, 12, and 15.  
The direction of effect for each meta-analysis locus was consistent across the three ethnic 
groups.  The majority of individual p-values in each group were less than 0.05, indicating 
a relatively high level of agreement on the association with the cortisol feature, even 
though the MAF often varied.  The sample size for the meta-analysis SNPs is less than 
the 839 total individuals either due to missingness for the phenotype or SNP missingness. 
In order to determine whether the SNP effects were similar across ethnic groups, 
we performed an assessment of heterogeneity between the three ethnic groups in METAL 
(Table 54).  I
2
 is the percentage of effect size variability due to true differences in effects 
across the ethnic groups 
107
.  Three of the I
2
 values were 0 or close to 0 indicating that 
variability in effect estimates at that SNP is due to sampling error. Although two of the I
2
 
values suggested that 32% and 58% of the variability between groups is due to true 
heterogeneity, p-values were >0.05 indicating no evidence of statistically significant 





















AUC rs2111270 A 12 12473003 0.23  761 5.004 5.63E-07  +++ LOH12CR1* 
AFA      0.06    0.0007   
CAU      0.27    0.0014   
HIS      0.29    0.0127   
Bedtime rs2410611 T 8 19292641  0.29  761 -4.953 7.32E-07  --- 
SH2D4A;  
AFA      0.19    0.0013  
CSGALNACT1 
CAU      0.19    0.7694   
HIS      0.37    1.33E-05   
CAR rs7174390 T 15 55813252  0.41  761 -4.99 6.05E-07  --- GCOM1; 
AFA      0.28    0.0065  GRINL1A 
CAU      0.45    0.0092   
HIS      0.46    0.0009   
Wakeup rs7929069 A 11 134437775  0.18  756 -4.921 8.59E-07  ---  
AFA      0.23    0.0115   
CAU      0.16    0.0008   
HIS      0.16    0.0037   
Wakeup rs6473381 A 8 83760172 0.34   761 -5.008 5.51E-07  ---  
AFA      0.26    0.0067   
CAU      0.39    0.3101   
HIS      0.36    1.48E-05   





















AUC 16  rs2111270 A 0.23 (0.10) 32.5 2.965 (2) 0.227 
Bedtime rs2410611 T 0.29 (0.09) 58.7 4.848 (2) 0.089 
CAR rs7174390 T 0.41 (0.07) 0 0.265 (2) 0.876 
Wakeup rs7929069 A 0.18 (0.03) 0 1.764 (2) 0.414 




 This study examined the key question of whether genetic factors contribute to 
inter-individual variation in cortisol profiles by assessing the genome-wide associations 
of seven cortisol features.  We identified novel genetic loci associated with the features of 
the diurnal cortisol curve in a multi-ethnic study population, with 1 SNP (rs290827) 
being significantly associated with the CAR in African Americans (β= -0.278, 
p=9.43x10
-10
).  There is no evidence of association for this locus in the other two ethnic 
groups.  Additionally, the direction of effect for this SNP is not consistent for European 
Americans (β=0.041, p=0.45) and Hispanic Americans (β=0.060, p=0.10) compared to 
the African American findings.  However, for the African Americans the ‘G’ allele was 
the minor allele (frequency=0.36), while for the European Americans and the Hispanic 
Americans the ‘G’ allele was the major allele (EA frequency=0.63, HIS frequency=0.52).   
Beyond the genome-wide significant result in the African Americans, we had 
many suggestive loci at p<1x10
-6
 across ethnic groups for multiple cortisol features. 
Additionally, there were six gene regions that were implicated either by the GWAS 




LOH12CR1.  Three of the six genes, PAX5, ERBB4, and PRDM10, are involved in 
central nervous system development.   
PAX5, a B-cell specific transcription factor, has implications for midbrain and 
cerebellum development 
108
.  As a B-cell transcription factor, PAX5 has also been 
associated with a number of cancers, specifically leukemias and lymphomas 
109
.  ERBB4 
(also designated as HER4), a cell surface and epidermal growth factor receptor, is 
involved in the central nervous system through regulating GABA concentrations 
110
.  
ERBB4 has previously been associated with schizophrenia 
111
, as well as breast and 
ovarian cancers 
112, 113
.  PRDM10 (also designated as Tristanin), a zinc-finger 
transcription factor, impacts the central nervous system through dendrite initiation 
114
.  
The remaining genes have less clear functions:  PDZRN4 is involved in ubiquitin-protein 
ligase activity, OSTF1 is an osteoclast-stimulating factor, and LOH12CR1 has a loss of 
heterozygosity 
115
.   While the precise function of LOH12CR1 is not clear, it is located 
near a tumor suppressor locus that has been associated with leukemia 
116, 117
. 
There have only been two other genome-wide studies of cortisol features.  In a 
salivary cortisol AUC GWAS 
104
, an association was found with four novel SNPs 
(rs9470080, rs9394309, rs7748266, rs1360780) in the FKBP5 gene and cortisol AUC 
measured in the Rotterdam Study.  FKBP5 is located on chromosome 6.  Our analyses 
were unable to confirm associations at any of these loci.  Our p-values for the 
associations with these loci among MESA Stress Study participants for AUC range from 
0.27 to 0.91.  In the Rotterdam analysis the four FKBP5 SNPs, which are in high linkage 




AUC.  These SNPs in our GWAS had mixed directions of effect (0.02, 0.006, -0.02,        
-0.03).  In a GWAS study of morning serum cortisol measured in a group of Hutterites 
from Utah 
105
, two genome-wide significant loci were identified in women, one on 
chromosome 11 (D11S1981, p=0.000084) and the other on chromosome 14 (D14S74, 
p=0.000091).  Their genome-wide screen used a total of 891 microsatellite markers and 
412 intragenic SNPs for analysis.  The two identified loci were microsatellite markers 
and were not available in our HapMap imputed genome-wide dataset; therefore possible 
replication cannot be assessed. 
In examining genetic effects across multiple ethnic groups there are a few 
concerns.  First, differences in population structure make it difficult to compare the 
effects for single SNPs since they are likely to have differing linkage disequilibrium 
patterns with functional (unmeasured) variants underlying the association signal 
95-97
.  
Differences in allele frequencies across groups can also make individual SNP replication 
difficult, since it shifts the power to detect effects of similar size given the same alpha 
criteria 
118, 119
.  The differences in underlying genetic architecture and in allele 
frequencies across populations make it unlikely that SNPs will replicate across ethnic 
groups.  These intricacies may explain why our most significant result did not replicate in 
the other groups. 
A second concern is that complex traits like cortisol are a complex function of 
both genes and environment that differ in distribution across racial/ethnic groups 
120
.  
Given these differences, new approaches that allow for the assessment of entire genes or 




Since humans are 99% genetically similar, gene structure (exon and intron organization) 
is not likely to differ across ethnic groups.  Therefore, the overall impact of mutations 
(positive of deleterious) of a gene or gene region is the better unit of inference to compare 
across ethnic groups.  New methods such as the sequence kernel association test      
(SKAT) 
84
 have been developed to address this analytic need and will be a part of future 
studies. 
 With unique phenotype information also come limitations.  First, while the 
cortisol phenotype data itself is very rich, the restricted sample sizes when stratified by 
ethnic group specific analysis allows for limited power to detect association.  Even if a 
pooled analysis had been performed, a GWAS on ~800 individuals would be under 
powered.  Compared to other recently published GWAS studies where samples sizes are 
on the order of tens or hundreds of thousands 
121-124
, the small sample sizes for these 
analyses are unlikely to reach the standard genome-wide significance threshold   
(p<5x10
-8
).  However, the novel cortisol features measured and estimated from three 
consecutive days greatly reduces phenotypic variability compared to a single cortisol 
measurement, thus increasing power.  Additionally, the availability of these detailed 
cortisol features in a multi-ethnic sample is an unusual opportunity and allowed for a 
unique genetic epidemiology opportunity in spite of the power limitations. 
A second limitation is the use of HapMap imputed variants, which are not 
functional SNPs.  Utilizing rare-variant analyses or focusing on functional SNPs is an 
important direction for future work 
125
.  Exome and whole genome sequencing is 
revealing a greater level of rare variants than had been previously expected 
126




a variety of algorithms available which aid in the selection of functional SNPs by 
bioinformatic prediction of the impacts of different mutations on protein or mRNA 
function 
127-129
.   
Thirdly, compliance with cortisol sampling protocols is necessary for estimating 
reliable cortisol features 
79, 94
.  Compliance with taking samples at the requested times 
was greatest for wakeup (Sample 1) and bedtime (Sample 6) collections, and poorest 
during the middle of the day.  Compliance within 10 minutes of the sampling protocol 
was 68% for Sample 1, 53% for Sample 2, 57% for Sample 3, 43% for Sample 4, 44% 
for Sample 5, and 75% for Sample 6.  The deviations from protocol in the middle of the 
day would be particularly important in the estimations of CAR, AUC, EDSlope and 
LDSlope.  
For the calculation of the cortisol features, we were particularly concerned with 
compliance of Sample 2, which was designed to assess the maximum cortisol 
concentration throughout the day.  For the calculation of CAR, if Sample 2 was taken 
more than 30 minutes late (an hour or more after wakeup) it was defined as missing, 
since it would no longer be representative of the maximum cortisol concentration given 
that concentrations decrease rapidly after peaking.  
Despite the limitations, this work has a number of notable strengths.  First is the 
richness of the cortisol data.  The availability of multiple samples per day and the 
repeated cortisol measurement across three days allowed for the characterization of 
multiple cortisol features, including time of day variables, an area measure, and multiple 




ethnic population. Given that previous cortisol GWAS work has been done only in 
European populations, this work represents the first genome-wide significant finding 
among African Americans for the cortisol awakening response, as well as suggestive 
evidence in African Americans in five of the seven cortisol features.  This work also 
presents the first suggestive evidence of genetic associations in Hispanic Americans in 
four of the seven features.  With the continuous advances in genomic technologies and 
the combined consortia efforts to pool data, the GWAS presented here represent a first 







Overall, this dissertation illustrates that genetic analyses across ethnic groups can 
provide new insights into the role of genes in cortisol features and their relationship with 
chronic disease risk factors.  Chapter 3 examined the relationship between variation in six 
stress response candidate genes and features of the diurnal cortisol curve.  Chapter 4 
investigated gene-by-cortisol interactions and their associations with anthropometric, 
metabolic, and inflammatory outcomes.  Chapter 5 examined genome-wide association 
studies (GWAS) of seven cortisol features and found suggestive evidence of association 
across cortisol features and ethnic groups.  In this conclusion chapter, I review the role of 
gene-based associations, gene-by-cortisol interactions, and GWAS in better 
understanding the complex influence of stress on common chronic disease risk factors.    
 
Gene-based Association 
 Unlike GWAS studies which are hypothesis generating, candidate gene 
approaches are driven by a priori knowledge of individual genes or pathways of    
interest 
130




results in increased relative power compared to GWAS studies adjusted for multiple 
comparisons 
131
.   
We were interested in examining the relationship between six selected stress 
response candidate genes and the cortisol features.  Rather than assessing each SNP in the 
six gene regions individually, Chapter 4 of the dissertation employs a gene-based 
association approach to examine the cumulative evidence of multiple markers in a gene 
region across ethnic groups in predicting cortisol features, which was possible through 
the use of the innovative SKAT statistical methodologies 
84
.  This gene-based analytic 
approach is especially useful in investigating effects across ethnic groups as it allows us 
to address two concerns that arise in individual SNP based analyses: that individual SNPs 
may not replicate across ethnic groups due to 1) differences in underlying patterns of 
linkage disequilibrium and 2) differences in allele frequencies 
118 ,119
.   
While there are several other gene-based association methods available (e.g. 
Cohort Allelic Sum Test (CAST) 
91
, Weighted Sum Statistic (WSS) 
92
, C-alpha test 
93
), 
SKAT has several advantages.  First, SKAT is a more powerful method, even when 
sample sizes are small (n=500) 
84
, which is of particular importance given the small 
ethnic group specific sample sizes for this dissertation.  Second, SKAT allows for the 
individual variant effects to vary from mean zero in either direction, and does not assume 
that all variants have similar direction or magnitude of effect.  Thirdly, it allows for the 
adjustment of covariates.  SKAT additionally allows for the assessment of common 
variants by implementing an unweighted linear kernel, which fit our needs since we are 




In the stress response gene analyses for Chapter 4, three of the six gene regions 
had significant (p-value < 0.05) associations with cortisol features in at least one ethnic 
group: ADRA2A, ADRB2, and SLC6A4.  In the meta-analyses across the three ethnic 
groups, ADRA2A was a suggestive predictor (p-value < 0.1) of four out of the seven 
cortisol features, ADRB2 was a suggestive predictor of CAR, and SLC6A4 was a 
significant predictor (p-value < 0.05) of EDSlope.   
 There are three ways in which future gene region based work can expand upon the 
approach used in Chapter 4.  First is the expansion to other candidate genes or genomic 
regions of interest in physiological pathways.  This expanded list could include other 
genes of the HPA axis, such as FKBP5, or length polymorphisms, such as the “s” allele 
and “l” allele of SLC6A4.  There are also a number of bioinformatics tools designed to 
visualize biological pathways as a means of selecting candidate genes 
132-134
 or to select 
potentially disease related genes 
135-139
.  As the analyses presented for the gene regions in 
this dissertation were limited to common tagging SNPs, utilizing rare-variant analyses or 
focusing on functional SNPs is another important direction for future work.  There are a 
variety of algorithms available which aid in the selection of functional SNPs by 
predicting the impacts of different SNPs at a given locus 
127-129
.  
A third avenue for future studies would rely on the ability of regional analysis 
programs, such as SKAT, to incorporate multiple genes or environments into the analytic 
framework.  This option would then allow for assessing the cumulative effect of multiple 
genes in a physiologic pathway on an outcome, which may be a more reasonable 




isolation.  This integration of multiple gene regions would then also allow for the 
evaluation of epistasis, which could be operating across the different segments of the 
stress responsivity pathway.   
 The gene-based analyses presented in this dissertation are novel in their ability to 
examine the variation in multiple gene regions across ethnic groups in predicting cortisol 
features, which was possible through the use of the innovative SKAT methodologies as 
well has the unique, highly detailed cortisol phenotype information.  The gene-based 
analytic approach allowed us to address the concern that individual SNPs may not 
replicate across ethnic groups due to differences in underlying patterns of linkage 
disequilibrium or to differences in allele frequencies 
93, 132, 133
, by examining a larger 
analysis unit which is unlikely to differ across populations.  The restriction to common 
variants in these analyses is additionally a unique implementation of the SKAT 
framework.   
 
Gene-by-Environment Interaction Studies 
 Complex and chronic disease are inherently due to a mixture of genetic and 
environmental effects, which may vary across backgrounds.  As such, assessment of 
gene-by-environment interactions is of particular interest for these outcomes.  In essence, 
gene-by-environment interactions assess whether the presence of an environmental factor 
alters the relationship between a genotype and outcome, or conversely, that the genotype 
is modifying the relationship between the environment and the outcome.  In Chapter 5 of 




between cortisol features and chronic disease risk factors.  Cortisol features were the 
environmental factor, conceptualized as the internal stress environment. 
Chapter 5 of this dissertation examined the key question of whether gene-by-
cortisol interactions influence chronic disease risk factors, which was implemented using 
a two-step approach.  We first looked for evidence of gene-by-cortisol interaction by 
implementing an extension to the SKAT framework, which is a variance component 
score test that assumes the coefficients of the gene-by-environment interaction term to be 
random effects 
98
.  Since SKAT does not provide estimates of specific SNP-by-cortisol 
interaction parameters (i.e. magnitude or direction of effect) we also used traditional least 
squares regression approaches to estimate SNP-by-cortisol interaction terms when there 
was evidence of a significant gene-level interaction (interaction p-value < 0.05) in more 
than one ethnic group for a given gene-by-cortisol relationship.   
We found six stress response gene-by-cortisol interactions in multiple ethnic 
groups in predicting chronic disease outcomes: one for ln(Glucose), three for ln(IL-6 + 
1), and two for ln(TNF-α +1).  There was not significant evidence of interaction in more 
than one ethnic group in predicting average BMI.  The interaction between SLC6A4 and 
ODSlope in predicting average fasting Glucose had the most significant evidence across 
the ethnic groups, with interaction p-values ≤0.01 for African Americans and European 
Americans.  Of the SNPs in the SLC6A4 region with interaction p-values <0.05, four 
were identical across the two groups (rs2020942, rs140701, rs2066713, and rs3794808), 
and their direction of effect was consistent.  Of the remaining five instances of gene-by-




rs6580582 ) that were comparable in direction of effect (ADRB2-by-Bedtime interaction 
on ln(IL-6 + 1)), one (NR3C2-by-EDSlope on ln(IL-6 + 1)) had a single SNP 
(rs17024681) in both ethnic groups, but it varied in direction of effect, and three where 
no SNPs were consistent across the ethnic groups. 
The gene-level evidence of interaction with cortisol features for NR3C1 and 
SLC6A4 are particularly interesting.  NR3C1 is a glucocorticoid receptor that is occupied 
when cortisol concentrations are high 
36
.  This interaction indicates that when the body is 
under stress and cortisol concentrations are high, variation in NR3C1 influences the 
downstream effect these heighted cortisol levels on metabolic and inflammatory risk 
factors.  While previous work has shown that polymorphisms in the promoter region of 
SLC6A4 are associated with CAR 
62
, to my knowledge there is no published information 
on associations with a measure of overall decline (ODSlope).  As SLC6A4 is 
hypothesized to impact the stress response, the interaction between variations in the gene 
region and stress hormone levels having downstream effects on metabolism is also 
important.  Our findings that the relationship between cortisol features and chronic 
disease risk factors in some ethnic groups is influenced by variation in stress response 
genes supports the notion that variations in the HPA axis stress responsivity pathway may 
be relevant in some groups but not others in explaining variations in chronic disease 
burden.  These findings are only preliminary evidence and should be followed up by 
future work both due to the small ethnic group specific sample sizes in these interaction 




Gene-by-environment interactions can be difficult to dissect.  Given the 
underlying heterogeneity in both the genes and the environment, it can be difficult to 
isolate which variable is influencing the other.  The hypothesis for Chapter 5 was that 
polymorphisms in the stress response genes were modifying the association between 
cortisol features and chronic disease outcomes.  The results from these analyses indicate 
that we found evidence of statistical interaction, but they do not provide direct evidence 
of biological interaction.  Future stress and cortisol work should strive to understand the 
underlying biological processes of the statistical interactions identified.   
Concerns regarding the biological process through which interactions exhibit their 
effects in gene-by-environment interactions can be addressed in a variety of ways.  While 
the stress response genes for the analyses in this dissertation were selected due to their 
relationship with cortisol and the stress response, using algorithms for pathway     
analysis 
135-139
 to elucidate additional genes along the cortisol metabolic pathway or other 
pathways involved in stress response may shed light on physiologically relevant 
mechanisms.  Similarly, the evaluation of functional SNPs in the gene-based approach 
also extends to interaction studies, where the implications of differences in amino acid 
substitutions may allow for easier interpretation than the evaluation of tagging SNPs in 
non-coding regions.  Also paralleling the future directions for the gene-based analyses, 
the evidence of gene-by-cortisol interaction may encourage the future investigation of 
gene-gene interactions and epistasis in understanding the intricate relationships between 




be utilized in the evaluation of the physiological implications of any identified 
interactions (e.g. gene-by-environment, gene-gene, epistatic). 
This work makes several unique contributions to the cortisol literature.  The genes 
for this analysis were selected under the construct of HPA axis stress responsivity and 
they were tested for interaction with a biomarker of the stress response, cortisol.  To my 
knowledge, evaluation of gene interaction with the internal stress environment on 
downstream chronic disease risk factors has not previously been published.  Not only is 
each individual unique in their genetic and cortisol features, but an individual’s ability to 
respond to or cope with heightened stress as a result of activation of the stress 
responsivity pathway is likely to also be unique, and therefore may have different 
influences on chronic disease states.  Given the complex and multifaceted nature of these 
analyses, replication of the gene-by-cortisol interaction findings is necessary.  We have 
approved proposals for replication in the CARDIA Study for the gene-by-cortisol 
interaction studies of anthropometric, metabolic, and inflammatory factors. 
 
Genome-wide Association Studies of Complex Traits 
GWAS takes advantage of high throughput data to assess millions of individual 
markers, and are often hypothesis generating.  While there has been much progress in the 
GWAS field, a number of challenges remain 
140
.  For example, individual variants 
identified by GWAS only explain a small fraction of phenotype associations, and need to 
be followed up with additional analyses (e.g. sequencing data, animal models, in vitro 
studies) to confirm potentially causal associations 
141




populations using GWAS approaches can be challenging as outcome prevalence 
estimates differ across groups as do background genetic and environmental factors 
97
.  In 
order to address complex differences across ethnic groups in GWAS studies, methods for 
the consideration of genetic ancestry have been beneficial in admixed populations, such 
as African Americans and Hispanic Americans 
142-144
.  Future GWAS work in the MESA 




The power to detect genome-wide associations (p<5x10
-8
) can be a difficult 
threshold to attain.  Compared to other recently published GWAS studies where samples 
sizes are on the order of tens or hundreds of thousands 
121-124
, the GWASs in this 
dissertation are very underpowered given the small ethnic group specific sample sizes 
(maximum sample size of 454 Hispanic Americans).  However, the novel cortisol 
features measured and estimated from three consecutive days greatly reduces the 
variability compared to a single cortisol measurement, thus increasing power. 
In the analysis of complex traits, given often small sample sizes and modest effect 
estimates, replication of findings is extremely important 
153,154
.  The GWAS 
investigations in this dissertation were unable to replicate the findings of previous cortisol 
genome-wide association studies 
104,105
.  In the previous morning serum cortisol GWAS 
of 504 Hutterites in the western United States 
105
, two genome-wide significant loci were 
identified in women, one on chromosome 11 (D11S1981, p=0.000084) and the other on 
chromosome 14 (D14S74, p=0.000091).  Their genome-wide screen used a total of 891 




available in our HapMap imputed genome-wide dataset and therefore possible replication 
cannot be assessed until 1000Genomes data is available.  In the salivary cortisol AUC 
GWAS of ~1,700Europeans from the Rotterdam Study 
104
, an association was found with 
four novel SNPs (rs9470080, rs9394309, rs7748266, rs1360780) in the FKBP5 gene and 
cortisol AUC.  FKBP5 is located on chromosome 6.  Approximately 2,800 participants 
from the Whitehall II Study were available for GWAS replication.  However, none of the 
SNPs of interest from the Rotterdam sample replicated in Whitehall II.  Our analyses 
were also unable to confirm associations at any of these loci.  Our p-values for the 
associations with these loci among MESA Stress Study participants for AUC range from 
0.27 to 0.91.  In the Rotterdam analysis the four FKBP5 SNPs, which are in high linkage 
disequilibrium, have a reported estimate of effect of -0.55, corresponding to a decrease in 
AUC.  These SNPs in our GWAS had mixed directions of effect (0.02, 0.006, -0.02,        
-0.03) compared to those reported by Velders et al.  This lack of significant replication 
may be attributable to the underpowered nature of our GWAS sample or differences in 
gene and/or environmental factors. 
  Most successful GWAS center on consortia efforts, which allows for increased 
power with increasing sample size and opportunities for replication.  The Cortisol 
Network (CORNET) is a recently established cortisol consortium, which is comprised 
mainly of European individuals.  There is an agreement with the Cortisol Network 





There are also additional opportunities for replication in other ethnic groups.  We 
have an approved proposal for GWAS replication in the Coronary Artery Risk 
Development in Young Adults (CARDIA) Study, which has cortisol samples available 
for European Americans and African Americans.  While they only collected cortisol 
samples for one day, they did collect multiple samples across that day, which should 
allow for calculation of the cortisol features used in this dissertation.  Permission has also 
been obtained to perform replication in the Mid-Life in the U.S. (MIDUS) Study, which 
has salivary cortisol data available at four time points throughout the day in a sample of 
African Americans and European Americans.  There has not been a replication sample 
identified for the Hispanic Americans. 
The GWAS work presented in this dissertation makes several substantive 
contributions to the cortisol literature.  To my knowledge this is the first population-
based, multi-ethnic assessment of the role genetics plays in cortisol profiles.  Second, due 
to the detailed and repeated assessment of cortisol concentrations across multiple days 
among the MESA Stress Study participants, a range of time point, area, and slopes 
features were available for examination that have never been considered for GWAS 
studies.  The use of multiple slope features extends upon previous cortisol work which is 
typically limited to wakeup, bedtime, or cortisol awakening response variables; these 






 Two main limitations of the work presented in this dissertation, power and sample 
size, have already been addressed.  An additional limitation Previous work has shown 
that compliance with cortisol sampling protocols is necessary for estimating reliable 
cortisol features 
79, 94
.  Compliance with taking samples at the requested times was 
greatest for wakeup (Sample 1) and bedtime (Sample 6) collections, and poorest during 
the middle of the day.  Compliance within 10 minutes sampling protocol was 68% for 
Sample 1, 53% for Sample 2, 57% for Sample 3, 43% for Sample 4, 44% for Sample 5, 
and 75% for Sample 6.  The deviations from protocol in the middle of the day would be 
particularly important in the estimations of CAR, AUC, EDSlope and LDSlope.   
For the calculation of the cortisol features, there was particular concern with 
compliance of Sample 2, which was designed to assess the maximum cortisol 
concentration throughout the day.  For the calculation of CAR, if Sample 2 was taken 
more than 30 minutes late (an hour or more after wakeup) it was defined as missing, 
since it would no longer be representative of the maximum cortisol concentration given 
that concentrations decrease rapidly after peaking.  Overall, the combining of cortisol 
features across multiple days reduces the variability in cortisol feature estimation 
compared to single cortisol measurements.  Future cortisol studies need to consider 
multiple measures per day across multiple days in establishing reliable cortisol estimates. 
The MESA has already begun assessing cortisol feature reliability over time as a 
future extension of this dissertation work.  The MESA Stress Study II has recently 




concentrations were assessed eight times per day over two consecutive days.  The change 
in protocol was designed to aid in the estimation of slope features by having more 
samples taken throughout the latter portion of the day, and to improve compliance by 
reducing the burden of sample collection on participants to only two days instead of 
three.  Once these data are available it will be possible to estimate the stability of the 
cortisol profile within and across individuals over time, and the repeat assessment over 
two time points may add to feature reliability. 
 
Concluding Remarks 
 In this dissertation, cortisol was considered an embodiment of external 
experience.  An internal climate that is different across racial/ethnic groups, ages, gender, 
socioeconomic status, and chronic stress states.  Overall, this dissertation illustrates that 
genetic analyses across ethnic groups can provide new insights into the role of genes in 






Table A1: Chromosomal location of each stress response gene. 
Stress Response Gene Location 
Alpha-2A-adrenergic receptor gene (ADRA2A)  10q24-q26 
Beta-2-adrenergic receptor gene (ADRB2)  5q31-q32 
Glucocorticoid receptor gene (NR3C1) 5q31.3 
Mineralocorticoid receptor gene (NR3C2) 4q31.1 
Serotonin transporter gene (SLC6A4) 17q11.1-q12 
Tyrosine hydroxylase gene (TH)  11p5.5 
 
Table A2: Start and end positions of genes of interest, ±5kb, and over size of gene regions. 
Stress Response Gene Start Position (bp) End Position (bp) Overall Size (bases) 
ADRA2A 112,821,000 112,836,000 15,000 
ADRB2 148,181,000 148,194,000 13,000 
NR3C1 142,632,000 142,770,000 138,000 
NR3C2 149,214,000 149,589,000 375,000 
SLC6A4 25,544,000 25,592,000 48,000 
TH 2,136,000 2,155,000 19,000 
bp= Chromosomal base pair. 
Table A3: Number of SNPs with a minor allele frequency (MAF) of 5% or greater in each gene 
region for each ethnic group. 
 Number of SNPs in each gene region with MAF > 0.05 







ADRA2A 12 10 11 
ADRB2 77 52 62 
NR3C1 52 58 56 
NR3C2 358 322 327 
SLC6A4 30 22 24 




Table A4: Gene-level main effect and meta-analysis results for NR3C1. 
    SKAT MetaSKAT 
Outcome Race Q p-value p-value 
AUC AFA 1259.67 0.41   
 EA 2371.85 0.22   
 HIS 3958.20 0.32 0.31 
     
Bedtime AFA 1542.37 0.32   
  EA 1384.40 0.46   
  HIS 2938.33 0.48 0.52 
     
CAR AFA 987.60 0.51   
  EA 349.75 0.91   
  HIS 448.75 0.98 0.98 
     
EDSlope AFA 402.14 0.91   
  EA 290.52 0.94   
  HIS 5266.97 0.19 0.58 
     
LDSlope AFA 668.66 0.74   
  EA 165.66 0.98   
  HIS 6503.15 0.13 0.33 
     
ODSlope AFA 655.27 0.75   
  EA 2246.58 0.25   
  HIS 6590.86 0.13 0.18 
     
Wakeup AFA 747.40 0.69   
  EA 1964.35 0.30   





Table A5: Gene-level main effect and meta-analysis results for NR3C2. 
    SKAT MetaSKAT 
Outcome Race Q p-value p-value 
AUC AFA 7461.46 0.84   
 EA 7933.53 0.59   
 HIS 23224.90 0.39 0.66 
     
Bedtime AFA 9086.91 0.65   
  EA 12372.80 0.19   
  HIS 23331.31 0.40 0.37 
     
CAR AFA 8208.19 0.72   
  EA 9515.75 0.39   
  HIS 17985.57 0.58 0.66 
     
EDSlope AFA 6265.41 0.94   
  EA 6846.74 0.71   
  HIS 9028.81 0.99 0.99 
     
LDSlope AFA 10173.25 0.50   
  EA 9639.74 0.39   
  HIS 16030.00 0.78 0.74 
     
ODSlope AFA 8485.26 0.74   
  EA 11348.85 0.27   
  HIS 25992.34 0.30 0.37 
     
Wakeup AFA 10352.27 0.49   
  EA 8841.67 0.49   





Table A6: Gene-level main effect and meta-analysis results for TH. 
    SKAT MetaSKAT 
Outcome Race Q p-value p-value 
AUC AFA 304.63 0.66   
 EA 147.07 0.78   
 HIS 1041.61 0.35 0.64 
     
Bedtime AFA 300.57 0.67   
  EA 161.15 0.75   
  HIS 1143.65 0.31 0.56 
     
CAR AFA 318.50 0.6   
  EA 494.36 0.22   
  HIS 1274.97 0.22 0.26 
     
EDSlope AFA 882.09 0.06*   
  EA 726.70 0.12   
  HIS 329.19 0.89 0.27 
     
LDSlope AFA 809.60 0.08*   
  EA 409.65 0.31   
  HIS 428.25 0.81 0.51 
     
ODSlope AFA 342.74 0.59   
  EA 349.34 0.40   
  HIS 1412.79 0.22 0.29 
     
Wakeup AFA 284.32 0.72   
 EA 525.84 0.22   





Table A7: Individual SNP-by-Bedtime interactions in ADRB2 in predicting ln(IL-6 + 1), with an interaction p-value < 0.05, in order of 
significance by ethnic group. 
  Cortisol       Coded   SNP Effects Cortisol Effects Interaction Effects 
Outcome Feature Gene Race SNP Allele Freq B p-value B p-value B p-value 
ln(IL-6 + 1) Bedtime ADRB2 AFA rs1991795 T 0.34 0.15 0.02 0.10 0.11 -0.15 0.005 
     rs10477394 T 0.35 0.15 0.03 0.11 0.11 -0.15 0.006 
     rs10053209 G 0.44 0.16 0.02 0.09 0.16 -0.15 0.01 
     rs10463408 G 0.40 0.15 0.03 0.08 0.21 -0.14 0.01 
     rs10064479 T 0.60 0.15 0.03 0.08 0.21 -0.14 0.01 
     rs877741 T 0.40 0.15 0.03 0.08 0.22 -0.14 0.01 
     rs877743 G 0.60 0.15 0.03 0.08 0.22 -0.14 0.01 
     rs246503 G 0.14 0.25 0.03 0.02 0.65 -0.19 0.03 
     rs6580582 T 0.31 0.12 0.10 0.06 0.32 -0.12 0.03 
     rs246502 T 0.14 0.25 0.03 0.02 0.66 -0.18 0.04 
               
    HIS rs1991795 T 0.57 0.04 0.17 0.12 0.002 -0.08 0.01 
     rs10477394 T 0.57 0.04 0.15 0.12 0.002 -0.08 0.01 
     rs1347110 G 0.66 0.04 0.22 0.10 0.004 -0.07 0.02 
     rs6580582 T 0.53 0.05 0.10 0.12 0.005 -0.07 0.03 





Table A8: Individual SNP-by-Bedtime interactions in NR3C2 in predicting ln(IL-6 + 1), with an interaction p-value < 0.05, in order of significance 
by ethnic group. 
  Cortisol       Coded   SNP Effects Cortisol Effects Interaction Effects 
Outcome Feature Gene Race SNP Allele Freq B p-value B p-value B p-value 
ln(IL-6 + 1) Bedtime NR3C2 AFA rs11724292 C 0.06 0.31 0.06 0.00 0.97 -0.36 0.006 
     rs3846312 G 0.78 -0.11 0.19 -0.13 0.01 0.19 0.01 
     rs4835131 G 0.30 -0.12 0.10 -0.14 0.01 0.16 0.01 
     rs6850597 G 0.30 -0.12 0.10 -0.14 0.01 0.16 0.01 
     rs2356374 G 0.72 -0.12 0.10 -0.14 0.02 0.16 0.01 
     rs9762822 T 0.82 -0.13 0.14 -0.11 0.03 0.18 0.02 
     rs4579099 T 0.27 -0.13 0.07 -0.12 0.02 0.15 0.02 
     rs3846310 G 0.89 -0.06 0.59 -0.09 0.04 0.22 0.02 
     rs3846322 T 0.83 0.21 0.02 0.02 0.72 -0.18 0.02 
     rs7698917 T 0.81 -0.15 0.07 -0.11 0.03 0.17 0.02 
     rs3846320 G 0.88 -0.17 0.14 -0.08 0.08 0.18 0.02 
     rs13118475 T 0.28 0.06 0.39 -0.11 0.03 0.14 0.03 
     rs2883930 G 0.48 -0.14 0.06 -0.17 0.03 0.12 0.04 
     rs10018805 C 0.86 -0.21 0.05 -0.10 0.06 0.15 0.04 
               
    EA rs6535583 T 0.27 -0.09 0.17 -0.03 0.62 0.17 0.01 
     rs6857011 T 0.27 -0.09 0.17 -0.03 0.62 0.17 0.01 
     rs6856424 G 0.73 -0.09 0.17 -0.03 0.62 0.17 0.01 
     rs12499208 T 0.43 0.17 0.01 0.17 0.01 -0.15 0.01 
     rs1879827 T 0.75 0.14 0.07 0.15 0.003 -0.20 0.02 
     rs6535580 G 0.75 0.15 0.06 0.15 0.003 -0.20 0.02 




     rs10031194 T 0.25 0.15 0.06 0.15 0.003 -0.20 0.02 
     rs17483687 C 0.14 -0.10 0.22 0.03 0.51 0.17 0.03 
     rs1403142 G 0.57 0.15 0.03 0.19 0.003 -0.13 0.03 
     rs1403143 T 0.57 0.15 0.03 0.19 0.003 -0.13 0.03 
     rs12506077 T 0.57 0.15 0.03 0.19 0.003 -0.13 0.03 
     rs7693171 T 0.43 0.15 0.03 0.19 0.003 -0.13 0.03 
     rs1040288 G 0.43 0.15 0.03 0.19 0.003 -0.13 0.03 
     rs7687754 G 0.57 0.15 0.03 0.19 0.003 -0.13 0.03 
     rs7665528 G 0.57 0.15 0.03 0.19 0.003 -0.13 0.03 
     rs4835128 T 0.43 0.15 0.03 0.19 0.003 -0.13 0.03 
     rs4835488 T 0.57 0.15 0.03 0.19 0.003 -0.13 0.03 
     rs6855032 G 0.43 0.15 0.03 0.19 0.003 -0.13 0.03 
     rs1879829 T 0.56 0.02 0.79 0.20 0.002 -0.14 0.04 





Table A9: Individual SNP-by-EDSlope interactions in NR3C2 in predicting ln(IL-6 + 1), with an interaction p-value < 0.05, in order of 
significance by ethnic group. 
  Cortisol       Coded  SNP Effects Cortisol Effects Interaction Effects 
Outcome Feature Gene Race SNP Allele Freq B p-value B p-value B p-value 
ln(IL-6 + 1) EDSlope NR3C2 AFA rs1490453 G 0.62 0.22 0.0003 0.02 0.85 0.27 0.003 
     rs7688969 C 0.62 0.22 0.0005 0.04 0.73 0.26 0.004 
     rs17024681 C 0.75 0.30 2.85E-05 0.09 0.30 0.28 0.004 
              
    EA rs13109933 T 0.50 0.28 0.0006 -0.22 0.14 0.36 0.003 
     rs1996025 T 0.91 0.53 0.001 0.00 1.00 0.70 0.005 
     rs6831212 T 0.56 0.26 0.002 -0.19 0.17 0.35 0.006 
     rs1512341 T 0.56 0.26 0.002 -0.19 0.17 0.35 0.006 
     rs1512327 G 0.56 0.26 0.002 -0.19 0.17 0.35 0.006 
     rs17582031 T 0.12 -0.32 0.01 0.29 0.02 -0.47 0.01 
     rs7698307 T 0.12 -0.32 0.01 0.29 0.02 -0.47 0.01 
     rs6840422 G 0.88 -0.32 0.01 0.29 0.02 -0.47 0.01 
     rs2048546 C 0.88 -0.32 0.01 0.29 0.02 -0.47 0.01 
     rs17485033 G 0.88 -0.32 0.01 0.29 0.02 -0.47 0.01 
     rs16998733 T 0.12 -0.32 0.01 0.29 0.02 -0.47 0.01 
     rs13123626 T 0.67 -0.20 0.03 0.38 0.009 -0.33 0.02 
     rs1994624 G 0.62 -0.21 0.02 0.40 0.009 -0.33 0.02 
     rs2137331 T 0.44 0.25 0.003 -0.16 0.26 0.31 0.02 
     rs13133379 T 0.22 -0.25 0.05 0.23 0.04 -0.44 0.03 
     rs17484839 T 0.88 -0.29 0.02 0.25 0.03 -0.40 0.04 
     rs17024681 C 0.88 -0.29 0.02 0.25 0.03 -0.40 0.04 




     rs6834935 T 0.88 -0.29 0.02 0.25 0.03 -0.40 0.04 
     rs2063555 C 0.12 -0.28 0.03 0.24 0.04 -0.39 0.04 
     rs7686433 G 0.87 -0.31 0.02 0.25 0.03 -0.37 0.04 
     rs10519963 G 0.88 -0.31 0.02 0.25 0.03 -0.37 0.04 






Table A10: Individual SNP-by-Bedtime interactions in NR3C1 in predicting ln(TNF-α + 1), with an interaction p-value < 0.05, in order of 
significance by ethnic group. 
  Cortisol       Coded   SNP Effects Cortisol Effects Interaction Effects 
Outcome Feature Gene Race SNP Allele Freq B p-value B p-value B p-value 
ln(TNF-α + 1) Bedtime NR3C1 EA rs10482689 T 0.18 0.31 0.01 0.17 0.07 -0.39 0.001 
  
   
rs10482642 G 0.82 0.31 0.01 0.17 0.07 -0.39 0.001 
  
   
rs10515521 G 0.82 0.31 0.01 0.17 0.07 -0.39 0.001 
  
   
rs17339831 G 0.82 0.31 0.01 0.17 0.07 -0.39 0.001 
  
   
rs11740792 G 0.18 0.31 0.01 0.17 0.07 -0.39 0.001 
  
   
rs10482633 T 0.82 0.31 0.01 0.17 0.07 -0.39 0.001 
  
   
rs4128428 T 0.82 0.31 0.01 0.17 0.07 -0.39 0.001 
  
   
rs258750 G 0.29 0.21 0.04 0.19 0.08 -0.31 0.002 
  
   
rs190488 T 0.71 0.19 0.05 0.18 0.08 -0.30 0.003 
  
   
rs258813 G 0.71 0.19 0.05 0.18 0.08 -0.30 0.003 
  
   
rs852977 G 0.29 0.19 0.05 0.18 0.08 -0.30 0.003 
  
   
rs860457 T 0.71 0.19 0.05 0.18 0.08 -0.30 0.003 
  
   
rs852982 G 0.71 0.19 0.05 0.18 0.08 -0.30 0.003 
  
   
rs2963149 T 0.29 0.19 0.05 0.18 0.08 -0.30 0.003 
  
   
rs2918417 T 0.29 0.19 0.05 0.18 0.08 -0.30 0.003 
  
   
rs2918416 T 0.29 0.19 0.05 0.18 0.08 -0.30 0.003 
  
   
rs1866388 G 0.29 0.19 0.05 0.18 0.08 -0.30 0.004 
  
   
rs10052957 G 0.71 0.19 0.05 0.18 0.08 -0.30 0.004 
  
   
rs17287758 G 0.82 0.29 0.03 0.13 0.07 -0.34 0.008 
  




HIS rs258763 T 0.60 0.14 0.004 0.10 0.04 -0.14 0.004 
  
   





   
rs4634384 T 0.57 0.13 0.008 0.10 0.06 -0.12 0.009 
  
   
rs6877893 G 0.43 0.14 0.005 0.10 0.06 -0.12 0.009 
  
   
rs852980 G 0.42 0.13 0.006 0.10 0.06 -0.12 0.01 
  
   
rs33383 T 0.58 0.13 0.006 0.10 0.06 -0.12 0.01 
  
   
rs33388 T 0.58 0.13 0.008 0.10 0.07 -0.12 0.01 
  
   
rs10482682 T 0.28 0.07 0.22 0.06 0.14 -0.13 0.01 
  
   
rs17209237 G 0.20 0.12 0.05 0.05 0.22 -0.16 0.01 
  
   
rs17287745 G 0.31 0.09 0.10 0.07 0.13 -0.13 0.01 
  
   
rs258747 G 0.42 0.13 0.007 0.09 0.08 -0.12 0.01 
  
   
rs10482634 G 0.18 0.09 0.17 0.04 0.28 -0.16 0.02 
  
   
rs17399352 T 0.82 0.09 0.17 0.04 0.28 -0.16 0.02 
  
   
rs17209251 G 0.18 0.11 0.09 0.05 0.25 -0.16 0.02 
  
   
rs4986593 G 0.18 0.11 0.10 0.04 0.28 -0.16 0.02 
  
   
rs10482655 T 0.82 0.09 0.17 0.04 0.29 -0.16 0.02 
  
   
rs11750172 G 0.18 0.09 0.18 0.04 0.29 -0.16 0.02 
  
   
rs17339455 T 0.82 0.09 0.18 0.04 0.29 -0.16 0.02 
  
   
rs11745958 T 0.18 0.09 0.18 0.04 0.29 -0.16 0.02 
  
   
rs9324916 G 0.82 0.09 0.18 0.04 0.29 -0.16 0.02 







Table A11: Individual SNP-by-Wakeup interactions in NR3C2 in predicting ln(TNF-α + 1), with an interaction p-value < 0.05, in order of 
significance by ethnic group. 
  Cortisol       Coded   SNP Effects Cortisol Effects Interaction Effects 
Outcome Feature Gene Race SNP Allele Freq B p-value B p-value B p-value 
ln(TNF-α + 1) Wakeup NR3C2 EA rs3843410 T 0.76 1.22 0.006 0.01 0.92 -0.42 0.01 
  
   
rs4835491 G 0.76 1.18 0.007 0.01 0.94 -0.41 0.01 
  
   
rs12499208 T 0.43 0.82 0.006 0.08 0.50 -0.28 0.01 
  
   
rs1403142 G 0.57 0.80 0.008 0.07 0.55 -0.27 0.02 
  
   
rs1403143 T 0.57 0.80 0.008 0.07 0.55 -0.27 0.02 
  
   
rs12506077 T 0.57 0.80 0.008 0.07 0.55 -0.27 0.02 
  
   
rs7693171 T 0.43 0.80 0.008 0.07 0.55 -0.27 0.02 
  
   
rs1040288 G 0.43 0.80 0.008 0.07 0.55 -0.27 0.02 
  
   
rs7687754 G 0.57 0.80 0.008 0.07 0.55 -0.27 0.02 
  
   
rs7665528 G 0.57 0.80 0.008 0.07 0.55 -0.27 0.02 
  
   
rs4835128 T 0.43 0.80 0.008 0.07 0.55 -0.27 0.02 
  
   
rs4835488 T 0.57 0.80 0.008 0.07 0.55 -0.27 0.02 
  
   
rs6855032 G 0.43 0.80 0.008 0.07 0.55 -0.27 0.02 
  
   
rs10050229 G 0.33 -0.55 0.08 -0.31 0.006 0.28 0.02 
  
   
rs4835493 T 0.23 0.98 0.03 0.02 0.83 -0.36 0.03 
  
   
rs2272089 T 0.78 1.06 0.02 -0.02 0.82 -0.37 0.03 
  
   
rs6844155 G 0.78 1.06 0.02 -0.02 0.82 -0.37 0.03 
  
   
rs7694064 G 0.78 1.06 0.02 -0.02 0.82 -0.37 0.03 
  
   
rs7694200 G 0.78 1.06 0.02 -0.02 0.82 -0.37 0.03 
  
   
rs7694706 G 0.22 1.06 0.02 -0.02 0.82 -0.37 0.03 
  
   
rs3843411 T 0.23 0.97 0.03 0.01 0.93 -0.35 0.03 
  
   









HIS rs3916013 T 0.89 0.69 0.02 -0.02 0.76 -0.30 0.01 
  
   
rs13116347 G 0.11 0.43 0.07 0.001 0.99 -0.24 0.01 
  
   
rs2356374 G 0.94 0.64 0.09 -0.05 0.35 -0.35 0.02 
  
   
rs6850597 G 0.06 0.63 0.09 -0.04 0.38 -0.34 0.02 
  
   
rs17484357 G 0.12 0.56 0.03 -0.006 0.91 -0.23 0.03 
  
   
rs7691250 G 0.12 0.53 0.04 -0.008 0.89 -0.23 0.03 
  
   
rs10010766 T 0.40 0.40 0.03 0.07 0.41 -0.16 0.03 
  
   
rs4579099 T 0.06 0.61 0.13 -0.05 0.33 -0.33 0.04 




Table A12: Two degree of freedom test of individual SNP-by-Bedtime interactions in predicting ln(IL-6 + 1).  SNPs ordered by significance in the 
additive model for the individual SNP-by-Bedtime interactions in Table A7. 
  Cortisol       Coded   Minor  SNP Effects Interaction Effects 
Outcome Feature Gene Race SNP Allele Freq Alleles B p-value B p-value 
ln(IL-6 + 1) Bedtime ADRB2 AFA rs1991795 T 0.34 1 0.15 0.21 -0.13 0.19 
  
      
2 0.29 0.03 -0.31 0.005 
  
   
rs10477394 T 0.35 1 0.15 0.20 -0.15 0.13 
  
      
2 0.30 0.03 -0.31 0.006 
  
   
rs10053209 G 0.44 1 0.20 0.09 -0.16 0.10 
  
      
2 0.31 0.03 -0.30 0.01 
  
   
rs10463408 G 0.40 1 0.17 0.14 -0.14 0.14 
  
      
2 0.28 0.05 -0.28 0.02 
  
   
rs10064479 T 0.60 1 0.17 0.14 -0.14 0.14 
  
      
2 0.28 0.05 -0.28 0.02 
  
   
rs877741 T 0.40 1 0.17 0.14 -0.14 0.15 
  
      
2 0.28 0.05 -0.28 0.02 
  
   
rs877743 G 0.60 1 0.17 0.14 -0.14 0.15 
  
      
2 0.28 0.05 -0.28 0.02 
  
   
rs246503 G 0.14 1 0.25 0.02 -0.18 0.04 
  
      
2 -0.44 0.91 0.20 0.94 
  
   
rs6580582 T 0.31 1 0.05 0.67 -0.04 0.70 
  
      
2 0.27 0.10 -0.27 0.02 
  
   
rs246502 T 0.14 1 0.25 0.02 -0.18 0.05 
  
      
2 -0.44 0.91 0.20 0.94 
  
   
rs17108773 G 0.42 1 -0.08 0.48 0.09 0.35 
  
      









HIS rs1991795 T 0.57 1 0.04 0.50 -0.10 0.06 
  
      
2 0.09 0.15 -0.15 0.02 
  
   
rs10477394 T 0.57 1 0.04 0.47 -0.10 0.06 
  
      
2 0.09 0.13 -0.15 0.02 
  
   
rs1347110 G 0.66 1 0.02 0.70 -0.08 0.11 
  
      
2 0.09 0.16 -0.14 0.05 
  
   
rs6580582 T 0.53 1 0.05 0.36 -0.09 0.16 
  
      
2 0.10 0.10 -0.15 0.02 
  
   
rs30297 G 0.92 1 0.01 0.93 0.06 0.02 
  
      
2 0.01 1E-05 -0.20 0.03 
  
   
rs17778143 T 0.65 1 0.02 0.74 -0.07 0.18 
  
      
2 0.09 0.16 -0.12 0.07 
  
   
rs11742884 T 0.66 1 0.02 0.74 -0.07 0.18 






Table A13: Two degree of freedom test of individual SNP-by-Bedtime interactions in predicting ln(IL-6 + 1).  SNPs ordered by significance in the 
additive model for the individual SNP-by-Bedtime interactions in Table A8. 
  Cortisol       Coded   Minor SNP Effects Interaction Effects 
Outcome Feature Gene Race SNP Allele Freq Alleles B p-value B p-value 
lm(IL-6 + 1) Bedtime NR3C2 AFA rs11724292 C 0.06 1 0.31 0.06 0.002 0.97 
  
      
2 0.01 0.02 -0.36 0.006 
  
   
rs3846312 G 0.78 1 -0.20 0.07 0.26 0.004 
  
      
2 -0.05 0.83 0.21 0.34 
  
   
rs4835131 G 0.30 1 -0.11 0.32 0.17 0.06 
  
      
2 -0.24 0.13 0.30 0.03 
  
   
rs6850597 G 0.30 1 -0.11 0.32 0.17 0.06 
  
      
2 -0.24 0.13 0.30 0.03 
  
   
rs2356374 G 0.72 1 -0.10 0.35 0.15 0.09 
  
      
2 -0.25 0.12 0.32 0.03 
  
   
rs9762822 T 0.82 1 -0.20 0.08 0.26 0.00 
  
      
2 -0.05 0.82 -0.27 0.38 
  
   
rs4579099 T 0.27 1 -0.12 0.27 0.14 0.12 
  
      
2 -0.27 0.09 0.30 0.04 
  
   
rs3846310 G 0.89 1 -0.11 0.37 0.25 0.01 
  
      
2 2.27 0.11 -4.57 0.15 
  
   
rs3846322 T 0.83 1 0.21 0.07 -0.20 0.05 
  
      
2 0.46 0.06 -0.22 0.44 
  
   
rs7698917 T 0.81 1 -0.26 0.02 0.25 0.01 
  
      
2 -0.05 0.81 0.00 0.99 
  
   
rs3846320 G 0.88 1 -0.15 0.29 0.14 0.26 
  
      





   
rs13118475 T 0.28 1 0.16 0.15 0.07 0.42 
  
      
2 0.05 0.74 0.31 0.03 
  
   
rs2883930 G 0.48 1 -0.13 0.29 0.15 0.15 
  
      
2 -0.29 0.06 0.25 0.04 
  
   
rs10018805 C 0.86 1 -0.17 0.14 0.07 0.44 
  
      
2 -0.03 0.98 0.29 0.46 
  
   
rs4835133 G 0.19 1 0.14 0.23 -0.15 0.12 
  
      
2 0.45 0.08 -0.22 0.45 
  




EA rs6535583 T 0.27 1 -0.21 0.03 0.30 0.0009 
  
      
2 -0.11 0.42 0.21 0.17 
  
   
rs6857011 T 0.27 1 -0.21 0.03 0.30 0.0009 
  
      
2 -0.11 0.42 0.21 0.17 
  
   
rs6856424 G 0.73 1 -0.21 0.03 0.30 0.00 
  
      
2 -0.11 0.42 0.21 0.17 
  
   
rs12499208 T 0.43 1 0.10 0.31 -0.12 0.19 
  
      
2 0.37 0.008 -0.32 0.01 
  
   
rs1879827 T 0.75 1 0.12 0.27 -0.20 0.04 
  
      
2 0.30 0.17 -0.37 0.18 
  
   
rs6535580 G 0.75 1 0.12 0.26 -0.19 0.05 
  
      
2 0.31 0.17 -0.37 0.19 
  
   
rs6535581 G 0.75 1 0.12 0.26 -0.19 0.05 
  
      
2 0.31 0.17 -0.37 0.19 
  
   
rs10031194 T 0.25 1 0.12 0.26 -0.19 0.05 
  
      
2 0.31 0.17 -0.37 0.19 
  
   
rs17483687 C 0.14 1 -0.20 0.06 0.21 0.03 
  
      





   
rs1403142 G 0.57 1 0.05 0.58 -0.04 0.65 
  
      
2 0.37 0.01 -0.32 0.01 
  
   
rs1403143 T 0.57 1 0.05 0.58 -0.04 0.65 
  
      
2 0.37 0.01 -0.32 0.01 
  
   
rs12506077 T 0.57 1 0.05 0.58 -0.04 0.65 
  
      
2 0.37 0.01 -0.32 0.01 
  
   
rs7693171 T 0.43 1 0.05 0.58 -0.04 0.65 
  
      
2 0.37 0.01 -0.32 0.01 
  
   
rs1040288 G 0.43 1 0.05 0.58 -0.04 0.65 
  
      
2 0.37 0.01 -0.32 0.01 
  
   
rs7687754 G 0.57 1 0.05 0.58 -0.04 0.65 
  
      
2 0.37 0.01 -0.32 0.01 
  
   
rs7665528 G 0.57 1 0.05 0.58 -0.04 0.65 
  
      
2 0.37 0.01 -0.32 0.01 
  
   
rs4835128 T 0.43 1 0.05 0.58 -0.04 0.65 
  
      
2 0.37 0.01 -0.32 0.01 
  
   
rs4835488 T 0.57 1 0.05 0.58 -0.04 0.65 
  
      
2 0.37 0.01 -0.32 0.01 
  
   
rs6855032 G 0.43 1 0.05 0.58 -0.04 0.65 
  
      
2 0.37 0.01 -0.32 0.01 
  
   
rs1879829 T 0.56 1 -0.10 0.32 -0.05 0.56 
  
      
2 0.12 0.40 -0.37 0.01 
  
   
rs2293162 T 0.06 1 0.28 0.07 0.12 0.009 
  
      
2 0.01 0.02 -0.29 0.04 
  
   
rs1879828 T 0.45 1 -0.09 0.36 -0.06 0.53 





Table A14: Two degree of freedom test of individual SNP-by-EDSlope interactions in predicting ln(IL-6 + 1).  SNPs ordered by significance in 
the additive model for the individual SNP-by-Bedtime interactions in Table A9. 
  Cortisol       Coded   Minor SNP Effects Interaction Effects 
Outcome Feature Gene Race SNP Allele Freq Alleles B p-value B p-value 
ln(IL-6 + 1) EDSlope NR3C2 AFA rs1490453 G 0.62 1 0.24 0.009 0.24 0.11 
  
      
2 0.43 0.001 0.53 0.005 
  
   
rs7688969 C 0.62 1 0.23 0.01 0.26 0.09 
  
      
2 0.42 0.001 0.52 0.005 
  
   
rs17024681 C 0.75 1 0.23 0.007 0.29 0.04 
  
      
2 0.84 4.8E-05 0.76 0.002 
  




CAU rs13109933 T 0.50 1 0.38 0.007 0.24 0.26 
  
      
2 0.56 0.0005 0.72 0.003 
  
   
rs1996025 T 0.91 1 0.53 0.001 -0.0004 1.00 
  
      
2 0.01 0.002 0.70 0.005 
  
   
rs6831212 T 0.56 1 0.45 0.001 0.47 0.02 
  
      
2 0.51 0.003 0.72 0.005 
  
   
rs1512341 T 0.56 1 0.45 0.001 0.47 0.02 
  
      
2 0.51 0.003 0.72 0.005 
  
   
rs1512327 G 0.56 1 0.45 0.001 0.47 0.02 
  
      
2 0.51 0.003 0.72 0.005 
  
   
rs17582031 T 0.12 1 -0.33 0.013 0.29 0.02 
  
      
2 -0.20 0.63 -0.47 0.01 
  
   
rs7698307 T 0.12 1 -0.33 0.01 0.29 0.02 
  
      
2 -0.20 0.63 -0.47 0.01 
  
   





      
2 -0.20 0.63 -0.47 0.01 
  
   
rs2048546 C 0.88 1 -0.33 0.01 0.29 0.02 
  
      
2 -0.20 0.63 -0.47 0.01 
  
   
rs17485033 G 0.88 1 -0.33 0.01 0.29 0.02 
  
      
2 -0.20 0.63 -0.47 0.01 
  
   
rs16998733 T 0.12 1 -0.33 0.01 0.29 0.02 
  
      
2 -0.20 0.63 -0.47 0.01 
  
   
rs13123626 T 0.67 1 -0.20 0.12 -0.41 0.05 
  
      
2 -0.45 0.03 -0.66 0.03 
  
   
rs1994624 G 0.62 1 -0.20 0.12 -0.38 0.07 
  
      
2 -0.45 0.03 -0.69 0.02 
  
   
rs2137331 T 0.44 1 0.41 0.003 0.34 0.10 
  
      
2 0.50 0.003 0.66 0.01 
  
   
rs13133379 T 0.22 1 -0.26 0.12 -0.44 0.06 
  
      
2 -0.48 0.27 -0.77 0.59 
  
   
rs17484839 T 0.88 1 -0.30 0.03 0.25 0.03 
  
      
2 -0.20 0.64 -0.41 0.04 
  
   
rs17024681 C 0.88 1 -0.30 0.03 0.25 0.03 
  
      
2 -0.20 0.64 -0.41 0.04 
  
   
rs17484873 T 0.89 1 -0.30 0.03 0.25 0.03 
  
      
2 -0.20 0.64 -0.41 0.04 
  
   
rs6834935 T 0.88 1 -0.30 0.03 0.25 0.03 
  
      
2 -0.20 0.64 -0.41 0.04 
  
   
rs2063555 C 0.12 1 -0.29 0.03 0.24 0.04 
  
      
2 -0.19 0.65 -0.40 0.04 
  
   





      
2 0.006 0.99 0.57 0.59 
  
   
rs10519963 G 0.88 1 -0.33 0.01 -0.47 0.02 
  
      
2 0.006 0.99 0.57 0.59 
  
   
rs17484783 T 0.88 1 -0.33 0.01 -0.47 0.02 




Table A15: Two degree of freedom test of individual SNP-by-Bedtime interactions in predicting ln(TNF-α + 1).  SNPs ordered by significance in 
the additive model for the individual SNP-by-Bedtime interactions in Table A10. 
  Cortisol       Coded   Minor SNP Effects Interaction Effects 
Outcome Feature Gene Race SNP Allele Freq Alleles B p-value B p-value 
ln(TNF-α + 1) Bedtime NR3C1 EA rs10482689 T 0.18 1 0.28 0.04 -0.39 0.001 
  
      
2 -0.80 0.68 1.55 0.59 
  
   
rs10482642 G 0.82 1 0.28 0.04 -0.39 0.001 
  
      
2 -0.80 0.68 1.55 0.59 
  
   
rs10515521 G 0.82 1 0.28 0.04 -0.39 0.001 
  
      
2 -0.80 0.68 1.55 0.59 
  
   
rs17339831 G 0.82 1 0.28 0.04 -0.39 0.001 
  
      
2 -0.80 0.68 1.55 0.59 
  
   
rs11740792 G 0.18 1 0.28 0.04 -0.39 0.001 
  
      
2 -0.80 0.68 1.55 0.59 
  
   
rs10482633 T 0.82 1 0.28 0.04 -0.39 0.001 
  
      
2 -0.80 0.68 1.55 0.59 
  
   
rs4128428 T 0.82 1 0.28 0.04 -0.39 0.001 
  
      
2 -0.80 0.68 1.55 0.59 
  
   
rs258750 G 0.29 1 0.33 0.02 -0.35 0.004 
  
      
2 0.29 0.24 -0.63 0.04 
  
   
rs190488 T 0.71 1 0.31 0.03 -0.33 0.006 
  
      
2 0.28 0.26 -0.62 0.04 
  
   
rs258813 G 0.71 1 0.31 0.03 -0.33 0.006 
  
      
2 0.28 0.26 -0.62 0.04 
  
   
rs852977 G 0.29 1 0.31 0.03 -0.33 0.006 
  
      





   
rs860457 T 0.71 1 0.31 0.03 -0.33 0.006 
  
      
2 0.28 0.26 -0.62 0.04 
  
   
rs852982 G 0.71 1 0.31 0.03 -0.33 0.006 
  
      
2 0.28 0.26 -0.62 0.04 
  
   
rs2963149 T 0.29 1 0.31 0.03 -0.33 0.006 
  
      
2 0.28 0.26 -0.62 0.04 
  
   
rs2918417 T 0.29 1 0.31 0.03 -0.33 0.006 
  
      
2 0.28 0.26 -0.62 0.04 
  
   
rs2918416 T 0.29 1 0.31 0.03 -0.33 0.006 
  
      
2 0.28 0.26 -0.62 0.04 
  
   
rs1866388 G 0.29 1 0.30 0.03 -0.35 0.005 
  
      
2 0.26 0.30 -0.54 0.11 
  
   
rs10052957 G 0.71 1 0.30 0.03 -0.35 0.005 
  
      
2 0.26 0.30 -0.54 0.11 
  
   
rs17287758 G 0.82 1 0.24 0.08 -0.34 0.008 
  
      
2 2.23 0.62 -2.59 0.68 
  




HIS rs258763 T 0.60 1 0.18 0.01 -0.14 0.06 
  
      
2 0.26 0.01 -0.26 0.007 
  
   
rs10041520 T 0.42 1 0.16 0.02 -0.10 0.20 
  
      
2 0.24 0.02 -0.25 0.01 
  
   
rs4634384 T 0.57 1 0.16 0.02 -0.10 0.20 
  
      
2 0.24 0.02 -0.25 0.01 
  
   
rs6877893 G 0.43 1 0.18 0.01 -0.09 0.21 
  
      
2 0.25 0.01 -0.25 0.01 
  
   





      
2 0.25 0.02 -0.24 0.01 
  
   
rs33383 T 0.58 1 0.17 0.02 -0.09 0.23 
  
      
2 0.25 0.02 -0.24 0.01 
  
   
rs33388 T 0.58 1 0.16 0.02 -0.11 0.15 
  
      
2 0.24 0.02 -0.24 0.01 
  
   
rs10482682 T 0.28 1 0.09 0.16 -0.14 0.05 
  
      
2 0.06 0.65 -0.21 0.08 
  
   
rs17209237 G 0.20 1 0.15 0.03 -0.13 0.07 
  
      
2 0.09 0.73 -0.34 0.21 
  
   
rs17287745 G 0.31 1 0.12 0.07 -0.13 0.07 
  
      
2 0.10 0.46 -0.22 0.07 
  
   
rs258747 G 0.42 1 0.17 0.02 -0.11 0.15 
  
      
2 0.24 0.02 -0.23 0.02 
  
   
rs10482634 G 0.18 1 0.11 0.10 -0.14 0.07 
  
      
2 0.01 0.97 -0.29 0.29 
  
   
rs17399352 T 0.82 1 0.11 0.10 -0.14 0.07 
  
      
2 0.01 0.97 -0.29 0.29 
  
   
rs17209251 G 0.18 1 0.14 0.05 -0.13 0.07 
  
      
2 0.02 0.95 -0.30 0.29 
  
   
rs4986593 G 0.18 1 0.14 0.05 -0.13 0.09 
  
      
2 0.02 0.95 -0.29 0.29 
  
   
rs10482655 T 0.82 1 0.12 0.10 -0.14 0.08 
  
      
2 0.01 0.97 -0.29 0.29 
  
   
rs11750172 G 0.18 1 0.11 0.10 -0.13 0.08 
  
      
2 0.01 0.97 -0.29 0.29 
  
   





      
2 0.01 0.97 -0.29 0.29 
  
   
rs11745958 T 0.18 1 0.11 0.10 -0.13 0.08 
  
      
2 0.01 0.97 -0.29 0.29 
  
   
rs9324916 G 0.82 1 0.11 0.10 -0.13 0.08 
  
      
2 0.01 0.97 -0.29 0.29 
  
   
rs17209258 G 0.17 1 0.13 0.07 -0.13 0.10 





Table A16: Two degree of freedom test of individual SNP-by-Bedtime interactions in predicting ln(TNF-α + 1).  SNPs ordered by significance in 
the additive model for the individual SNP-by-Bedtime interactions in Table A12. 
  Cortisol       Coded   Minor SNP Effects Interaction Effects 
Outcome Feature Gene Race SNP Allele Freq Alleles B p-value B p-value 
ln(TNF-α + 1) Wakeup NR3C2 EA rs3843410 T 0.76 1 1.53 0.002 -0.54 0.004 
  
      
2 0.14 0.94 -0.02 0.97 
  
   
rs4835491 G 0.76 1 1.39 0.006 -0.48 0.01 
  
      
2 0.97 0.56 -0.34 0.56 
  
   
rs12499208 T 0.43 1 0.60 0.21 -0.22 0.23 
  
      
2 1.74 0.006 -0.59 0.01 
  
   
rs1403142 G 0.57 1 0.54 0.26 -0.19 0.29 
  
      
2 1.72 0.007 -0.58 0.02 
  
   
rs1403143 T 0.57 1 0.54 0.26 -0.19 0.29 
  
      
2 1.72 0.007 -0.58 0.02 
  
   
rs12506077 T 0.57 1 0.54 0.26 -0.19 0.29 
  
      
2 1.72 0.007 -0.58 0.02 
  
   
rs7693171 T 0.43 1 0.54 0.26 -0.19 0.29 
  
      
2 1.72 0.007 -0.58 0.02 
  
   
rs1040288 G 0.43 1 0.54 0.26 -0.19 0.29 
  
      
2 1.72 0.007 -0.58 0.02 
  
   
rs7687754 G 0.57 1 0.54 0.26 -0.19 0.29 
  
      
2 1.72 0.007 -0.58 0.02 
  
   
rs7665528 G 0.57 1 0.54 0.26 -0.19 0.29 
  
      
2 1.72 0.007 -0.58 0.02 
  
   
rs4835128 T 0.43 1 0.54 0.26 -0.19 0.29 
  
      





   
rs4835488 T 0.57 1 0.54 0.26 -0.19 0.29 
  
      
2 1.72 0.007 -0.58 0.02 
  
   
rs6855032 G 0.43 1 0.54 0.26 -0.19 0.29 
  
      
2 1.72 0.007 -0.58 0.02 
  
   
rs10050229 G 0.33 1 -0.69 0.15 0.33 0.07 
  
      
2 -1.02 0.15 0.54 0.05 
  
   
rs4835493 T 0.23 1 1.10 0.02 -0.40 0.02 
  
      
2 0.16 0.94 -0.13 0.86 
  
   
rs2272089 T 0.78 1 1.39 0.007 -0.50 0.01 
  
      
2 -0.29 0.88 0.15 0.83 
  
   
rs6844155 G 0.78 1 1.39 0.007 -0.50 0.01 
  
      
2 -0.29 0.88 0.15 0.83 
  
   
rs7694064 G 0.78 1 1.39 0.007 -0.50 0.01 
  
      
2 -0.29 0.88 0.15 0.83 
  
   
rs7694200 G 0.78 1 1.39 0.007 -0.50 0.01 
  
      
2 -0.29 0.88 0.15 0.83 
  
   
rs7694706 G 0.22 1 1.39 0.007 -0.50 0.01 
  
      
2 -0.29 0.88 0.15 0.83 
  
   
rs3843411 T 0.23 1 1.09 0.02 -0.38 0.03 
  
      
2 0.14 0.95 -0.12 0.87 
  
   
rs3857079 T 0.70 1 1.12 0.02 -0.38 0.04 
  
      
2 0.34 0.82 -0.14 0.78 
  




HIS rs3916013 T 0.89 1 0.81 0.009 -0.34 0.007 
  
      
2 -0.02 0.99 -0.06 0.94 
  
   





      
2 0.79 0.60 -0.57 0.32 
  
   
rs2356374 G 0.94 1 0.81 0.08 -0.45 0.03 
  
      
2 3.57 0.15 -1.37 0.10 
  
   
rs6850597 G 0.06 1 0.74 0.10 -0.41 0.03 
  
      
2 3.57 0.15 -1.37 0.10 
  
   
rs17484357 G 0.12 1 0.65 0.02 -0.26 0.02 
  
      
2 0.53 0.80 -0.39 0.72 
  
   
rs7691250 G 0.12 1 0.61 0.02 -0.25 0.02 
  
      
2 0.52 0.81 -0.38 0.73 
  
   
rs10010766 T 0.40 1 0.33 0.25 -0.12 0.31 
  
      
2 0.81 0.03 -0.34 0.03 
  
   
rs4579099 T 0.06 1 0.76 0.12 -0.43 0.05 
  
      
2 3.57 0.15 -1.36 0.10 
  
   
rs4835131 G 0.06 1 0.61 0.17 -0.34 0.07 





Figure A1: LocusZoom plot of the association between loci of the ADRA2A gene region among 
European Americans in predicting AUC. 
 
 
Figure A2: LocusZoom plot of the association between loci of the ADRA2A gene region among 










Figure A3: LocusZoom plot of the association between loci of the ADRA2A gene region among 
Hispanic Americans in predicting Bedtime. 
Figure A4: LocusZoom plot of the association between loci of the ADRA2A gene region among 








Figure A5: LocusZoom plot of the association between loci of the ADRA2A gene region among 
European Americans in predicting EDSlope. 
 
Figure A6: LocusZoom plot of the association between loci of the ADRB2 gene region among  








Figure A7: LocusZoom plot of the association between loci of the ADRB2 gene region among 
European Americans in predicting CAR. 
 
Figure A8: LocusZoom plot of the association between loci of the ADRB2 gene region among 









Figure A9: LocusZoom plot of the association between loci of the SLC6A4 gene region among 
European Americans in predicting CAR. 
Figure A10: LocusZoom plot of the association between loci of the TH gene region among 






Figure A11: LocusZoom plot of the association between loci of the TH gene region among 




























Figure A15: LocusZoom plot of the interaction between loci of the ADRB2 gene region and 
Bedtime among African Americans in predicting ln(IL-6 + 1). 
 
 
Figure A16: LocusZoom plot of the interaction between loci of the ADRB2 gene region and 






Figure A17: LocusZoom plot of the interaction between loci of the NR3C2 gene region and 
Bedtime among African Americans in predicting ln(IL-6 + 1). 
 
 
Figure A18: LocusZoom plot of the interaction between loci of the NR3C2 gene region and 






Figure A19: LocusZoom plot of the interaction between loci of the NR3C2 gene region and 
EDSlope among African Americans in predicting ln(IL-6 + 1). 
 
 
Figure A20: LocusZoom plot of the interaction between loci of the NR3C2 gene region and 






Figure A21: LocusZoom plot of the interaction between loci of the NR3C1 gene region and 
Bedtime among European Americans in predicting ln(TNF-α + 1). 
 
 
Figure A22: LocusZoom plot of the interaction between loci of the NR3C1 gene region and 






Figure A23: LocusZoom plot of the interaction between loci of the NR3C2 gene region and 






Figure A24: Quantile-Quantile plot of the observed and expected p-values for associations with 
AUC among European Americans. 
 
  
Figure A25: Quantile-Quantile plot of the observed and expected p-values for associations with 





Figure A26: Quantile-Quantile plot of the observed and expected p-values for associations with 
CAR among European Americans. 
 
Figure A27: Quantile-Quantile plot of the observed and expected p-values for associations with 





Figure A28: Quantile-Quantile plot of the observed and expected p-values for associations with 
LDSlope among European Americans. 
 
Figure A29: Quantile-Quantile plot of the observed and expected p-values for associations with 





Figure A30: Quantile-Quantile plot of the observed and expected p-values for associations with 
Wakeup among European Americans. 
 
Figure A31: Quantile-Quantile plot of the observed and expected p-values for associations with 





Figure A32: Quantile-Quantile plot of the observed and expected p-values for associations with 
Bedtime among African Americans. 
 
Figure A33: Quantile-Quantile plot of the observed and expected p-values for associations with 








Figure A34: Quantile-Quantile plot of the observed and expected p-values for associations with 
EDSlope among African Americans. 
 
Figure A35: Quantile-Quantile plot of the observed and expected p-values for associations with 





Figure A36: Quantile-Quantile plot of the observed and expected p-values for associations with 
ODSlope among African Americans. 
 
Figure A37: Quantile-Quantile plot of the observed and expected p-values for associations with 





Figure A38: Quantile-Quantile plot of the observed and expected p-values for associations with 
AUC among Hispanic Americans. 
 
Figure A39: Quantile-Quantile plot of the observed and expected p-values for associations with 





Figure A40: Quantile-Quantile plot of the observed and expected p-values for associations with 
CAR among Hispanic Americans. 
 
Figure A41: Quantile-Quantile plot of the observed and expected p-values for associations with 





Figure A42: Quantile-Quantile plot of the observed and expected p-values for associations with 
LDSlope among Hispanic Americans. 
 
Figure A43: Quantile-Quantile plot of the observed and expected p-values for associations with 





Figure A44: Quantile-Quantile plot of the observed and expected p-values for associations with 







Figure A45: GWAS results for Wakeup.  Analyses were run separately for African Americans 
(AFA), European Americans (EA), and Hispanic Americans (HIS).  Individual SNP p-values 
located above the blue line are suggestive of genome-wide significance –log10(p<1x10
-6












Figure A46: GWAS results for Bedtime.  Analyses were run separately for African Americans 
(AFA), European Americans (EA), and Hispanic Americans (HIS).  Individual SNP p-values 
located above the blue line are suggestive of genome-wide significance –log10(p<1x10
-6











Figure A47: GWAS results for cortisol awakening response (CAR).  Analyses were run 
separately for African Americans (AFA), European Americans (EA), and Hispanic Americans 
(HIS).  Individual SNP p-values located above the blue line are suggestive of genome-wide 
significance –log10(p<1x10
-6
).  Individual SNP p-values located above the red line have reached 












Figure A48: GWAS results for Area under the Curve (AUC).   Analyses were run separately for 
African Americans (AFA), European Americans (EA), and Hispanic Americans (HIS).  
Individual SNP p-values located above the blue line are suggestive of genome-wide significance 
–log10(p<1x10
-6











Figure A49: GWAS results for Early Decline Slope (EDSlope).   Analyses were run separately 
for African Americans (AFA), European Americans (EA), and Hispanic Americans (HIS).  
Individual SNP p-values located above the blue line are suggestive of genome-wide significance 
–log10(p<1x10
-6










Figure A50: GWAS results for Late Decline Slope (LDSlope).  Analyses were run separately for 
African Americans (AFA), European Americans (EA), and Hispanic Americans (HIS).  
Individual SNP p-values located above the blue line are suggestive of genome-wide significance 
–log10(p<1x10
-6










Figure A51: GWAS results for Overall Decline Slope (ODSlope).   Analyses were run separately 
for African Americans (AFA), European Americans (EA), and Hispanic Americans (HIS).  
Individual SNP p-values located above the blue line are suggestive of genome-wide significance 
–log10(p<1x10
-6
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